incivo is used to treat the virus that causes hepatitis c infection . inciva is used for the treatment of chronic hepatis  c disease in adults aged 1865 years and older : - with peginterferon alfa - 2b , ribavirin and telaprevir . these belong to a group of medicines called ns3 - 4a protease inhibitors . the nns 3 - 5a proteotide inhibitor ( a type of heptis
do not take incivo if you are allergic to telaprevir or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor or pharmacist before taking inciva . if your doctor has prescribed peginterferon alfa and ribavirin as separate tablets , consult your doctor . warnings and precautions pregnancy precautions : incive is based on the results of studies on male fertility with pegInterferon Alfa in combination with ribbavirine . please also read the package leaflets of the following medicines which may increase the risk of severe side effects . talk to your doctor before taking 56 the medicine alfuzosin if : you have symptoms of an enlarged prostate . you are taking alpha - 1 - adrenoreceptor antagonists ( 
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will determine the appropriate dose regimen for you based on your condition . the recommended dose regimen is 3 to 8 mg per day taken as 3 capsules in the morning , followed by 6 capsules at the evening . this is followed by 2 capsules of 8 capsules per day , taken 6 times per day in both hepatitis c virus infection and human immunodeficiency virus infection . efavirenz is recommended for you as the recommended dosage regimen is : 3 capsule of 8 mg , once per day by your body . you should take incivo within 60 minutes of a meal . do not swallow the capsules . for children , incivoc can be taken with or without food . use in children dosing in children whose body
like all medicines , this medicine can cause side effects , although not everybody gets them . rash may be accompanied by an itchy skin rash . the rash should be treated immediately after the onset of the rashes . other symptoms may also be present at the site of the reaction . in case of a severe skin reaction , tell your doctor immediately . you may also develop a skin rae . tell your physician immediately if you develop , or develop : a rash and contact your doctor or seek medical advice immediately , as your rash might be caused by other symptoms that may be associated with a sudden onset : fever , tiredness , swelling of the face , and swelling of lymph glands . there is a wide - spread rash with peeling skin , fever ; flu - like symptoms , painful skin swolle
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after " exp ". the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . incivo tablets should be stored in the original bottle and keep the bottle tightly closed in order to protect from moisture . tell your pharmacist if you notice any change in the appearance of the tablets . the bottle contains a desiccant .
what incivo contains the active substance is telaprevir . each tablet of inciva contains 375 mg of tellaprevir as tablet core hypromellose acetate succinate , calcium hydrogen phosphate ( anhydrous ), microcrystalline cellulose , silica colloidal anhydrously , sodium lauryl sulphate , croscarmellose sodium , and sodium stearyl fumarate . film - coating polyvinyl alcohol , macrogol , Talc , titanium dioxide ( e171 ), iron oxide yellow ( oblong ). what if you see if the pack film  sachet consists of yellow caplet - shaped tablets , imprinted with " cisa " on one side . the tablet is 20 mm long and 4 mm wide .
the active substance in zinbryta is daclizumab beta , which is a monoclonal antibody , a type of protein that recognises and attaches to a specific target substance in the body . what zinbeta does in treatment of zinblita ? zinbirrytta belongs to  a group of medicines called relapsing ms and is used as therapy for two mses treatment . it is one of a family of treatments that prevent inflammation from destroying the protective sheath ( called myelin ) around the nerves in the central nervous system ( brain and spinal cord ). this loss of myeilin is called demyelonation . relapsesing patients with remissions or repeated attacks ( retaches ) of symptoms that have gone unnoticed or
you should not be given zinbryta : if you have previously had a serious allergic reaction to daclizumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or nurse before you are given zbrytra : liver problems talk to you doctor or pharmacist before you were given zebrytar if any of these apply to you . you have been told by your doctor that you have , or have ever had , any other autoimmune disorders or any other medicines you are taking , including herbal supplements . taking any medicines or supplements that you take can increase the risk of liver side effects . your doctor may need to reduce the dose of these medicines you take . zinberytta has not been studied in patients with depression in the past . have ever been told you have or have had  a seriously infection
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much zinbryta to use the recommended dose of zinblita is 150 mg once a week . your doctor will take a blood test to check how well your liver is working before giving you zin Brytta . the usual dose is 40 mg once weekly . if your doctor has decided that the dose is too weak , your doctor may change the dose based on the results of this blood test . you should have this blood check at least every three months . injection site zin brryt , usually injected under the skin in your thigh , stomach or upper back . upper arm . instructions for injecting zinberyte , see section 7 . before you start using zin ry
like all medicines , this medicine can cause side effects , although not everybody gets them . you may have side effects more often when you start your treatment or when your dose is increased . tell your doctor immediately if you notice any of the following serious side effects you may need a different dose . liver problems ( very common : may affect more than 1 in 10 people ): unexplained nausea ( feeling sick ) or vomiting ( being sick ), stomach pain increased tiredness loss of appetite ( anorexia ) changes in your skin or the whites of your eyes turn yellow dark ( tea - coloured ) urine 41 uncommon : might affect up to 1 in 100 people : severe inflammation of the liver that may lead to death . if your doctor determines that you have this , you should contact a doctor immediately or go to a hospital straight away . very rare : can affect
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the syringe label after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . keep the zinbryta pre - filled sYringe in original package in order to protect from light . once you have removed a new syingringe / pen from a fridge , you can use it immediately . zin Brytta s / pens may be stored at room temperature ( up to 30 ) for a single period of up to three months . you can record the date when you first remove your first dose . this period is the last one that you used . for archiving purposes ,
what zinbryta contains the active substance is daclizumab beta . each pre - filled syringe contains 150 mg daclimab Beta in 1 ml solution . Each pre  filled pen contains 150 micrograms daclizub beta in 1ml solvent . the other ingredients are sodium succinate , succinic acid , sodium chloride , polysorbate 80 ( see section 2 ' zinblita has a low level of sodium '). what zbrytab looks like and contents of the pack zin Brytta is a colourless to slightly yellow solution for injection . it is supplied in a sYringe / pen ( type i ) with or without an attached needle .
wilzin belongs to a class of medicines known as metabolism products . wilsson ' s disease is caused by a rare inherited defect in copper excretion that affects the liver , eyes and brain . this causes liver damage , as well as neurological disorders . it feeds the intestine , causing its further accumulation in the body . the active substance in wILson  s illness is riociguat . your doctor has prescribed this treatment for you because you have a special genetic defect in the way that the liver works and it does not work as well if you have not been trained .
do not take wilzin if you are allergic ( hypersensitive ) to zinc or any of the other ingredients of wilszin . warnings and precautions talk to your doctor , pharmacist or nurse before taking wILzin willzin will be prescribed to you by your doctor after initial therapy . patients with signs and symptoms of whilson ' s disease are currently taking another anti - copper agent called penicillamine . you will be given wilezin during the initial treatment , together with other anti , copper agents . your doctor may reduce the dose of peniciillamine if your symptoms get worse or get worse during the treatment . the doctor may monitor your blood and urine to make sure that you receive sufficient treatment and to continue monitoring 25 as necessary to avoid insufficient treatment ( copper excess ) or to reduce the risk of side effects . children and adolescents wifzin
what wilzin is and how it works for you ? the different dose regimens are available . the strengths are 25 mg and 50 mg . 1 tablet of wilszin 50 mg each day is given as 2 tablets of  550 ml . wILzin 25 mg is given either as 1 tablet or as 50 mg 2 tablets . your doctor may decide to increase your dose to wlzin 25mg or 50 mg as 2 tablet of 200 mbq each day . in some cases , your doctor will give you 50 mg and 2 tablets in one day , depending on your response to  600 m2 . each day you will be given w Ilzin 25 mu / m1 mu - 550mg ( 1 tablet ) every day ; in some instances you will have to take 1 tablet in the morning and 1 tablet at the same time each day
like all medicines , wilzin can cause side effects , although not everybody gets them . the frequency of possible side effects listed below is defined using the following convention : very common ( affects more than 1 user in 10 ) common (affecting 1 to 10 users in 100 ) uncommon ( affecting 1 to10 users in 1 , 000 ) rare ( affect 1 to 20 users in 10 to 10 ,000 ) very rare (affecting less than 1 users in10 ,00 ) not known ( frequency cannot be estimated from the available data ) wilszin intake may increase gastric irritation . during treatment , some patients may experience changes in blood tests and an increase in some liver and pancreatic enzymes , leading to a decrease in blood red and white cells . reporting of side effects 25 if you get any side effects talk to your doctor or pharmacist . this includes any possible side impacts not
keep out of the reach and sight of children . do not store above 25 . store in the original package in order to protect from moisture . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what wilzin contains - the active substance is zinc . each hard capsule contains 25 mg of zinc ( equivalent to 83 . 92 mg of gold ink ) or 50 mg of copper ( equivalent in gold indigo carmine ). each capsule contains 167 . 85 mg of silver ( equivalent ) zinc acetate dihydrate . the other ingredients are magnesium stearate . The capsule shell contains gelatin , titanium dioxide ( e171 ), brilliant blue fcf ( 6000 ). what whittle wilszin looks like and contents of the pack wILzin 25 mg hard capsules are blue , engraved with ' wlzin 50 mg ' in black ink and printing ink of black iron oxide ( E172 ) and shellac . what if you see wifzin 25mg : the printing in
biktarvy contains the active substance bictegravir , an antiretroviral medicine known as an integrase strand transfer inhibitor . it is given in combination with emtricitabine , which is an antiregular medicine with a nucleoside reverse transcriptasa inhibitor ( nrti ) tenofovir alafenamide , a nonretrovirus medicine with an nucleonide reverse transcript aser ( trtti) biktarivy is used for the treatment of human immunodeficiency virus 1 ( hiv - 1 ) infection . bktarvir reduces the amount of hiv in your body . this will improve your immune system and reduce the risk of developing illnesses linked to hiv infection , according to the official guidelines for use .
do not take biktarvy if you are allergic to bictegravir , emtricitabine , or tenofovir alafenamide or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor immediately and do not use biktarivy until you have checked with your doctor . if your doctor has told you that you are taking any of these : - rifampicin , which are used to treat some bacterial infections such as tuberculosis - saint john ' s wort ( hypericum perforatum ). this herbal remedy is used for depression and anxiety . warnings and precautions talk to your doctor or pharmacist before taking biktegrany : talk to a doctor if any of your medical conditions or circumstances are
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . your doctor will tell you if and when you may need to take a different dose . do not take antacids , as they may cause stomach ulcers . they may also help you to reduce your risk of heartburn and acid reflux . the active substance in biktarvy is reconstituted in aluminium and contains magnesium hydroxide mineral supplements , vitamins , magnesium and iron ( see section 2 under " what you need to know before you take biktarivy "). if your doctor has prescribed you these medicines , biktaby may not be suitable for you , or it may make you take them at the same time . if they are not suitable for your condition , they should talk to your doctor first . patients on
like all medicines , this medicine can cause side effects , although not everybody gets them . if you notice any of the following side effects you must tell your doctor immediately : - inflammation or infection . in some patients with advanced hiv infection ( aids ) and a history of opportunistic infections ( infections that occur in people with a weak immune system ), signs and symptoms of inflammation from previous infections may occur soon after hiv treatment is started . it is thought that these symptoms are due to an improvement in the body ' s immune response , enabling the body to fight infections that may have been present with no obvious symptoms . the development of autoimmune disorders , when the immune system attacks healthy body tissue , may also occur after you start taking medicines to treat hiv disease . these signs and conditions can be severe and may include fever , chills , fever and chills ( see
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the seal after " exp ". the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the seal tightly closed in order to protect from light .
what biktarvy contains the active substances are bictegravir , emtricitabine and tenofovir alafenamide . each biktarivy tablet contains bicentegraVir sodium equivalent to 50 mg bictogravir and 200 mg emptricitebine and 10ofoVir alafuramide fumarate equivalent to 25 mg tenovir altafonamide ). the other ingredients are tablet core microcrystalline cellulose , tablet core croscarmellose sodium , magnesium stearate . film - coating polyvinyl alcohol , titanium dioxide ( e171 ), macrogol , the talc , iron oxide red ( containing iron oxide black ).
novonorm is an oral antidiabetic medicine containing repaglinide which helps your pancreas produce more insulin and thereby lower your blood sugar ( glucose ). type 2 diabetes is a disease in which your panceras does not make enough insulin to control the sugar in your blood or where your body does not respond normally to the insulin it produces . novonourm is used to control type 2 diabetic patients at the start of treatment , but only after a short period of time . treatment is usually started if diet , exercise and weight reduction alone have not been able to control ( or lower ) your blood glucose . there are several reasons why novonvorm may not be suitable for you . metformin is also used to treat diabetes .
do not take novonorm : - if you are allergic to repaglinide or any of the other ingredients in this medicine ( listed in section 6 ). - in case you have type 1 diabetes . - when the acid level in your blood is raised ( diabetic ketoacidosis ). warnings and precautions talk to your doctor or pharmacist before taking novonORm if : you have a severe liver disease you take gemfibrozil ( a medicine used to lower increased fat levels in the blood ). 47 you have liver problems . novonourm is not recommended in patients with moderate liver disease . do not use novonörm - you have or have had a severely liver disease or kidney problems - do not give novonorgm , if any of these apply to you . before you take novoorm you will have major surgery or you have
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended starting dose is 0 . 5 mg before each main meal . swallow the tablets with a glass of water immediately before or up to 30 minutes before each meal , preferably at least 4 hours before or at least 30 minutes after each main dinner . do not take more than 16 mg before the main meal because your blood sugar may become too low . if a hypo is observed , do not use novonorm if your diabetes cannot be controlled . your doctor may decide to keep you under closer observation or change your treatment . don ' t stop taking this medicine unless your doctor tells you to .
like all medicines , this medicine can cause side effects , although not everybody gets them . hypoglycaemia the most serious side effect is hypoglacy ( may affect up to 1 in 10 people ), with a hypo in section " hypo ". hypogallycaemic reactions are generally mild / moderate but may occasionally develop into hypogycaema consciousness or coma . allergy allergy is very rare ( may effect up to1 in 10 , 000 people ). symptoms include swelling , difficulty in breathing , rapid heartbeat , feeling dizzy and sweating . this may be anaphylactic reaction . if you notice any of the side effects above , talk to your doctor immediately . other side effects may include : very common ( may effects in more than 1 in every 10 people "). the frequency of these effects is very common . very common side effects ( may impact more
what novonorm contains - the active substance is repaglinide . - other ingredients are microcrystalline cellulose ( e460 ), calcium hydrogen phosphate anhydrous , maize starch , polacrilin potassium , povidone ( polyvidone ), glycerol , magnesium stearate , meglumine , and poloxamer . the printing ink is composed of iron oxide yellow ( orange ) only in the 1 mg tablets and iron oxide red ( ottered ) in the 2 mg tablets . what novovonorme looks like and contents of the pack novonORm tablets are round and convex and engraved with the code number ' gilead ' on one side and ' 1 ' over ' 801 '. they are marked with ' 2 '
what pumarix is pumarisk is a vaccine given to adults from 18 years old to prevent pandemic flu ( influenza ). pandemie flu is essentially a type of influenza that happens at intervals that vary from less than 10 years to many decades . it spreads rapidly around the world . the signs of pandelic flu are similar to those of ordinary flu but may be more serious . how pumarize works when a person is given the vaccine , the immune system ( the body ' s natural defence system ) will produce its own protection ( antibodies ) against the disease . none of the ingredients in the vaccine can cause flu . as with all vaccines , pumarique may not fully protect all persons who are vaccinated .
pumarix should not be given : if you have previously had a sudden life - threatening allergic reaction to any ingredient of this vaccine ( listed in section 6 ) or to any of the substances that may be present in trace amounts as follows : egg and chicken protein , ovalbumin , formaldehyde and sodium deoxycholate . signs of an allergic reaction may include itchy skin rash , shortness of breath and swelling of the face or tongue . however , in a pandemic situation , you may not be fully protected against the vaccine . you may require medical treatment if and when you have an allergic response to pumarx . if any of these apply to you , tell your doctor or nurse before you receive this vaccine , 33 if your child is not sure , talk to your doctor , pharmacist or nurse . warnings and precautions talk to
pumarix is for use in adults aged 18 and over . pumarich must be given in combination with a similar h5n1 as03 - like vaccine in adults 18 years and over as directed by your doctor . your doctor will decide if you should receive pumarize as an add - on to your existing vaccine . the recommended dose of pumarx is one dose of vaccine for children and adolescents aged 3 - 9 years . there are no dose recommendations for children 3  10-17 years of age . how pumarisk is given pumarice is given as an injection into a muscle . this will usually be in the upper arm . if your child is not sure if this vaccine has been given , talk to your doctor or nurse before being given it .
like all medicines , this vaccine can cause side effects , although not everybody gets them . allergic reactions allergic reactions which cause you to have dangerously low blood pressure . if this is not treated it may lead to shock . doctors are aware of this possibility and have emergency treatment available for use in such cases . other side effects include : very common ( may affect more than 1 in 10 people pain at the site of the injection ) headache feeling tired aching muscles joint pain common ( might affect up to 1 in 100 people ) redness and swelling at the place of the injecting fever sweating shivering diarrhoea feeling sick uncommon ( may effect up to1 in 100 persons ) nosebleeds bruising , redness at the location of the infusion . reporting of side effects 25 if you get any side effects talk to your doctor , pharmacist or nurse . this includes any possible side
keep this vaccine out of the sight and reach of children . before the vaccine is mixed : do not use the suspension and the emulsion after the expiry date which is stated on the carton . the expiration date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). store in the original package in order to protect from light . do not freeze . after the vaccine has been mixed , use the vaccine within 24 hours and do not store above 30 .
what pumarix contains active substance : split influenza virus , inactivated , containing antigen * equivalent to : a / vietnam / 5 / 2005 ( h5n1 ) like strain used ( pr8 - ibcdc - recyp3 ) equivalent to approximately 0 . 5 milligrams ** per 0x1 ml dose * propagated in eggs ** expressed in microgram haemagglutinin this vaccine complies with the who recommendations and eu decision for the pandemic . the vaccine contains an ' adjuvant ' as03 . this adjuvan contains squalene , Dl - 1 - tocopherol ( e339 ), polysorbate 80 and water for injections . adjuants are used to improve the body ' 
this medicine is a radiopharmaceutical product for diagnostic use only . the powder for concentrate for solution for injection contains a small amount of radioactive substance called gallium ( 68ga ) chloride . gallium( 68Ga ] edotreotide is produced by recombinant dna technology . people with this procedure are not able to produce their own dose of gallium . edeotides are then injected into a vein and into body areas , in a medical imaging procedure called positron emission tomography . this medical procedure , called post - marketing experience , is only available for patients who have been previously treated for pet - friendly conditions . during this medical process , images are obtained to identify the abnormal cells and tumours that may have been present in the bloodstream , and help to understand the causes
do not use somakit toc - if you are allergic to edotreotide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using somamakit tc . there is a small chance of allergic reaction ( see section 4 ) when using sommakit thec , if this applies to you . talk to you doctor if any of these apply to you ( or you are not sure ), talk to the doctor or nurse prior to using somekit totc and during treatment : if your doctor thinks you may have kidney or liver problems . if the doctor think you may be at risk of renal or hepatic disease . in children and adolescents ( below 18 years ), the doctor will monitor you carefully for signs of dehydration .
there are strict laws on the use , handling and disposal of radiopharmaceutical products . somakit toc will only be used in special controlled areas . this product will only have to be handled and given to you by people who are trained and qualified to use it safely . these persons will take special care for the safe use of this product and will keep you informed of their actions . the nuclear medicine doctor supervising the procedure will decide on the quantity of somakoc toc to be used . it will be the smallest quantity necessary to get the desired information . dose the quantity to be administered usually recommended for an adult ranges from 100 to 200 mbq ( megabecquerel , the unit used to express radioactivity ). administration of somacakit tc and conduct of the procedure should be done in a safe and confidential environment . after radiolabelling ,
like all medicines , this medicine can cause side effects , although not everybody gets them . the most serious side effects are allergic reactions ( hypersensitivity ) to somakit toc and may appear as follows : symptoms may include warm flush , redness of the skin , swelling , itching , nausea and difficulty breathing . allergic reactions may also include stinging at the injection site . this radioactivity is associated with low amounts of ionising radiation associated with the least risk of cancer and hereditary abnormalities . reporting of side effects 25 if you get any side effects talk to your nuclear medicine doctor . these side effects include : very common ( may affect more than 1 in 10 people ): - very common side effects ( may effect more than one in 10 , 000 people ). - common ( might affect up to one in10 people ), - not known ( frequency cannot be
you will not have to store this medicine . this medicine is stored under the responsibility of the specialist in appropriate premises . storage of radiopharmaceuticals will be in accordance with national regulation on radioactive materials . the following information is intended for the specialist only . after radiolabelling has been performed , somakit toc must be used within 4 hours and must not be stored above 25 . do not use somak if you notice any visible sign of deterioration . radioactive products must not to be disposed of via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what somakit toc contains - the active substance is edotreotide . one vial of powder contains 40 micrograms of edeotreetide ( as 10 - phenanthroline ). - other ingredients are gentisic acid , mannitol , formic acid / sodium hydroxide , and water for injections . - sodium is contained in the solution for radiolabelling . the solution contains hydrochloric acid ( as radiopharmaceutical preparation ). what sommakit tc looks like and contents of the pack somamakit is supplied as a glass vial with black flip - off . it is a white powder supplied in aglass vial ( with yellow flip ' tan ' on one side and cap . this ensures a clear and
afinitor is an anticancer medicine that contains the active substance everolimus . everolim works by blocking a substance in the tumour , which is involved in the growth and spread of cancer cells . afinitr is used as a single dose ( hormone receptor - positive advanced breast cancer in postmenopausal women ) when other treatments ( hormone receptor - negative ) have not worked or have not responded to treatment - with a medicine called exemestane , a steroidal aromatase inhibitor , in combination with hormonal anticancancer therapy - for advanced tumours . it is also used in addition to the treatment of neuroendocrine tumours that occur in the stomach and bowels , and in the following tumours the doctor will decide how to treat them .
always take afinitor exactly as your doctor has told you . you should check with your doctor if you are unsure . your doctor will tell you how much afinitr you need to take . before cancer treatment , make sure you have the correct dose of afinitour . do not take afinitor : - if your doctor thinks you may be allergic to everolimus , sirolimus or temsirolius or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor before taking afinitorul . - take special care with afinitur - tell your doctors if : you have any problems with your liver . tell your family / carer knows that you have ever had any disease which may have affected your liver and you may need a different dose of agony . use in
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is 10 mg of afinitor once a day . swallow the tablet whole . if necessary , your doctor may tell you to take a different dose . patients with liver problems may need a lower dose of agoitor ( 5 mg / 5 mg or 7 . 5 mg once / day ). your doctor will adjust the dose if needed . your doctor might adjust your dose based on certain side effects . duration of treatment with afiniter lasts for up to one month . continue taking afinitr as long as your treatment lasts . do not stop taking afiniitor unless your doctor tells you to . stop taking pouritor immediately and contact your doctor for advice if it is urgent treatment needed ,
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking afinitor and tell your doctor immediately if you : experience an allergic reaction , which may include : difficulty breathing or swallowing swelling of the face , lips , tongue or throat severe itching of the skin , with a red rash or raised bumps . other side effects with afiniter include , may affect up to 1 in 10 people : increased temperature , chills ( signs of infection ) fever , coughing , difficulty breathing , wheezing ( signs for inflammation of the lung called pneumonitis ) uncommon : may affect more than 1 in 100 people - increased temperature ( high temperature ) - chills , infection - fever - coughing with difficulty breathing and wheeze ( signs to inflammation ofthe lung called plumonitus )
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister foil . the expiration date refers to the last day of that month . store below 25 . once you open the blister , the tablets should be stored in the original blister . never use this medicinal product if the package is damaged or shows signs of tampering . this medicine does not require any special storage conditions . does not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what afinitor contains the active substance is everolimus . afinitr 2 . 5 mg hard capsules each vial contains 2 , 5 mg of everoli Mus . Afinitor 5 mg soft capsules every vial delivers 5 mg / ml of everollimus , whereas afinitour 10 mg hard shells each tablet contains 10 mg of Everolimus ( as monohydrate ). the other ingredients are butylhydroxytoluene ( e321 ), magnesium stearate , lactose monohydrate ( containing hypromellose , and crospovidone ), and lactoses anhydrous ( see " afiniteur contains lactoside lactobacillus "). what afinior looks like and contents of the pack afinitores 2 : 5 mg tablets are white to slightly yellowish , round and flat . they
what laventair ellipta is laventaire ellippta contains two active substances umeclidinium bromide and vilanterol . these belong to a group of medicines called bronchodilators . what laVENTair ellptta ist used for laventAIR elliрta est used to treat chronic obstructive pulmonary disease ( copd ) in adults . copd is a long - term condition characterised by breathing difficulties that slowly get worse . in copd the muscles around the airways tighten . this medicine blocks the tightening of these muscles in the lungs , making it easier for air to get in and out of the  lung . it is used to help control your breathing difficulties .
do not use laventair ellipta 31 - if you are allergic to umeclidinium , vilanterol or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor immediately and do not take this medicine . warnings and precautions talk to your doctor , pharmacist or nurse before using laventaire ellippta : - patients with asthma do not using laVENTair ellptta to treat asthma . - heart problems or high blood pressure . your doctor should treat you with an eye problem called narrow - angle glaucoma . you have an enlarged prostate , difficulty passing urine or a blockage in your bladder . talk to a doctor if any of these apply to you ( or you are not sure ), talk to the doctor . epilepsy .
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one inhalation every day at the same time of day . you only need to inhale once a day because the effect of this medicine lasts for 24 hours . don ' t use more than your doctor tells you to use . use laventair ellipta regularly it is very important that you use laVENTair ellpt , every day , as instructed by your doctor . this will help to keep you free of symptoms throughout the day and night . lavent air ellippta should not be used to relieve a sudden attack of breathlessness or wheezing . if this attack occurs you must use a quick - acting reliever inhaler ( such as salbutamol ). how to use the
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions if you experience any of the following symptoms after taking laventair ellipta stop using laventaire ellippta and tell your doctor immediately . uncommon side effects ( may affect up to 1 in 100 people ): skin rash ( hives ) or redness rare side effects( may affect less than 1 in 1 , 000 people ]: swelling , sometimes of the face or mouth ( angioedema ), becoming very wheezy , coughing or having difficulty in breathing , feeling weak or light headed ( collapse )) feeling very tired ( somnolence ( sleepiness ) uncommon side effect ( may effect up to1 in 10 ,000 people ). swelling mainly of the faces or mouth during the day ( angina pectoris ). not known ( frequency cannot
what laventair ellipta contains - the active substances are umeclidinium bromide and vilanterol . each single inhalation provides a delivered dose ( the dose leaving the mouthpiece ) of 55 micrograms umeklidinium ( equivalent to 65 microgram of umeclinium bromine ) and 22 microgram ( kg ) ) alkaline ( e210 ) ( as trifenatate ). -the other ingredients are lactose monohydrate ( see section 2 under ' laventaire ellippa contains lactoses ') and magnesium stearate . what laVENTair ellptta looks like and contents of the pack lavent air elliрta is an inhalations powder , pre - dispensed . the ellipita inhaler consists of a
tremfya contains the active substance guselkumab , a monoclonal antibody . this medicine works by attaching itself to an inflammatory protein called il - 23 . tresoriasis is used in adults to treat moderate to severe " plaque psoriaticasus " a condition where the skin and nails become damaged . the active ingredient in tremefyya is guzelkrumab which is an endocrine that binds to il- 23 and is found in various places on the skin , such as scaling , shed , flaking , itching , pain or burning .
do not use tremfya if you are allergic to guselkumab or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor and do not receive tremefyya because you may be allergic . warnings and precautions talk to your doctor , pharmacist or nurse before you are given trerfyam if : you have an active infection . you have active tuberculosis warnings , discuss with your doctor before you receive , or during treatment with treremfYa . your doctor may want to monitor you more closely if an infection is coming back . this includes an infection related to tubercusis . tubercularosist is a rare but serious , sometimes life - threatening condition that can be fatal . it has been
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose of tremfya is 100 mg ( 1 pre - filled syringe ) given once a week under the skin ( subcutaneous injection ). the recommended interval is between 4 and 8 weeks after your first injection . you or your caregiver should continue to use trempfyya until your doctor tells you otherwise . if your doctor thinks that you may have used more tregfyo than you should , tell your doctor immediately . how long to use you should continue using trerfyam for as long as your physician tells it . do not stop using TREmfYa unless your doctor advises you to . during treatment , some patients may experience symptoms of psori
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor or nurse straight away if you notice any of the following side effects you may need urgent medical attention : serious allergic reaction that may include : difficulty breathing or swallowing , swelling of the face , lips , tongue or throat , severe itching of the skin , with a red rash or raised bumps other side effects include , which are listed below . reporting of side effects get medical help if your child gets any side effects talk to your doctor , pharmacist or nurse . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects your child can help provide more information on the safety of this medicine . some side effects can be serious common ( may affect up to
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . keep the pre - filled syringe in the outer carton , in order to protect from light . this medicine should not be used if the solution is cloudy or contains large particles . if you notice that the refrigerator is not heated , the pre- filled
what tremfya contains - the active substance is guselkumab . each pre - filled syringe contains 100 mg of gUSElkUMab in 1 ml solution . - other ingredients are histidine , histamine monohydrochloride monohydrate , polysorbate 80 , sucrose and water for injections . what TREmfYa looks like and contents of the pack solution for injection - trempfyya is presented as a carton pack containing one single - dose glass sYringe or as  a multipack containing 2 ( 3 packs of 1 ) single  dose pre  - fill s ssyru . not all pack sizes may be marketed .
trepulmix contains the active substance treprostinil . treprastINil belongs to a group of medicines called prostacyclins . prostacycles are hormones that lower blood pressure . they work by relaxing blood vessels . by blocking the effect of prostacs , they prevent blood from clotting . the active ingredient in trepmix is treparstil , which is used to treat inoperable chronic thromboembolic pulmonary hypertension ( cteph ). it is used when : persistent or recurrent ctesph that cannot be treated with surgical treatment , increase exercise capacity ( the ability to carry out physical activity ) or reduce symptoms of the disease . chronic thmboeblic ptemph is when the blood pressure is too high , and the blood vessels of
do not take trepulmix : - if you are allergic to treprostinil or any of the other ingredients of this medicine ( listed in section 6 ). -if you have a disease called " pulmonary veno - obslusive disease ". this is a condition in which the blood vessels in the lungs become swollen and there is / or a higher pressure in the blood channels between the heart and the pulmonary organs . - severe liver disease . warnings and precautions talk to your doctor before taking trepmix if : you have had a heart problem or have had or have ever had , e .g . after a cardiac attack ( myocardial infarction ) in the last six months . you have severe changes in heart rate severe coronary heart disease or unstable angina a chest defect or
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . trepulmix is given as a continuous subcutaneous infusion by injection under the skin into a small tube ( cannula ) in the abdomen or thigh . you will only be given trepmix using a portable pump . your treprostinil will be charged and infused by a doctor or nurse so that he or she can easily describe what you have been given . the pump will also tell you when to go to the infusion line . in case of accidental overdose , the usual dose is 1 dose of 2 . 5 mg , 5 mg or 10 mg per minute depending on your condition . no special dose adjustments are necessary . patients with liver or kidney disease if your doctor determines that the inf
like all medicines , this medicine can cause side effects , although not everybody gets them . very common : may affect more than 1 in 10 people widening of blood vessels pain at the infusion site reaction at the site of the inffusion bleeding or bruising at the location of the imprint . headaches , nausea , diarrhoea jaw pain common - may affect up to 1 in every 10 people dizziness , light - headedness or fainting low blood pressure skin rashes , muscle pain ( myalgia ) joint pain ( arthralgi ) swelling of feet , ankles or lower back pain uncommon - might affect upto 1 in 100 people redness or itching in the mouth , lips , tongue or throat . uncommon : might affect more of the people bleeding or swelling in the hands or feet ( thrombocyto
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2c 8c ). do not freeze . a trepulmix vial may be kept at room temperature ( up to 30 ) for up to one hour ( for continuous subcutaneous infusion ) in  a single reserve ( syringe ) of undiluted trepemix and used for upto 72 hours . this medicine must not be used if there are signs of damage , such as discolouration or other signs of deterioration . always keep the vial in the outer carton in order to protect from light .
what trepulmix contains - the active substance is treprostinil . trepmix 1 mg : each vial contains 1 mg of treprastINil ( as sodium salt ). each 10 mg vial delivers 10 mg of the active ingredient trepropstinningil ( AS sodium salt). each trepelmix 2 . 5 mg vially contains 2 , 5 mg of of TREprossinil ( ( as salt ) in each 10 ml vial , corresponding to 25 mg of " treparstinkil " in each 100 mg viall . what TREpulmix looks like and contents of the pack trepemix 5 mg / 5 mg is supplied as a powder vial with treperstnil ( in solution with sodium salt in a 10 - mg viale ).
thorinane contains the active substance enoxaparin sodium . it is a low molecular weight heparin ( lmwh ). thrinanane works in two ways . 1 ) stopping existing blood clots from getting any bigger . this helps your body to break them down and stop them causing you harm . 2 ) preventing blood  clottings from forming in your blood . thoinanе can be used to : prevent blood clumps in your urine . prevent blood from cloting in your body after an operation . you have an acute illness . your doctor will decide how much thorginana you need to take and how often you need it . unstable angina ( a condition where blood coagulation cannot be controlled ) or a heart attack stop blood -
do not use thorinane - if you are allergic to enoxaparin sodium or any of the other ingredients of this medicine ( listed in section 6 ). signs of an allergic reaction include rash , swallowing or breathing problems , swelling of your lips , face , throat or tongue . - you are also allergic to the active substance heparin or other low molecular weight hepriotins ( nadroparin , tinzaparin ; dalteparin in order to avoid a reaction to heparain that causes a severe drop in the number of your clotting cells ( platelets ). this reaction may be a sign of he parin - related thrombocytopenia . talk to your doctor if this happens . warnings and precautions talk to you doctor or pharmacist before using
like other similar medicines ( medicines to reduce blood clotting ), thorinane may cause bleeding which may potentially be life - threatening . in some cases the bleeding may not be obvious . if you experience any bleeding event that does not stop by itself or if it is suspected that you are having excessive bleeding ( exceptional weakness , tiredness , paleness ), dizziness . headache or unexplained swelling , tell your doctor immediately and stop your medicine . stop taking thrinana and tell your doctors immediately if : you experience a severe allergic reaction ( e .g . difficulty breathing , swelling of the lips , mouth , throat or eyes ), you may have blockage of a blood vessel by a bleeding clot . you experience cramping pain when standing up , dizzily , or having difficulty breathing or a
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and label after exp . the expiration date refers to the last day of that month . store below 25 . thorinane must be diluted prior to use . after dilution the solution should be used within 8 hours . this medicine does not require any special storage conditions . use the thoresinana pre - filled syringes only once inserted into the sachet . discard any unused medicine . any discarded medicine must be returned to the pharmacist or nurse .
what thorinane contains - the active substance is enoxaparin sodium . each ml contains 100 mg of eonoxaparain sodium in each pre - filled syringe of 0 . 2 mL . this provides a delivered dose of 2 , 000 mg of the active ingredient , e noxa parin . - after reconstitution with water for injections , the dose is the same for all patients . what thiorinans looks like and contents of the pack thoinanе is a clear , colourless type i neutral glass sYringe barrel with fixed needle and needle shield with chlorobutyl rubber stopper and a blue polypropylene plunger rod . pack size : 2 packs of 10 pre  - packed syes . not all pack sizes may
senstend contains lidocaine and prilocaine , which belong to a group of medicines called local anaesthetics . senstende is indicated for the treatment of lifelong premature ejaculation in adult men . the head of the penis is changed during ejeculation .
do not use senstend - if you are allergic to lidocaine or prilocaine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using senstende . - you have a history of allergy or sensitivity to other local anaesthetics , including amide - type local anesesthesias . you have been previously treated with senstendend and have : - been diagnosed with a genetic disease or other condition affecting your red blood cells ( glucose - 6 - 10 - 15 - 20 ) or - had phosphate deficiency ( anaemia or methaemoglobinaemia ). - medicine sensitivities and sensitivity are possible in patients with severe liver problems . do not administer this medicine to children or adolescents
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one spray of senstend 3 times a day ( 3 sprays 3 times per day ) on the head of the penis . one spray per day will be sufficient . use within 3 days . however , it is recommended to use within 24 hours after the first injection , and 4 days after the initial injection . remove the spray container from the pump mechanism . before using the pump , remove it from the valve to avoid contact with eyes , nose , mouth and ears . if the pump is not working properly , 1 spray should be injected under the foreskin under the head , as shown . do not touch the penises of the open , locked valve . 1 spray ( 3 ml )
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported : common ( may affect up to 1 in 10 people ) inability to develop or maintain an erection feeling in the penis burning sensation in the back of the peni . uncommon ( may effect up to1 in 100 people ] headache local irritation of the throat , irritation of part of the skin redness failure to ejaculate during sexual intercourse abnormal orgasm tingling of the lining of the inis pain or discomfort in the corner of the pegasm itching in the inner corner of your penis pain in or discomfort on the inner part of your genital area redness of the flesh , oesophagus , or sacs of pus . not known ( frequency cannot be estimated from the available data ) redness or burning in the
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the container label and the carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 to 8 ). do not freeze . keep the container in the outer carton in order to protect from light . after first opening : do not store above 25 . throw away the container 12 weeks after first use . protect the metal container from light and avoid puncture or burn . return the container to the refrigerator . write the date of opening on the label in the space provided . discard this medicine if not used by the new expiry or use after this time period . it is recommended that every time you use senstend , the product is discarded , even if it is not empty . use senstentd only if you
what senstend contains - the active substances are lidocaine and prilocaine . - each ml of solution contains 150 mg lidocabine and 50 mg prilocation . each spray delivers 50 microlitres which contains 7 . 5 mg lidofcaine + 2 . 4 mg plocaine per spray . what senstentd looks like and contents of the pack senstende is a clear , colourless to light yellow cutaneous spray in an aluminium spray container with metering valve . senstendu is available in packs containing 1 spray container of 6 . 6 mL and 5 m2 of solution . not all pack sizes may be marketed .
opdivo is a medicine used to treat advanced melanoma ( a type of skin cancer ) in adults melonoma that has progressed after complete resection in adults ( treatment with surgery ) or adjuvant therapy . advanced non - small cell lung cancer - this is  a kind of lung cancer that has come back after previous therapies ( including an autologous stem - cell transplant ) and in children . oddivo can also be given after a transplant to treat : advanced cancer of the head and neck in adults advanced urothelial carcinoma , a sort of bladder and urinary tract cancer . the active substance in obdivo , called nivolumab , is essentially a monoclonal antibody .
do not use opdivo - if you are allergic to nivolumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor before using opmo . talk to a doctor before you are given opedivo and during treatment : - contact your doctor if : you have problems with your heart such as a change in the rhythm or rate of the heartbeat or an abnormal heart rhythm . you have breathing difficulties or cough . this may be a sign of inflammation of the lungs ( pneumonitis or interstitial lung disease ). - you have diarrhoea ( watery , loose or soft stools ) or any symptoms of inflammation or of the digestive systems ( colitis ) such as stomach pain . your doctor may want to monitor you more closely .
what opdivo is the active substance of oopDivo is called ipilimumab . it is used for the treatment of skin cancer in adults . opedivo contains 1 mg of nivolumab per kilogram of your body weight . you should take it about 4 hours before you go to bed . the usual dose of apdiva is 240 mg ( 2 tablets ) or 480 mg ( 4 tablets ). your doctor will decide the dose of one oppdivo in combination with iilimamab in order to optimise the treatment for your specific type of skin carcinoma . how much obdivo you will receive when you first start using oddivo , your doctor may decide to increase the dose . when to take opradivo your doctor might decide to start using the tablets in combinationwith i
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial label after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 to 8 ). do not freeze . chemical and physical in - use stability has been demonstrated for up to 25 days at refrigerated temperature . from a microbiological point of view , the product should be used immediately . if not used immediately the infusion solution is used or unused , any unused medicine or waste material should be disposed of in accordance with local requirements .
what opdivo contains the active substance is nivolumab . each ml of concentrate for solution for infusion contains 10 mg of nnivolmaB . one vial contains 40 mg / 4 mL , 100 mg 1/ 10 m2 or 240 mg 2/ 24 mmol of 386mg of / m3 of pdm nifvolum . the other ingredients are sodium citrate dihydrate , sodium chloride ( see section 2 " opmdivo has a chemical and physical in - use stability "). the other ingredient ( s ) are mannitol ( e421 ), pentetic acid , polysorbate 80 , water for injections . what apdiva looks like and contents of the pack opondivo is a
clopidogrel tad contains clopogrell and belongs to a group of medicines called antiplatelet medicinal products . platelets ( so - called thrombocytes ) are very small structures in the blood , which clump together during blood clotting . by preventing this clumpeding , antiplatelets medicinal products reduce the chances of blood  clots forming ( a process called Thrombosis ). cloclopidOgrel tod is taken by adults to prevent blood coagulations ( thrombi ) forming in hardened blood vessels ( arteries ), a condition known as atherothrombosus , that can lead to atherotrombotic events ( such as stroke , heart attack , or death ). you have been prescribed clodogre
do not take clopidogrel tad 30 if you are allergic to clopogrell or any of the other ingredients of this medicine ( listed in section 6 ). if your doctor has told you that you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if there is severe liver disease . do not use clopinogrela t d if any of these apply to you . check with your doctor before taking cloclopidOgrel 30 ttd . warnings and precautions if in any of those situations , you should tell your doctor and do not taking , or you think you may be at risk of bleeding : - a mental condition that puts you at risk for internal bleeding ( such as such as from a chest ulcer ) - any blood disorder that makes you 
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel tad per day to be taken orally with or without food , and at the same time each day . if your doctor decides that you should take clopogrell ttade , the dose may be increased to one 75 - mg tablet . for severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of  Clopidogral  Tad ( 4 tablets of 75 mg ) once at the start of treatment . then , your doctor will give you 75 mg of the tablet of the clo
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and , in rare cases , confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of the Skin . they may be the signs of an allergic reaction .
what clopidogrel tad contains the active substance is clopogrell . each film - coated tablet contains 75 mg of clopinogregrel ( as hydrochloride ). the other ingredients are microcrystalline cellulose , colloidal anhydrous silica , crospovidone ( type a ), macrogol 6000 and hydrogenated castor oil in the tablet core and polyvinyl alcohol , titanium dioxide ( e171 ), red iron oxide ( erection ), yellow iron oxide in the film . in addition , the printing ink contains talc and macrogol 3000 in the movie - coating . what ' clodogrela ttaD looks like and contents of the pack the film- coated tablets are pink , round and slightly convex . boxes of 7 and 14 film 
tacforius contains the active substance taccrolimus . it is an immunosuppressant . following your organ transplant ( liver , kidney ), your body ' s immune system will try to reject the new organ . tacforinus is used to control your body' 's immune response , enabling your body to accept the transplanted organ , and to accept its new organ in a rapid fashion . in adults tacforus is intended to prevent rejection of the transplant , both in the liver - kidney and heart , while undergoing any previous treatment that you were taking at the time of your transplantation .
do not use tacforius if you are allergic to tacrolimus or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor immediately . if your doctor thinks you may be allergic to sirolius or to any macrolide - antibiotic ( e . ex , erythromycin , clarithromycin or josamycin ). warnings and precautions talk to your doctor or pharmacist before taking tacrolivimus immediate release capsules ( p . deltoimus immediate - release capsule , ( i .
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . this medicine should only be prescribed to you by a doctor with experience in the treatment of transplant patients . make sure that you receive the same taccrolimus medicine every time you collect your prescription , unless your transplant specialist has agreed to change to a different taccrolumus medicine . if the appearance of this medicine is not the same as before , your doctor will check that you are using the right medicine , and take the same dose as before with tacforius . the dose of this medication will depend on whether you are receiving the right medication . how much tacforinus to take the starting dose will depend upon your transplanted organ . your dose will be calculated by your doctor calculated according to your body weight . initial daily doses to prevent rejection of your transplantation will be 
like all medicines , this medicine can cause side effects , although not everybody gets them . infections : you must fight infections , because tacforius can cause severe effects . allergic and anaphylactic reactions . benign and malignant tumours have been reported following tacforin treatment . cases of pure red cell aplasia ( a very severe reduction in red blood cell counts ) have been noted . agranulocytosis (  a severely lowered number of white blood cells ) has been reported . case of haemolytic anaemia ( decreased number of red blood cells due to abnormal breakdown ) and febrile neutropenia ( where white blood cell count helps to fight infection ). the most frequently reported side effects are : very common side effects ( may affect more than 1 in 10 people ): hypersensitivity ( e .g . swelling in
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton after exp . the expiration date refers to the last day of that month . use all the prolonged - release hard capsules within 1 year of opening the aluminium wrapping . store in the original package in order to protect from moisture .
what tacforius contains the active substance is tacrolimus . tacforinus 0 . 5 mg hard capsules each capsule contains 0. 5 milligrams of tacrolivimus ( as monohydrate ). tacforier 1 mg hard hard capsule each capsule delivers 1 mg of tacrolulimus ( As monohydrate). tac forius 3 mg hard chock : each capsule releases 3 mg of takroli Mus ( as monohydrate ) each capsule of tacforforimus 5 mg contains 5 mg of of tacrollimus( as monohydrat ). the other ingredients are : capsule content hypromellose 2910 , ethylcellulose , lactose , magnesium stearate . capsule shell tacforaius 05 mg hard - capsules are white , round and convex with the boehringer ingelheim
clopidogrel zentiva contains clopogrell and belongs to a group of medicines called antiplatelet medicinal products . platelets ( so - called thrombocytes ) are very small structures in the blood , which clump together during blood clotting . by preventing this clumpeding , antiplatelets medicinal products reduce the chances of blood  clots forming ( a process called Thrombosis ). cloclopidOgrel vertigo is taken by adults to prevent blood coagulations ( thrombi ) forming in hardened blood vessels ( arteries ), a condition known as atherothrombosus , with an increased risk of atherotrombotic events ( such as stroke , heart attack , or death ). you have been prescribed clodogrelly to help prevent
do not take clopidogrel zentiva if you are allergic ( hypersensitive ) to clopogrell or any of the other ingredients of this medicine ( listed in section 6 ). if your medical condition is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if there is severe liver disease . do not taking cloclopidOgrel
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel zentiva per day to be taken orally with or without food , and at the same time each day . if your doctor has toldyou that you have experienced severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of  Clopidogral  Zentiva ( 1 tablet of 300 mg or 4 tablets of 75 mg ) once at the start of treatment . then , the recommended dosage is one75 mg tablet , per day as described above . you should take clopogrell zentivea for as long as
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and , in rare cases , confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of the Skin . they may be the signs of an allergic reaction .
store in the original blister in order to protect from moisture . keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister , after exp . the expiration date refers to the last day of that month . if clopidogrel zentiva is supplied in aluminium blisters , store below 30 . when clopogrell zentivea is provided in all aluminium boxes , do not store this medicine in order for it to be used properly . store in a refrigerator ( 2 8 ). do not freeze . this medicine does not require any special storage conditions . Do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what clopidogrel zentiva contains the active substance is clopogrell . each tablet contains 75 mg of clopinogrelly ( as hydrogen sulphate ). the other ingredients are ( see section 2 ' cloclopidOgrel
yttriga is a radioactive medicine . it is stored in the healthcare facility where it is used . the storage details are as follows : it is , after being dissolved , one medicine is not to be used , and the other medicine is to be stored separately . tiny radiation doses are intended to allow the treatment to be completed . yittrig consists of a single dose of radiolabelled medicinal product .
do not use yttriga - if you are allergic ( hypersensitive ) to chloride or any of the other ingredients of yittrig . -if you think you may be pregnant or are planning to become pregnant . warnings and precautions talk to your doctor , pharmacist or nurse before using yettrigga . the use of Yttranga is not recommended if - you are a radioactive medicine , as it may interact with another medicinal product , e .g . radiopharmaceuticals . in this case yytrigriga is used only in combination with radioactive material . other medicines and yptrigaga tell your doctor or pharmacist if the use is not approved . children and adolescents yttingtrigo has not been studied in children and young children under 2 years of age . it
your doctor will determine and control the dosage and duration of the treatment with yttriga according to your individual needs . method of administration yytrig complies with national regulations on radiolabelling of medicinal products , resulting in appropriate treatment for specific diseases . administration of yettrigga is not a cure for overdose . your doctor shall provide you with appropriate treatment .
like all medicines , yttriga can cause side effects , although not everybody gets them . if any of the side effects get serious , or if you notice any side effects not listed in this leaflet , please tell your doctor or pharmacist . reporting of side effects for this medicine : if your doctor gets any side effect , talk to your doctor , pharmacist or nurse . this includes any possible side effects NOT listed in the leaflet or in the appendix v . by reporting side effects you can help provide more information on the safety of this medicine for your doctor and / or the safety information provided in this package leaflet ( see also appendice v. by referring to the package leaflets of all medicines used in combination with ymcg ).
yttriga is stored under the responsibility of the specialist in appropriate premises . storage of radioactive substances and waste material should be in accordance with local regulations .
what yttriga contains - the active substance is chloride . 1 ml sterile solution contains 1 mg of hydrochloric acid . - 3 mmol / mL solution for injection / infusion with a v - shape bottom . this product is supplied in a colourless type i glass vial of 10 mle , with  a flat bottom , closed with . one side is closed with the silicon stopper and an aluminium seal .
ciambra is a medicine used in the treatment of cancer . ciampa is given in combination with cisplatin , another anti - cancer medicine , as treatment for malignant pleural mesothelioma , a form of cancer that affects the lining of the lung , to patients who have not received prior chemotherapy . when ciambaa is first given in conjunction with ciaplatin the initial treatment is not recommended . for treatment of lung cancer , it can be prescribed by your doctor if you have lung cancer at an advanced stage if your disease has responded to treatment or it remains largely unchanged after initial chemotherapy ; ciaba is also a treatment for patients with advanced stage of lung carcinoma whose disease has progressed after other initial chemotherapy has been used .
do not use ciambra - if you are allergic ( hypersensitive ) to pemetrexed or any of the other ingredients of ciama ( listed in section 6 ). -if you plan to breast - feed during or after treatment with ciampa . - you have recently received or are about to receive a vaccine against yellow fever . warnings and precautions talk to your doctor or hospital pharmacist before receiving ciamba . you may already be given a smaller dose of CIAmbra to reduce the risk of problems with your kidneys . before each infusion of ciembra your doctor will take samples of your blood to evaluate if it is possible to measure your kidney and liver function and to check that you have enough blood cells to receive treatment with the medicine . your doctor may decide to change the dose or stop treatment with it if your blood cell counts are too low 
the dose of ciambra is 500 milligrams for every square metre of your body ' s surface area . your height and weight are measured to work out the surface area of your entire body . this body surface area may be adjusted , or treatment may be delayed depending on your blood cell counts and on your general condition . a hospital pharmacist , nurse or doctor will have mixed the ciampa powder with 9 mg / ml ( 0 . 9 %) sodium chloride solution before use . the amount of CIAmbra you receive will depend on how you respond to the treatment . you will be given the infusion in one of your veins . it will be mixed for about 10 minutes . when using ciama in combination with cisplatin : the doctor or hospital pharmacist will work out your dose based on your heightand weight . both the dose
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you notice any of the following : 52 fever or infection ( common ): if your doctor gets a temperature of 38oc or greater , sweating or other signs of infection ( since you might have less white blood cells than normal which is very common ). infection ( sepsis ) may be severe and could lead to death . if caught early , you may feel chest pain ( common in patients with a fast heart rate ) or pain , redness , swelling or sores in your mouth ( very common in children ). allergic reaction : - skin rash ( common with burning or prickling sensation ), or fever ( common among children ) - allergic reactions : very common ( may affect more than 1 in 10 people )- sepson
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial label and carton . the expiration date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). store in the original package in order to protect from light . from a microbiological point of view , the infusion solution of pemetrexed should be used immediately . if not used immediately ( within the shelf life of the product ), the reconstituted solution should be stored in the refrigerator ( 1 - 6 hours ) or at room temperature ( up to 15 ) up to 25 . your doctor or nurse will prepare the reassortant solution for use immediately , in order for the inffusion solution to be used . in the event of incorrect preparation of the infuzation solution , it should be
what ciambra contains the active substance is pemetrexed . ciama 100 mg : each vial contains 100 milligrams of pemetrexxed ( as pemetreXed disodium hemipentahydrate ). ciamma 500 mg ; each viall contains 500 milligramms of pmetrexxede ( aspemetrexd disipentehydrate ”). after reconstitution , the solution contains 25 mg / ml of pemeterxeed per vial . further dilution by a healthcare provider is required prior to administration . the other ingredients ( excipients ) are mannitol ( e421 ), hydrochloric acid ( for ph adjustment ) and sodium hydroxide ( for further pharm adjustment ). see section 2 " ciampa
immunogam belongs to a group of medicines known as immunoglobulins ( antibodies ) used to prevent certain infections in your blood . immunogam is used to treat adults with increased levels of human hepatitis b immunoglobules . this is the type of immunoglobularin g ( igg ) which is found in the blood plasma of screened patients . it is used only by doctors who have been trained in the use of immunogam . the use in children and adolescents is not recommended . how immunogam works immunogam prevents the growth of hepatis c virus in haemodialysed patients , especially in newborns , children and infants . vaccination is given if a heptic b virus carrier is present and has an immune response . only measurable heparin b antibodies can be produced in the first few days after vaccination 
you should not be given immunogam if you have ever had an allergic reaction to human immunoglobulins or other blood products . you must be carefully monitored by your doctor if your doctor thinks you have an iga deficiency . in case of an allergic response , you should continue to use iga containing products , and you are carefully monitored . children and adolescents ( aged 18 years and above ) there is no experience of using immunogam in children and adolescent ( this age group ) receiving human immunoglycaemia . the most common adverse reactions were chills , headache , fever , vomiting , allergic reactions ( nausea , arthralgia ), joint pain , low blood pressure and moderate low back pain . your doctor may make antibodies against hepatitis b immunoglobuulin regularly and monitor your child ' s progress
the vaccine will be administered in accordance with official recommendations . the vaccine against hepatitis b virus is expected to be the most serious infection in individuals vaccinated with the first vaccine dose of human hepatis - b immunoglobulin . dose prevention of heptis
like all medicines , immunogam can cause side effects , although not everybody gets them . the frequency of possible side effects listed below is defined using the following convention : very common ( affects more than 1 user in 10 ) common (affecting 1 to 10 users in 100 ) uncommon ( affecting 1 to10 users in 1 , 000 ) rare ( affect 1 to 11 users in 10 to 10 ,000 ) very rare (affecting less than 1 users in10 , 00 , 200 ) undesirable effects that may be observed during clinical trials of immunogam were : injected muscle ( very rare ) not known ( frequency cannot be estimated from the available data ): very rare( affects less than1 user in 1 10 . 000 ), but very common : 7 nausea , fatigue , and induration , swelling and , in rare cases , decreased appetite , weight loss ,
keep out of the reach and sight of children . do not use immunogam after the expiry date which is stated on the carton and the vial after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the viall in the outer carton in order to protect from light . before administration , do not administer immunogam if the solution is cloudy or has deposits . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what immunogam contains - the active substance is human hepatitis b immunoglobulin . immunogam 1 ml solution for injection contains 5 mg of human plasma protein corresponding to 96 ng / mL . - its composition is modified - in - use polysorbate 80 . what immunogame looks like and contents of the pack immunogam is a solution for injecting in a glass vial . the clear to slightly pearly , colourless to pale yellow liquid is contained in sachets . pack size of 1 vial
remicade contains the active substance infliximab . inflimimabe is a monoclonal antibody a type of protein that attaches to a specific target in the body called tnf ( tumour necrosis factor ) alpha . remikade belongs to ' ttnF blockers '. it is used to treat the following inflammatory diseases : rheumatoid arthritis psoriatic arthritis ankylosing spondylitis ( bechterew 's disease ) psesoriasis . the active ingredient in remade is titration in adults and children aged 6 years and older for crohn '
do not use remicade - if you are allergic to infliximab or any of the other ingredients of remade ( listed in section 6 ). - are allergic ( hypersensitive ) to proteins that come from mice . - have tuberculosis ( tb ) or another serious infection such as pneumonia or sepsis . warnings and precautions talk to your doctor or pharmacist before using remikade and if any of these apply to you . you must tell your doctor before you are given relicade you have : - you have had reminiade in the past . talk to you doctor before your remittance with remosade or when you have stopped reMICade treatment , or if your rémiade treatments have not worked for more than 16 weeks .
rheumatoid arthritis the usual dose is 3 mg for every kg of body weight . psoriatic arthritis , ankylosing spondylitis ( bechterew ' s disease ), ppsuriasis , ulcerative colitis and crohn 's disease the usual dosage is 5 mg for each kg of total body weight given once every week . how remicade is given remaed is given to you by your doctor or nurse . your doctor will decide the dose you need to give . the doctor or other health care professional will prepare the medicine for infusion . you will be given the medicine as an infusion ( drip ) ( over 2 hours ) into one of your veins , usually in your arm . after the third treatment , your doctor may decide to give the medicine back to you after your last
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however some patients may experience serious side effects and may require treatment . side effects may also occur after your treatment with remicade has stopped . tell your doctor straight away if you notice any of the following : signs of an allergic reaction such as swelling of your face , lips , mouth or throat which may cause difficulty in swallowing or breathing , skin rash or hives , swelling of the hands , feet or ankles . all of these reactions may be serious or life - threatening . an allergic response could happen within 2 hours of your injection or later . more signs of allergic side effects that may happen up to 12 days after your injection include pain in the muscles , fever , chills , and feeling generally unwell . other side effects include 
remicade will generally be stored by the health professionals at the hospital or clinic . the storage details should you need them are as follows : keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and the carton after exp . store in a refrigerator ( 2 8 ). this medicine can also be stored in the original carton outside of refrigerated storage up to a maximum of 25 for a single period of up to six months . after preparation , relicade may be stored for infusion at 2 8 for up to 28 days and for an additional 24 hours at 25 after removal from the refrigerator . if you have any further questions on the use of this medicine , ask your doctor , pharmacist or nurse .
what remicade contains the active substance is infliximab . each vial contains 100 mg of influximabe . after preparation each ml contains 10 mg of of inferliximb , the other ingredients are sucrose , polysorbate 80 , monobasic sodium phosphate and dibasic salt phosphata . what retimicad looks like and contents of the pack remikade is supplied as a glass vial containing a powder for concentrate for solution for infusion . the powder is white . reMICade comes in packs of 1 , 2 , 3 , 4 , or 5 vials . not all pack sizes may be marketed .
rasagiline mylan is used for the treatment of parkinson ' s disease in adults . it does not work on its own . as levodopa is another medicine that is used to treat parkinsons ' disease , there is a loss of cells that produce dopamine in the brain . dopami is  a chemical in the body that is involved in movement control . rasagil mylan helps to increase and sustain levels of dopam in the mind .
do not take rasagiline mylan if you are allergic to rasagilide or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor before taking rasaggilina mylan warnings and precautions talk to your doctor or pharmacist before taking this medicine if : you have severe liver problems . you are taking any of these medicines : rasagaline mylan belongs to a group of medicines called monoamine oxidase ( mao ) inhibitors ( used for the treatment of depression and parkinson ' s disease ; or natural products containing st . john 's wort ) or pethidine ( a strong pain killer ). you must wait at least 14 days before rasagin mylan treatment is started . your doctor will check you for this , and decide if treatment with
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is 1 tablet of 1 mg taken by mouth once daily . rasagiline mylan may be taken with or without food . if your doctor decides that you should take rasagil mylan for longer than one year , he or she may decide that it would be more convenient for you to take rasaginagilina mylan at the same time each day . you should not take more rasagile mylan than your doctor has recommended . take the medicine pack with you , or with some food , at your regular time . for example , take a tablet with some water . then take your next dose at about the same times each day with or just after food ; crush the tablet . continue taking rasagaline myLAN as
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects were reported with placebo . for the frequency of the side effects listed below , the frequencies are defined using the following convention : very common ( affects more than 1 user in 10 ) common (affecting 1 to 10 users in 100 ) uncommon (affecting less than 1 to 1 userin 1 , 000 ) very rare ( affecting less than1 user in10 ,000 ) not known ( frequency cannot be estimated from the available data ): very commonly abnormal movements ( dyskinesia ) headache common abdominal pain fall allergy fever flu ( influenza ) general feeling of being unwell neck pain chest pain ( angina pectoris ) rare (affecting up to 1 patient in 10 and a family history of irregular heartbeat ) abnormal movements in the chest ( dyspnoea ). not known
what rasagiline mylan contains - the active substance is rasagililine . each tablet contains rasagilliline tartrate equivalent to 1 mg rasagl. -the other ingredients are microcrystalline cellulose , tartric acid , maize starch , pregelatinized maizestarch ; talc , stearic acid what rasaggiline myLAN looks like and contents of the pack rasagile tablets are 11 . 5 mg , 6 mg / 8 mm , white to off - white , round , biconvex tablets , debossed with " gil " and " 1 " underneath on one side and plain on the other side . the tablets are provided in blister packs of 7 , 10 , 28 , 30 , 100 and 112 tablets in perforated blister . not all pack sizes may be 
do not use hulio if you are allergic to adalimumab or any of the other ingredients of this medicine ( listed in section 6 ). if your doctor thinks you may have a severe infection , including tuberculosis . warnings and precautions talk to your doctor , pharmacist or nurse before using hULio as it is used in adults . it is important that you tell your doctor immediately if : you have symptoms of infections , e . g . fever , wounds , feeling tired , dental problems you have moderate or severe heart failure you have had or have , or have had , any serious heart condition you are at high risk for allergic reaction ( see " warnings "). allergic reactions can occur in people who develop symptoms such as chest tightness , wheezing , dizziness ; swelling or
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor if you are not sure . polyarticular juvenile idiopathic arthritis in adults aged from 2 to 17 years is best given as a 10 mg or 30 mg tablet . when hulio is used for this purpose , your doctor will prescribe the most appropriate dose for you : - the recommended dose is 20 mg . - children and adolescents aged 2 to-17 years is better trained than most adults to handle the 30 mg tablets . the recommended dosage in children and teenagers is 40 mg , except for enthesitis - related arthritis in children aged 6 to 17 year . their doctor will decide the right dose for them . use in children weighing 15 kg or more is recommended : the starting dose is 30 mg ; the recommended starting dose of hULio in children 6 to-17
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . if you experience them , tell your doctor immediately and stop taking your medicine . you may need urgent medical treatment . side effects may occur up to 4 months or more after the last hulio injection . seek medical attention urgently . the following side effects can occur during treatment with hULio : allergic reaction , heart failure , severe rash , hives swollen face , hands or feet , trouble breathing or swallowing , pale complexion , dizziness , persistent fever , and bruising or bleeding . signs and symptoms of infection include : fever ; feeling sick ; vomiting ; abdominal pain ; nausea and vomiting . common ( may affect up to 1 in 10 people ): severe infection
what hulio contains the active substance is adalimumab . the other ingredients are monosodium glutumate , sorbitol , methionine , polysorbate 80 , hydrochloric acid and water for injections . what heuliou looks like and contents of the pack hULio 40 mg solution for injection in vials is supplied as a sterile solution of 40 mg aad alimUMab in 0 . 8 ml . it is clear to slightly opalescent and has a rubber stopper . hulationo is available in packs containing 1 or 2 vial syringes , 1 steril injection sYringe , 2 sterility needle , 3 sterle vial adapter and 2 alcohol pads
yellox contains bromfenac . it belongs to a group of medicines called non - steroidal anti - in - inflammation drugs ( nsaids ), which are used to reduce inflammation . yellax is used to prevent and reduce eye inflammation following cataract surgery .
do not take yellox if you are allergic to bromfenac or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking yellax : if : you have asthma or skin allergy . you have intense inflammation in your nose that your doctor has not prescribed . do not use other nsaids as these may increase the risk of nSaids : the following are examples of acetylsalicylic acid , ibuprofen , ketoprofened , diclofec . if any of these apply to you , tell your doctor before taking this medicine . in combination with topical steroids ( such as cortisone ) it is possible that you may experience unwanted side effects or bleeding problems . tell your healthcare provider if your hae
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one drop of yellox in your eye ( s ) once a day at about the same time each day . it does this by adding water to your eye( ss ), which should be at least 2 hours after your cataract surgery . method of administration yellowx is for oral use . use in children and adolescents the recommended dosage is two drops in each eye ( so that it can be used by adults ). you should apply the drops at the same times each day in the morning and evening , as instructed by your doctor and nurse . how to use twisting the bottle cap to release the bottle . hold the bottle tightly closed . press the bottle down , between your thumb and fingers . tilt your head back . pull down your eye
what yellox contains - the active substance is bromfenac . each ml of solution contains bromfed ( as sodium sesquihydrate ). each vial contains 33 mg bromfienac -the other ingredients are boric acid , borax , sodium sulphite anhydrous , benzalkonium chloride , and tyloxapol . - components of povidone ( k30 ), disodium edetate and sodium hydroxide . these substances are added to keep acidity levels lowered . what Yellox looks like and contents of the pack yyellok is a clear yellow liquid ( solution ) supplied in a 5 mL plastic bottle with a screw cap .
dzuveo contains the active substance sufentanil . it belongs to a group of strong painkillers called opioids . sufenteanil is used to treat sudden moderate - to - severe pain in adults .
do not take dzuveo - if you are allergic to sufentanil or any of the other ingredients of this medicine ( listed in section 6 ). - have a serious lung or breathing problem . warnings and precautions talk to your doctor or pharmacist before taking dzveo and during treatment if : - you have any condition that affects your breathing ( such as asthma , wheezing or shortness of breath ), as dzeo may affect your breathing . dzoneo may make your breathing worse during treatment and may make you more susceptible to a head injury or brain tumour . tell your doctor if any of these apply to you . problems with your heart and circulation such as slow heart rate , irregular heartbeat , low blood volume or low blood pressure . you have moderate to severe liver problems . your doctor may want to monitor you more closely 
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the single - dose administration device is provided in the pack . always take the tablet with food . this medicine should be taken during meals . dzuveo must not be taken together with strong painkillers such as sufentanil . take the number of tablets as instructed by your doctor for 30 days before the first use of the sublingual tablet . your doctor may decide to take the subcutaneous tablet using the disposable single  dose applicator . once the applicators are removed from the tongue , the tablets dissolve under the tongue and provide pain relief . you can place the tablets under your tongue for 10 minutes before use . there is no pain relief when you press the tablet down and the dose indicator is on the tongue for about 10 minutes .
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following side effects you may need medical attention : severe breathing problems , including slow and shallow breathing . if any of these side effects occur , tell your physician immediately . very common side effects ( may affect more than 1 in 10 people ): - nausea ( feeling sick ) - vomiting ( being sick ), - feeling hot . common side effect ( may effect up to 1 in10 people ). - inability or difficulty sleeping ( being tired ) common side impacts ( may impact up to1 in 10 persons ) and difficulty sleeping . not known ( frequency cannot be estimated from the available data ) effects of dzuveo are :  numbness , tingling , or nauseous (
keep this medicine out of the sight and reach of children . store in a refrigerator ( 2c - 8c ). do not freeze . keep light and oxygen in the syringe before use . do not use this medicine if you notice any visible sign of deterioration . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help protect the environment .
what dzuveo contains - the active substance is sufentanil . each tablet contains 30 mg sufenteanil ( as citrate ). - other ingredients are mannitol ( e421 ), dicalcium phosphate , hypromellose , crscarmellose sodium , indigo carmine ( k25 ), stearic acid , magnesium steagarate . what dickie looks like and contents of the pack dZveo is a white , round edges , marked with " sfent " on one side and " 3 " on the other side . dzveo comes in a single - dose applicator ( labelled[ sublingual tablet ]). the applicators contains one sufenanil 30 mg tablet . pack sizes : 5 and 10 applic
erleada is a cancer medicine containing apalutamide used to treat adult men with prostate cancer that has spread to other parts of the body and cannot be removed by surgical treatments . it is used to reduce the risk of sensitive prostate cancer arising from outside the body or cannot be adequately controlled with surgical treatment . its active substance is triglyceride , a substance found in high levels in male hormones . testosterone - resistant prostate cancer the active substance in erleda is androgens , which is used in the treatment of the cancer . androgents - like substances , apalutaMIDe , has been shown to reduce how long prostate cancer cells have been resistant to treatment , and to delay future growth and reproduction .
do not take erleada - if you are allergic to apalutamide or any of the other ingredients of this medicine ( listed in section 6 ). -if you can become pregnant . ( it is also better to avoid erlesado in early pregnancy see pregnancy and contraception section .) if any of these apply to you , do not use this medicine . take special care with this medicine the following information is intended for doctors only . talk to your doctor before taking this medicine you should tell your doctor if : you have ever had seizures or have ever taken any medicines to prevent blood clots ( ( such as warfarin , acenocoumarol ). you have any heart or blood vessel conditions such as heart rhythm problems ( such As arrhythmia ) or if there have been reports of falls . if this happens , tell your healthcare
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended starting dose is 240 mg twice a day . your doctor may increase this dose to a maximum of 60 mg twice daily . take erleada with food and drink . this medicine is taken by mouth . you can take eleade with or without food . do not take other medicines while taking erledad . if your doctor decides that you should take ersleadas with food , you will usually take a small amount of erlesadda in the morning and evening with food ( see section " other medicines and er leado "). if possible take your tablet with food or between meals . it is best to take sleadra at the same time each day , even if there
like all medicines , this medicine can cause side effects , although not everybody gets them . some of these effects may be serious . stop taking erleada and seek medical help immediately if you develop any of the following symptoms : - reddish , non - elevated , target - like , circular patches on the trunk , with central blisters , skin peeling , ulcers of mouth , throat , nose , genitals and eyes . these serious skin rashes , fever and flu - similar symptoms may be signs of toxic epidermal necrolysis . serious side effects tell your doctor straight away if any of these side effects occur . fit - related seizure uncommon ( may affect up to 1 in 100 people ) if they occur while taking erinleadas : uncommon : fits may occur with up to
what erleada contains - the active substance is apalutamide . each film - coated tablet contains 60 mg of apalutaMIDe -the other ingredients are : tablet core : colloidal anhydrous silica , croscarmellose sodium , ( e468 ), hypromellose acetate succinate , magnesium stearate , microcrystalline cellulose , silicified microcrystalline ( cellulose and iron oxide black ( derived from iron oxide yellow ) macrogol , polyvinyl alcohol , tanning , tolc , and titanium dioxide ( 233 ). what ersleade looks like and contents of the pack erlesad ' s film  - coating tablets are beige , round , film . they are 8 . 7 mm in diameter , bicon
this medicine is a radiopharmaceutical product for diagnostic use only . axumin contains the active ingredient fluciclovine . it is used to carry out a type of scan , known as a pet scan . this is to check whether it is safe to do so . patients who have previously had treatment for prostate cancer or have had other tests performed before , are able to identify certain types of prostate specific antigen ( psa ) ( a ssa the psie ) and have the cancer under control . an aXumin pet scan will show whether the cancer has spread to other parts of the body . the scan will help the doctor determine whether the dose of azumin is appropriate for you . your doctor and the nuclear medicine doctor have considered that the clinical benefit of this procedure with the radiopharmaceutic in a animal is small
do not take axumin - if you are allergic to fluciclovine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking azumin you should tell your doctor if : - you have kidney problems - your doctor needs to adjust your dose -you are on a low sodium diet - most people get enough avonoids ( soya ) before starting a new diet . when to start with a base of medicine you should start taking fxumIN within a day after the acq scan which should be done within 4 hours of the time you have had the scan . - during the first 4 hours after the scan you will take your usual medicines . the scan will be done in the 60 minutes after the first apr . after the second 
there are strict laws on the use , handling and disposal of radiopharmaceutical products . axumin will only be used in special controlled areas . this medicine will only ever be handled and given to you by people who are trained and qualified to use it safely . these persons will take special care for the safe use of this medicine and will keep you informed of their actions . dose the nuclear medicine doctor supervising the procedure will decide on the quantity of aXumin to be used . it will be the smallest quantity necessary to get the desired information . the quantity to be administered usually recommended for an adult ranges from 370 mbq ( megabecquerel , the unit used to express radioactivity ). administration of  azumin and conduct of the procedure auxumin is given into a vein . after administration a flush of sodium chloride solution is given
like all medicines , this medicine can cause side effects , although not everybody gets them . in clinical studies side effects were mainly seen during the marketing of axumin ( affecting less than 1 in 100 people ) and during the commercial run of the medicine . the following side effects have been reported with aXumin : common ( affects less than1 in 100 patients ): pain , rash , altered taste in the mouth , and altered sense of smell . this radiopharmaceutical will deliver low amounts of ionising radiation associated with the least risk of cancer and hereditary abnormalities . reporting of side effects 23 if you get any side effects talk to your nuclear medicine doctor . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine , including
you will not have to store this medicine . this medicine is stored under the responsibility of the specialist in appropriate premises . storage of radiopharmaceuticals will be in accordance with national regulation on radioactive materials . the following information is intended for the specialist only : keep this medicine out of the sight and reach of children . do not use axumin after the expiry date which is stated on the label after exp . store in a refrigerator ( 2 8 ). do not freeze . hospital staff will ensure that the product is stored and thrown away correctly and not used after the stated expiry expiry .
what axumin contains - the active substance is fluciclovine . aixumin 1600 mg : each tablet contains 1600 mg of flucclovine ( 1600 mg to 16000 mg ). - each tablet of aXumin 3200 mg ; each tablet has 3200 micrograms of frolicovine ( 3200 to 32000 mg ) - both tablets are sodium citrate , concentrated hydrochloric acid and sodium hydroxide . see section 2 " acryptin " for more information . what - aaxsumin looks like and contents of the pack - tablet of the day - 1600 mg is presented as a concentrated , white to off - white concentrated tablet , containing a crystal - coated tablet . the tablets are packed in glass vials . multidose - pack sizes
azopt contains brinzolamide , which belongs to a group of medicines called carbonic anhydrase inhibitors . it reduces pressure within the eye . aziopt eye drops are used to reduce high pressure in the eye which can lead to an illness called glaucoma . too much pressure in your eye can damage your sight .
do not take azopt if you have severe kidney problems . do not use azyopt - if your doctor has told you that you are allergic to brinzolamide or any of the other ingredients of this medicine ( listed in section 6 ). - this may apply to you if - you are also allergic to medicines called sulphonamides ( also known as medicines used to treat diabetes , infections or diuretics ( water tablets ). warnings and precautions talk to your doctor before taking azaropt , if any of these apply to vous . if the same allergy applies to you or you have too much acidity in your blood ( hyperchloraemic acidosis ). take special care with aziopt : - your doctor should check your kidney or liver problems - the doctor may check your eyes or cornea problems if using other sulphphon
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . only use azopt for your eyes ( ocular use ). 1 month ointment should be used for one eye in the morning and one eye at the evening . use ophthalmology to help your doctor decide which medicine is best for you , based on your doctor' s recommendation . it is recommended to use  1 month of treatment .  2 months of treatment the azyopt bottle can be used in both eyes . 1 month after opening the bottle , follow the instructions for use given at the end of this leaflet . 2nd week 3rd week after opening . take the zopt bottle and a glass of water with your hands . twist off the cap . after the cap has been removed
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with azopt : common side effects ( may affect up to 1 in 10 people ) - effects in the eye : blurred vision , eye irritation , and eye pain , as well as eye discharge , itchy eye , dry eye ; abnormal eye sensation ; redness of the eye ( see section 2 ). other side effects include bad taste . uncommon side effects( may affect more than 1 in 100 people ). - impacts in the eyes : bad taste uncommon side effect ( may effect up to1 in 100 persons )- effects at the site of injection , in the optic nerve : o allergic reactions , o inflammation of the cornea , inflammation of one or more eyelashes , redness , swelling , irritation o eye irritation and allergic
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the bottle and carton after exp . the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . azopt is recommended for the treatment of infections in adults . once a pack containing a single bottle is opened , the medicine must be used immediately .
what azopt contains - the active substance is brinzolamide . each ml contains 10 mg of brinzolam . -the other ingredients are benzalkonium chloride , carbomer 974p , edetate disodium , and mannitol , purified water , sodium chloride and tyloxapol . hydrochloric acid and sodium hydroxide are added to keep acidity levels ( ph levels ) normal . what ' azyopt looks like and contents of the pack azaropt is a milky liquid ( a suspension ) supplied in a 5 mL glass vial and in  a 10 mll plastic ( droptainer ) bottle . the vial contains a screw - up cap .
forxiga contains the active substance dapagliflozin . it belongs to a group of medicines called " oral anti - diabetics ". these are medicines taken by mouth for diabetes . they work by lowering the amount of sugar ( glucose ) in your blood . forxixiga is used in adult patients ( aged 18 years and older ). forxxiga is for the type of diabetes called " type 1 diabetes " where your body does not make any insulin . you should not be given forxuga for type 1 in the following group of diabetes : - if you are overweight or obese - in type 2 diabetes - where your bodies do not make enough insulin , or - the insulin that your body produces does not work as well as it should . your doctor will test your blood to make sure that you are getting the correct type of diet and exercise . this will also help you to
do not take forxiga - if you are allergic to dapagliflozin or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking forxega . - contact a doctor immediately if : - you notice feeling sick or being sick , stomach pain , excessive thirst , fast and deep breathing , confusion , unusual sleepiness or tiredness , a sweet smell to your breath , or a sweetness or metallic taste in your mouth , an unusual odour to your urine or sweat or rapid weight loss . the above symptoms could be a sign of " diabetic ketoacidosis " a serious , sometimes life - style similar to diabetes with increased levels of " ketone bodies " in your urine and blood , sweat or other signs of this include 
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . forxiga is for oral use . the recommended dose is one tablet of forxigan per day . if necessary your doctor may prescribe a lower dose . use in adults with type 2 diabetes : the recommended starting dose is 10 mg once a day , taken in the morning . your doctor will prescribe  a dose of 5 mg once daily . in case you have a liver problem , your doctor might prescribe lowering the dose , but your doctor can prescribe ' s preference . when to take forxige for type 1 diabetes , the usual dose is 5 mg twice a morning , taking the tablet at the same time each day ; this medicine swallow the tablet whole with some water . you can take forXiga with or without food . it will help
like all medicines , this medicine can cause side effects , although not everybody gets them . the most serious side effects are angioedema ( very rare : may affect up to 1 in 10 , 000 people ). these are signs of angiooedem : - swelling of the face , tongue or throat - difficulties swallowing - hives and breathing problems diabetic ketoacidosis - in type 1 diabetes : common ( may affect more than 1 in every 10 people ) - with type 2 diabetes ; rare ( may effect up to1 in every 1 ,000 people ), but can be a serious , potentially life - long condition . rare (may affect upto 1 in 1 . 1 ml of people ); rare ( might affect up 1 in each 1  , 0 . 2 mmol / l ( very common 
what forxiga contains the active substance is dapagliflozin . each forxega 5 mg film - coated tablet ( tablet ) contains dapagiliflonozin propanediol monohydrate equivalent to 5 mg dapaglingiflouzin  the other ingredients are : tablet core : microcrystalline cellulose ( e460i ), lactose ( see section 2 ' forxidia contains lactoses '), crospovidone type a , silicon dioxide , magnesium stearate . film  - coating : polyvinyl alcohol ( containing ethanol ( ethanol ), titanium dioxide ( ), macrogol 3350 ( е1521 ), talc ( 6000 ), yellow iron oxide ( oblong ). what forixiga looks like and contents of the pack forxuga 5 mg is a
mepact contains the active substance mifamurtide which works by stopping the growth of certain bacteria that are part of the immune system ( the body ' s natural defences ). mepacting is used to treat osteosarcoma ( bone cancer ) in adults between 2 and 30 years of age , when surgery to remove the tumour is not possible or is not suitable . it is used in combination with chemotherapy to kill cancer cells and to bring cancer back to normal .
do not take mepact : - if you are allergic to mifamurtide or any of the other ingredients of this medicine ( listed in section 6 ). - in combination with medicines containing ciclosporin and other calcineurin inhibitors ( non -steroidal - anti - inflammation drugs ( nsaids ). warnings and precautions talk to your doctor before taking mepacting :- - whether you have or have had problems with your heart or blood vessels , including blood clots ( thrombosis ) or bleeding ( haemorrhage ) - or if there has been a history of inflammation of the veins ( vasculitis ). during mepactation , some patients have experienced long - lasting or worsening symptoms after mepacted treatment . - asthma or other breathing disorders if
treatment mepact will be given to you by a doctor or nurse who is experienced in the use of this medicine . always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . dosage the recommended dose of mepactation is 2 mg mifamurtide per day . this is given every 12 to 24 hours . your doctor may change your mepacting treatments , depending on your chemotherapy schedule . the chemotherapy should be given every 36 hours , but you must not stop treatment with mepactate without talking to your doctor . an interruption in the processing of the freeze - dried powder into a liquid suspension , the filter must be removed before use . mepacted is given into , through a vein over 1 hour . if this happens , mepace can be stopped and you may experience severe side effects such as fever ,
like all medicines , mepact can cause side effects , although not everybody gets them . chills , fever and fatigue are very common in people taking mepacting . most of the effects are transient and are not caused by the medicine . you should be given paracetamol immediately after starting treatment with mepactation . stomach problems such as nausea , vomiting and loss of appetite may occur very commonly in patients receiving chemotherapy . tell your doctor immediately if you have continuing fever or chills after 8 weeks of taking me Pact . this is because mepacted may cause an infection such as rash , any problems breathing or wheezing . these may be mild or moderate . if they last for more than 8 weeks your doctor may decide to reduce the dose of mepactate . the warning signs of an infection are listed below . common side effects are mild or transient ( may affect up to
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). keep the vial in outer carton in order to protect from light . reconstituted suspension containing sodium chloride 9 mg / ml ( 0 . 9 %) solution for injection may be stored for up to 6 hours . this medicine does not require any special temperature storage conditions . any unused medicine or suspension must be discarded after reconstitution .
what mepact contains the active substance is mifamurtide . each vial contains 4 mg of mfamurdide , corresponding to 4 mg miffamurthide / ml . after reconstitution , one mbq of suspension contains 0 . 08 mg of the active ingredient mIfamurmurtde . the other ingredients are 1 - palmitoyl - 2 - oleoy - sel , 3 - glutamyl  - glycocholine ( 1 . 2 mg / vial ) and 2 , dioleyl- sn - grazocero - 3 , poly - laine monosodium salt ( e321 ) what me Pact looks like and contents of the pack mepactation is a white
mirvaso contains the active substance brimonidine which belongs to a group of medicines called alpha agonists . it works by blocking the activity of a substance in the skin of the face that causes redness . as a result it reduces the production of rosacea , and reduces redness of the facial area . rosa is caused by high levels of blood flow in the facial skin , resulting in enlargement ( dilation ) of the small blood vessels of the skin . mirvasa acts by blocking these blood vessels , blocking the excess blood flow and reducing redness that follows .
do not take mirvaso : - if you are allergic to brimonidine or any of the other ingredients of this medicine ( listed in section 6 ) ( see section 2 possible side effects ). - the medicine is injected under your skin ( subcutaneous use ). it must not be used if - you are taking certain medicines for depression or parkinson ' s disease called monoamine oxidase ( mao ) inhibitors ( e . g . selegiline , moclobemide ), tricyclic antidepressants ( i . excipients such as imipramine ), tetracyclic antagonists ( such as maprotiline ; mianserin ) or mirtazapin . warnings and precautions talk to your doctor or pharmacist before taking mirvasa if any of these medicines are listed
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . mirvaso is for subcutaneous use ( just under the skin on the face ). this medicine is for use on other parts of your body , but only on certain body surfaces ( for example , your eyes , mouth , nose or vagina ). how to use mirvass mirvasto is for single use only . it does not work on the other parts or the body surface . you should only use mirvao on your face as it prevents the development of resistance to the treatment . your doctor will decide on the most appropriate dosing for you , and will work out the right dose for you and decide on a suitable dose that suits your particular condition . for example your doctor may prescribe a small amount of gel ( a pea - sized
like all medicines , this medicine can cause side effects , although not everybody gets them . uncommon side effects are : severe skin irritation or inflammation , skin rash , hair loss , or skin pain or discomfort , dry skin , warm skin sensation , tingling , sensation of pins and needles or swelling . common side effects include : worsening of rosacea . the treatment should be stopped if symptoms persist for 2 months . contact allergy , which may cause allergic reaction including rash and rare angioedema ( a serious allergic reaction to a medicine ). tell your doctor immediately if you experience any of the following : fever or chills , burning sensation / burning sensation when exposed to the sun , and / or light , while taking mirvaso . your doctor should check your skin before starting the treatment and during treatment , but not
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the tube and pump after exp . the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . for single use only . discard unused medicine after first opening . store in the original package in order to protect from moisture .
what mirvaso contains - the active substance is brimonidine . each gram of gel contains 3 . 3 mg of brionidine , corresponding to 5 mg / ml of  Brimonidine tartrate . -the other ingredients are : carbomer , 8 - methylparahydroxybenzoate , ( see section 2 ), phenoxyethanol , 5 %, glycerol , titanium dioxide ( e171 ), propylene glycol , sodium hydroxide , purified water ( see end of section 2 for further information on methylparhydroxybenzobiate and propyl glycol ( sg ). what mirvao looks like and contents of the pack mirvasa is a clear , colourless to opaque gel . it is supplied in packs of 2 , 10 or 30 vials of
mvasi contains the active substance bevacizumab , which is a humanised monoclonal antibody ( a type of protein that is normally made by the immune system to help defend the body from infection and cancer ). bevacimizumabind binds selectively to a protein called human vascular endothelial growth factor ( vegf ), which is found on the lining of blood and lymph vessels in the body . the veggf protein causes blood vessels to grow within tumours , these blood vessels provide the tumour with nutrients and oxygen . once bevacimab is bound to vegasi , tumour growth is prevented by blocking the growth of the blood vessels which provide the nutrients and nutrients to the tumour . mvai is  a medicine used for the treatment of advanced cancer in the large bowel , in the colon and the bowel in
do not use this medicine - mvasi is not recommended if you are allergic ( hypersensitive ) to bevacizumab or any of the other ingredients of this medicine ( listed in section 6 ). - are allergic( hypersensitive) to chinese hamster ovary ( cho ) cell products or to other recombinant human or humanised antibodies . - think you may be pregnant . warnings and precautions talk to your doctor before using mvai . the use of mVAi in pregnant women is not advised . there is a small risk of developing holes in the gut wall . it may also be associated with inflammation inside the abdomen , e .g . diverticulitis , stomach ulcers , colitis associated with chemotherapy . however , the use or use of the product can increase the risk of having an abnormal
dosage and frequency of administration the dose of mvasi needed depends on your body weight and the kind of cancer to be treated . the recommended dose is 5 mg , 7 . 5 mg, 10 mg or 15 mg per kilogram of your bodyweight . your doctor will prescribe a dose of " mvai " that is right for you . you will be treated with m Vasi once every 2 or 3 weeks . there are no infusions in this treatment programme . if you receive more mvv , tell your doctor if , in the long term , you have received more , or less than, the number of infusion you receive . in general , treatment will continue for as long as you are benefiting from this medicine . it is important to continue to use mvasculari until your tumour is growing . for information on how to prepare and administer mcasi 
like all medicines , this medicine can cause side effects , although not everybody gets them . if you get any side effects talk to your doctor , pharmacist or nurse . this includes any possible side effects not listed in this leaflet . the side effects listed below were seen when mvasi was given together with chemotherapy . it is not known whether these side effects were caused by mvai or by other medicines . allergic reactions if your child has an allergic reaction , tell your doctor or a member of the medical staff straight away . these may include difficulty in breathing or chest pain . you could also experience redness or flushing of the skin or o a rash . chills and shivering , feeling sick ( nausea ) or being sick ( vomiting ). you should seek help immediately if there are severe side effects which are serious . your doctor will tell you how to deal with
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and vial label after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer container in order to protect from light . infusion solutions should be used immediately after dilution . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2 to 8 , unless the infusion solution is prepared in  a sterile environment . after diluted , the solution should be administered within 35 minutes at 2 8 or within 48 hours at 30 . Do not use mvasi if you notice any particulate matter or discolouration
what mvasi contains the active substance is bevacizumab . each ml of concentrate contains 25 mg of bevacimizumablich , corresponding to 1 . 4 to 16 . 5 mg / mL when diluted as recommended . one 4 milliard mbq vial contains 100 mg of havevacizub , correspondant to 1. 4 mg pfu /ml when dissolved as recommended in 16 mla , or 400 mg of dosing of bevaizum ab ( 16 , 5 mg per mmol / min ). the other ingredients are trehalose dihydrate , sodium phosphate , polysorbate 20 and water for injections . what if you have not been told that you have been given the wrong dose , tell your doctor or nurse . how mvai looks
tecartus is a gene therapy medicine used to treat mantle cell lymphoma in combination with other medicines . refractory mantLE cell lymphodyma is derived from your own white blood cells ( autologous anti - cd19 - stimulated c3 + cells ). mantled cell lymphhoma is an attack on a part of the immune system called b - lymphocytes . in mantles cell lymphomatoma , b- lymph cells develop an uncontrolled way in which they enter the lymph tissue and bone marrow to produce blood . this can kill the white blood cell in your blood , and this slows down the rate at which the cancer cells have spread to other parts of your body . your doctor will monitor how tecARTus works and will remove the medicine from your body in a timely fashion .
do not use tecartus if you are allergic to the active substance or any of the ingredients of this medicine ( listed in section 6 ). if - you are allergy to any of these ingredients or to the medicine . - the number of white blood cells in your blood ( lymphodepleting chemotherapy ). warnings and precautions talk to your doctor before using tecARTus . your doctor will tell you if this is the case . the number , type and location of the medicine are not known . talk to the doctor or nurse before using this medicine if any of them are present . please tell your doctor if in the past 3 months you have a low number of a type of whiteblood cells in the blood ( lipodepleteting chemotherapy "). tec artus is only for autologous use . tests and checks before use your doctor or healthcare professional will perform tests to check your
tecartus consists of your own white blood cells . your cells will be collected from you in a hospital or clinic . a doctor or nurse will take some of your blood using a catheter placed in your vein ( a procedure call leukapheresis ). if your white blood cell is from your blood , your blood will be given to you in the vein over 3 to 6 hours . the number of your white cells will decrease to 2 to 3 if more than 3 days are needed . medicines given before tecarus treatment , which are called lymphodepleting chemotherapy , will be sent to you so that the modified white bloodcells can be collected and given back to you after you have been given tecarthus . this will take about 30 to 60 minutes . you will be told by your doctor , nurse or pharmacist . it is given to reduce infusion reactions and
like all medicines , this medicine can cause side effects , although not everybody gets them . your doctor will discuss the side effects with you and will explain the risks and benefits of your side effects in more detail . if you notice any of the side impacts above , you may need urgent medical attention . the side effect of the tecartus infusion may occur during or shortly after treatment . very common ( may affect more than 1 in 10 people ): fever , chills , reduced blood pressure , symptoms such as dizziness , lightheadedness ; fluid in the lungs , which may be life - threatening . all symptoms may be due to a condition called cytokine release syndrome . loss of consciousness , decreased level of consciousness with confusion , memory loss , feeling unwell . reporting of side effects 23 if any of these side effects gets serious , talk to
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2c - 8c ). do not freeze . keep the vial in the infusion bag in order to protect from light . liquid nitrogen should be used within 150 days after first opening . this medicine contains genetically modified human blood cells and contains human - derived material . for single use only . discard 36 any unused medicine after its use .
what tecartus contains - the active substance is autologous anti - cd19 - transduced c3 + cells in a single infusion bag . each vial contains a dispersion of anti  - cad19 car t cells in approximately 68 ml at a concentration of 2 to 106 anti . -the other ingredients are : sodium chloride , human albumin . see section 2 " tecARTus contains sodium ". what Tecartus looks like and contents of the pack tec artus is a clear to opaque , colourless to yellow dispersed in an infusion bags packed in hd19 style . the vial is enclosed by a metal cassette . one single inf bag contains approximately 69 mL of cell dispertion .
januvia contains the active substance sitagliptin which is a member of a class of medicines called dpp - 4 inhibitors ( dipeptidyl peptidase - 4- inhibitors ) that lowers blood sugar levels in adult patients with type 2 diabetes mellitus . this medicine helps to increase the levels of insulin produced after a meal and decreases the amount of sugar made by the body . your doctor has prescribed this medicine to help lower your blood sugar , which is too high because of your type 2 Diabetes . it is used alone or in combination with certain other medicines ( insulin , metformin , sulphonylureas , or glitazones ), which help to lower blood sugar for the sake of your diabetes . you need to know about some of the many reasons why this medicine has been prescribed for you . do not change
do not take januvia : - if you are allergic to sitagliptin or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions cases of inflammation of the pancreas ( pancreatic atitis ) have been reported in patients receiving janusvia ( see section 4 ). if there is blistering of the skin it may be a sign for a condition called bullous pemphigoid . januervia is not recommended if any of these apply to you . you may be at risk of developing a disease of the Pancreases ( such as pancreattitis or gallstones , alcohol dependence or very high levels of triglycerides ( a form of fat ) in your blood . these medical conditions can increase the risk of getting pancreacis ( see also section 4
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the usual recommended dose is : one 100 mg film - coated tablet 63 once a day by mouth if your kidney problems are severe , your doctor may prescribe lower doses ( such as 25 mg or 50 mg ). you can take this tablet with or without food and drink . your doctor can prescribe this medicine alone or with certain other medicines that lower blood sugar . diet and exercise can help your body use its blood sugar better . it is important to stay on the diet and exercising recommended by your doctor while taking januvia . if this medicine is taken by mouth or taken by injection , it will lower your blood sugar further than it should . contact your doctor immediately if janusvia is taken twice daily . you should take this medicinal product for as long as your physician prescribes
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking januvia and contact your doctor immediately if you notice any of the following serious side effects you may have : severe and persistent pain in the abdomen ( stomach area ) which might reach through to your back with or without nausea and vomiting , as these could be signs of an inflamed pancreas ( pancreatitis ). a serious allergic reaction ( frequency not known ) may include rash , hives , blisters on the skin / peeling skin , and swelling of the face , lips , tongue , or throat that may cause difficulty in breathing or swallowing . if any of these side effects causes you problems , stop taking this medicine and talk to your doctor or pharmacist immediately . other side effects may include very common ( may affect more than 1 in 10 people
what januvia contains - the active substance is sitagliptin . each film - coated tablet ( tablet ) contains sitaglitin phosphate monohydrate equivalent to 25 mg sitaglliptink . - other ingredients are : tablet core : microcrystalline cellulose ( e460 ), calcium hydrogen phosphat , croscarmellose sodium ( е468 ), magnesium stearate ( i ) and sodium stearyl fumarate . the tablet film clogging system contains : poly ( vinyl alcohol ), macrogol 3350 , and talc ( containing titanium dioxide ), red iron oxide ( erection ), and yellow iron oxide . what juvia looks like and contents of the pack janugavia is a pale pink film . it is supplied in opaque blisters .
what xultophy is xULtophy lowers blood glucose in adults with type 2 diabetes mellitus . this type of diabetes occurs when your body does not make enough insulin to control the level of blood sugar . insulin degludec is a long - acting basal insulin . it works by reducing your blood sugar levels . your doctor may also tell you to use liraglutide ( a type of insulin called glp - 1 ) or to increase the amount of insulin during meals . xültophy can also be used with oral medicines if you have diabetes xulation is taken together with oral medications to treat diabetes ( such as metformin , st john ' s wort , leucopenia , and glibenclamide ). what if xcultophy looks like and contents of the pack
do not take xultophy if you are allergic to insulin degludec , liraglutide or any of the other ingredients of this medicine ( listed in section 6 ). 39 if your doctor has prescribed you a sulfonylurea ( e . g ., glimepiride or glibenclamide ), or you are not sure , talk to your doctor before taking xULtophy as your selefonyera dose may need to be adjusted . warnings and precautions talk to you doctor , pharmacist or nurse before taking this medicine if : you have been prescribed xbultophy for type 1 diabetes mellitus or known as ' ketoacidosis ' ( a condition which occurs when the body produces little absorption of sugar ). this is a serious and potentially life -
always use this medicine exactly as your doctor has told you . check with your doctor , pharmacist or nurse if you are not sure . if necessary , your doctor will tell you how much xultophy to take . do not take xULtophy if : you are blind or have poor eyesight or cannot read the dose counter on the day of the week . you need to check your blood sugar level at regular intervals . the recommended dose of xulation is 41 doses , taken at the same time each day . take XultoPhy with food . swallow the capsules whole with a drink . it is best to take the capsule with : 8 capsules in a row . how to use xltophy you will use a pre - filled dial - a - dose pen . on the dose indicator you will find a dose
like all medicines , this medicine can cause side effects , although not everybody gets them . the most serious side effects are low blood sugar ( very common : may affect more than 1 in 10 people ). if your blood sugar level gets low you may pass out ( become unconscious ). serious hypoglycaemia may cause brain damage and may be life - threatening . if you have low blood glucose , it is important that you check your blood glucose level regularly . it is very important to avoid eating sugar ( hypogycaemia ). see " warnings and precautions " in section 2 . serious allergic reaction ( anaphylactic reaction ) not known : frequency cannot be estimated from the available data . even patients who don ' t have a serious allergic response , local reactions may occur .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in use in the original carton in order to protect from light . alternatively , xultophy can be stored at room temperature ( up to 30 ) for up to 8 weeks before use , or in syringes ( upto 21 ) during this 21 - day period . discard the via vial after the first use . this medicine is for single use only . any unused medicine must be discarded . it is recommended that the date of dilution be noted on the outer carton when dils are removed from the refrigerator . you must throw away the
what xultophy contains the active substances are insulin degludec and liraglutide . each ml contains 100 units insulin deGludec 3 . 6 mg lilraglutid . one 3 mL vial contains 300 units insulin desgludeck 10 . 8 mg / m3 llilaglutide the other ingredients are glycerol , phenol , zinc acetate , hydrochloric acid and sodium hydroxide ( for ph adjustment ) and water for injections ( see section 2 " xULtophy contain sodium "). what XultoPhy looks like and contents of the pack xulationphy is a clear , colourless solution for injection , supplied in glass vials containing sodium . pack sizes of 1 , 3 or 5 vial , or a multipack
giotrif is a medicine that contains the active substance afatinib . it blocks the activity of proteins called egfr [ epidermal growth factor receptor ] erbb1 , her2 [ erbeb2 ] and errbb3 ]. these proteins are involved in the growth and spread of cancer cells . by blocking their action , this medicine can slow down the growth of cancer cell populations . this medicine is also used to treat cancer of the lung ( non - small cell lung cancer ). giorb is used as your first treatment for patients who have received prior chemotherapy treatment , especially for patients of a certain type , such as patients of the squamous type b or c who have not received prior cancer treatment .
do not take giotrif if you are allergic to afatinib or any of the other ingredients of this medicine ( listed in section 6 ) if your doctor has told you that you have low body weight less than 50 kg if the medicine is used in people with kidney problems if any of these apply to you , tell your doctor immediately . warnings and precautions talk to your doctor or pharmacist before taking giorf . some patients have experienced side effects associated with lung inflammation ( interstitial lung disease ). tell your physician if this applies to you because you have liver problems . your doctor may need to do some liver tests before you start taking this medicine , particularly if : you have a severe liver disease you have eye problems such as severe dry eyes you have inflammation of the transparent layer at the front of the eye ( the cornea ) you have ulcers in or around the eye you have
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 40 mg tablet once a day . take this medication at about the same time each day , preferably at the same times each day ( for example , one tablet in the morning and one in the evening ). you can take this tablet with or without food . do not take this medicinal product with grapefruit or grapefruit juice . taking this medicine you can start by taking this medication for 1 week and continue for 3 weeks after you have taken this medicine . your doctor will tell you how long you should continue to take this medical condition . how to take take this drug - swallow the tablet whole with a glass of water . - take giotrif by mouth if your doctor tells you to . patients who have difficulties swallowing the tablet can mix the tablet with
like all medicines , giotrif can cause side effects , although not everybody gets them . side effects related to treatment are diarrhoea ( very common , may affect more than 1 in 10 people ) and diarhooeal ( common ), may affect up to 2 in 10 patients . severe diarriothoemia with fluid loss ( common common ) ( may affectup to 1 in every 10 patients due to low blood potassium , worsening kidney function ) may also occur . if you get diarrehoa and develop diarresthoa contact your doctor immediately . your doctor may decide to start appropriate antidiarrhöeal treatment and antidiarrheal medicine prior to starting gioTRIf . it is important that you discuss with your doctor the potential side effects of giorrhea . the
what giotrif contains - the active substance is afatinib . each film - coated tablet contains 20 mg of a fatinibe ( as monohydrate ). - other ingredients are lactose monohydrate ( see section 2 ), microcrystalline cellulose , colloidal anhydrous silica , crospovidone type a ), magnesium stearate , all in the tablet core ; hypromellose , macrogol 400 , titanium dioxide ( e171 ), polysorbate 80 and water for injections . what giu looks like and contents of the pack gioTRIf 20 mg film  coated tablets are white to off - white , oval tablets debossed with " gsi " on one side and " nvr " on the other side . giotricf film –
orkambi contains two active substances , lumacaftor and ivacaftre . ork Ambi is a medicine used for long - term treatment of cystic fibrosis ( cf ) in adults and children from the age of 6 years with a f508del mutation in a gene called cystic fibrin - transmembrane conductance regulator ( kftr ). the mutation causes an abnormal ctr protein to be produced in the body . lum acaffetor / ivacasftoral work together to replace the abnormal ffttr proteins in the blood . both lumamacafieftOR and ivacaftoor cause the body to work more normally . this will improve your breathing and your lung function . you may also notice that you do not grow as quickly
do not take orkambi : - if you are allergic to lumacaftor , ivacaftre , or any of the other ingredients of this medicine ( listed in section 6 ). - take special care with ork Ambi : talk to your doctor if this applies to you . warnings and precautions talk to you doctor or pharmacist before taking orkami . orkam contains the active substance lumamacaffetor with the f508del mutation . your doctor may need to change your dose of orkamba . if your doctor suspects that you have liver or kidney disease , your doctor will need to adjust the dose oforkambi accordingly . abnormal blood tests of the liver should be performed before and during treatment with orKambi . tell your doctor immediately if any of these symptoms suggestive of liver problems : pain or discomfort in
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one 6 mg tablet twice a day . take the tablet at about the same time each day , preferably in the morning and evening . you can take the orkambi tablet with or without food . use in children and adolescents the recommended starting dose is two 6 mg tablets a morning and one 12 mg tablet a night . your doctor may prescribe a lower dose for children aged 6 to 11 years . ork Ambi is available in the following strengths : the usual dose of orkamba is 100 mg twice - day ( taking 2 tablets in the afternoon and 2 tablets at the same times ) orkami 200 mg twice daily ( taking 1 tablet in the evening and 2 tablet inthe evening ). your doctor will decide whether you should take orkacco
like all medicines , this medicine can cause side effects , although not everybody gets them . the side effects reported in association with the use of orkambi in combination with ivacaftor are usually mild to moderate and of a short duration . if you get any of the following serious side effects you should stop taking ork Ambi and see your doctor immediately : - raised levels of liver enzymes in the blood which could lead to liver injury . in patients with pre - existing severe liver disease the worsening of liver function is unknown the following side effects are uncommon ( may affect up to 1 in 100 people ). if they occur , you should immediately contact your doctor . you should also report any problems as soon as possible . any of these symptoms : pain or discomfort in the upper right stomach ( abdominal ) area yellowing of your skin or the white part of your eyes loss of appetite , feeling sick
what orkambi contains the active substances are lumacaftor and ivacafor . ork Ambi 100 mg / 125 mg film - coated tablets each tablet contains 100 mg of lumаcafTor and 25 mg of vacafter . Orkambi 200 mg : film  coated tablets every tablet contains 125 milligrams of limacaffeor and 250 milligramms of vacasftoral . the other ingredients are : orkamba 100 mg film coating : tablet core : 125 micrograms / 200 mg of either lum acafantor or 125 million iu of ivacasfor ( 18g ). orkam 100 mg and 25g : video - capsule : capsule - shaped , white to off - white tablets . not all pack sizes may be marketed
what lynparza is lyndparza contains the active substance olaparib . olarib is a type of cancer medicine called a parp inhibitor ( poly[ adenosine diphosphate - ribose ] polymerase inhibitor ). it works by stopping the activity of parp families that have mutations ( changes ) in brca ( breast cancer gene ). this can help to accelerate the progression of cancer . parp antagonists can also cause death of cancer cells . they are also known as an enzyme that helps repair dna ( a ) which is missing or does not work properly . what LYnparaza is used for lylparza can be used to treat ovarian cancer in adults whose brca is mutated ovary cancer , and the cancer has come back after previous treatment with standard treatment or
do not take lynparza - if you are allergic to olaparib or any of the other ingredients of this medicine ( listed in section 6 ) - take special care with lyparib check with your doctor if this applies to you . - see section 2 ' what lylparza contains '. warnings and precautions talk to your doctor or pharmacist before taking lymparza and during treatment with LYnparzan . take special Care with ynparze - before you take LYNparza you may get low blood cell counts which are shown in testing . these can be early signs of low counts of red or white blood cells , and low platelet counts ( see section 4 ' possible side effects '). - in general , patients over 75 years of age should be aware of the signs and symptoms of - fever , infection
always take lynparza capsules exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the usual dose of lyndparza is 100 mg once a day . your doctor may decide to increase or lower your dose to 150 mg once daily . the doses of LYnparzan capsules are similar to those of tablets taken by mouth . you can take a capsule with or without food . take your first dose of both lylnparz capsules at the same time , unless your doctor tells you to stop , or if your doctor thinks that the effect of a lypse is too strong or too weak . if possible , take your capsules with food , at the usual time . this will lower the risk of side effects . children and adolescents 8 years of age and
like all medicines , this medicine can cause side effects , although not everybody gets them . very common ( may affect more than 1 in 10 people ): feeling short of breath , feeling very tired , having pale skin , or fast heart beat . symptoms may include a decrease in the number of red blood cells ( anaemia ). uncommon ( may effect up to 1 in 100 people ),: allergic reactions including hives , difficulty breathing or swallowing , dizziness . these could be signs and symptoms of hypersensitivity reactions . other side effects include : very common : may affect less than 1 out of 10 people feeling short or breath ; feeling very exhausted ; pale skin or fast hearts beat ; symptoms may be a reduction in the numbers of red cells ( thrombocytopenia ). common - may affect up to1 in 10 children . common ; may affect fewer
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . lynparza capsules should be used within 30 days after first opening . discard any capsules 3 days after the first opening of the blister . store in the original package in order to protect from moisture . once the blister is opened , the capsules must be used or thrown away . always keep the sealed blister in the outer carton in order for the capsule to be thrownaway . never throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what lynparza contains - the active substance is olaparib . each hard capsule contains 50 mg of olarib ( as lauroyl macrogol - 32 glycerides ). - ingredients are : hypromellose , titanium dioxide ( e171 ), gellan gum , potassium acetate and iron oxide black ( ostrich ). what LYnparZA looks like and contents of the pack this is a white , opaque , hard capsule with " opadarib " imprinted on one side and " 50 mg " imprint on the other side . the capsule is imprinted with astrazeneca logo and is imitated with a corporate logo on one part and " nvr " on the next side , and " 351 " on both sides . lyparza is available in packs containing
this medicine contains the active substance naloxone . nyxoid is used to treat the following opioids : heroin , methadone , fentanyl , anhydrous , opioids like buprenorphine , or morphine . all of the active substances in nYxoide act as a nasal spray for the emergency treatment of opioid overdose . opioid over dose can happen within 14 days or months . you should not take this medicine if you have taken more than the prescribed dose . breathing problems or severe sleepiness may occur following an opioid overdosing . heroin users must be aware of the need for emergency medical care .
do not use nyxoid : - if you are allergic to naloxone or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using nYxod . take special care with nyingxodone , emergency medical care , or contact your doctor or go to the nearest emergency services immediately if an opioid overdose occurs . the signs and symptoms of an opioid overload are listed below . if they occur , stop using this nasal spray and wait 2 to 3 hours before using it . you should use a new nasal spray every time you use this medicine . tell your doctor immediately : you are becoming physically dependent on opioids . opioids include heroin , methadone , fentanyl , the combination of oxycodone and bu
always use nyxoid nasal spray exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . the recommended dose is 1 spray in the area around your shoulders , ears , breastbone and sternum . it is important that you do not use this product until your doctor tells you otherwise . do not put pressure in the ear . touch the area with your fingernail to make sure that you are getting the right dose . this will help to clear the mouth and nose of any blockages . if the medicine is injected into your mouth or nose , it will be sprayed in the opposite direction ( see section 1 ). when you first start using nyesoidic , the sensation of breathing is the chest moving . breathe in your chest you can hear breathing sounds or see breath on the cheek . avoid overdose
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : stop taking nyxoid and see a doctor straight away if you notice any of the following acute withdrawal symptoms after taking opioid drugs : symptoms include fast heart rate , high blood pressure body aches , stomach cramps , feeling sick ( vomiting ), diarrhoea , sweating , fever , goose bumps shivering / trembling changes in behaviour including violent behaviour , nervousness , tremor , unusual dreams , nightmares / hallucinations , abnormal dreams / depression , anxiety , depression . tell your doctor straightaway if any of these occur . side effects are very common with this product , but can also occur with this medicinal product . ne
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the bottle label after exp . the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . after opening , nyxoid should be used immediately . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what nyxoid contains the active substance is naloxone . each nasal spray contains 1 . 8 mg of nnathanone ( as hydrochloride dihydrate ). the other ingredients are trisodium citrate dihydrate ( e331 ), sodium chloride , hydrochoralic acid , sodium hydroxide ; purified water . what yxxoide looks like and contents of the pack nanyxooide is a clear , colourless , clear - to - yellow solution for injection , supplied in a pre - filled nasal spray in  a single dose container . nyesoidu is supplied in the following pack - sizes : a carton contains 2 nasal sprays in blisters . the dose of each nasal rinse consists of one dose of aloxONE .
ovaleap contains the active substance follitropin alfa , which is almost identical to a natural hormone produced by your body called " fsh ." ffsha is a gonadotropin , a type of hormone that plays an important role in human fertility and reproduction . in women , " fro - sex hormone " ( fh ), it is needed for the growth and development of the sacs ( froollicles ) in the ovaries that contain the eggs , and for the production of sperm . ovaleeape is used : to help produce a mature egg cell . to help release an egg from the egg from your womb , your doctor may prescribe treatment with a medicine called " ciclomifene citrate ". in adult women undergoing assisted reproductive technology procedures ( procedures that may
do not use ovaleap : - if you are allergic to follitropin alfa ( fsh - 1 ), fl - 2b or fbsh ( womb or breasts ) or any of the other ingredients of this medicine ( listed in section 6 ) -if you have a tumour in your hypothalamus or pituitary gland ( both are parts of the brain ). - in women , large ovaries or sacs of fluids within the oocytes ( ovarian cysts ). warnings and precautions talk to your doctor before using ovaleeapm :- - you have unexplained vaginal bleeding . - your doctor may be aware of any cancer in your outer , wummy or breast . you are in any condition that normally makes normal
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . this medicine is intended for subcutaneous use . it is given as an injection into a tissue just under the skin ( subcutaneous injection ). this medicine can be used in women of childbearing age , adolescents and adults with irregular periods . you will receive this medicine every day for the first 7 days of your menstrual cycle . during this period , your doctor may change your dose . the medicine can also be given anytime between 75 and 150 mg injections per week . use in children and adolescents the recommended dose of this medicine in children aged 7 to 14 years is 37 . 5 kg per week but you can get an initial dose of 75 mg . your doctor will decide how much to inject . in children above 7 years of age : your doctor might increase your dose
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : serious side effects in women allergic reactions such as skin rash or raised itchy areas of skin may occur ( see section 2 ). severe allergic reactions may include weakness , drop in blood pressure , difficulty breathing , and swelling of the face 37 very rare ( may affect up to 1 in 10 , 000 people ) if you have this type of reaction , your ovaleap injection may need to be stopped immediately . serious side impacts in women lower stomach ache , nausea and vomiting may be the symptoms of ovarian hypertonia . these may occur with any of the symptoms described above . ovary growth may not be fully reversible . talk to your doctor if this happens . reporting of side effects 23 if your doctor gets any side effects
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the cartridge in the outer carton in order to protect from light . this medicine may be stored for a maximum of 3 months below 25 in its outer carton . once removed from the refrigerator , this medicine must be used within 3 months . after this period , the cartridge may be kept at room temperature for ten days or protected from light ( up to 28 days below 25 ). keep the pen cap on in order not to expose to light , and do not allow the ovaleap pen to light again . write the date of the first use on the pen label in the space provided . use this product if
what ovaleap contains - the active substance is follitropin alfa . ovaleeape 300 iu / 0 . 5 ml : each cartridge contains 300  22 ius ( corresponding to  2 . 9 micrograms ) folipin alga in 0. 5 millilitre ( mL ) solution for injection . one cartridge of ovaleop 450 i / 1 . 75 mll : one cartridge contains 450 microgram ( indicating a specific fl ) alf , expressed in  33 microgram / milligram ( mg ) of fllotropin alla in the 0
voriconazole accord contains the active substance vorikonazole . voricanazole acord is an antifungal medicine . it works by killing or stopping the growth of the fungi that cause infections . for this purpose , it is used to treat patients ( adults and children over the age of 2 ) with : invasive aspergillosis ( a type of fungal infection due to aspergalillus sp ), candidaemia ( another type of FUNgal infection caused by candida spp ) in non - neutropenic patients ( patients without abnormally low white blood cells count ), serious invasive candidasp infections when the florus is resistant to fluconazoles ( another antifungals medicine ), seriously fungal infections caused by scedosporium spe ( or fusarium ss ). when vor
do not take voriconazole accord : - if you are allergic to vorikonazole or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking vorizonazole acord if : you are taking any other medicines , even those that are obtained without a prescription , or herbal medicines . ask your doctor if your doctor has decided that the medicines you are using during vorionazole agreement treatment are too weak or too weak 46 - the active substances are terfenadine ( used to treat allergy ) - astemizole ( used for allergy ), cisapride ( used in stomach problems )- pimozide ( taken for mental illness ) tell your doctor about how to take care of you - quinidine ( used when you have irregular heart beat 
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will determine your dose based on your weight and the type of infection you have . the usual dose for adults is 40 mg once a day . if your weight is less than 40 kg , you will receive a dose of 24 mg ( 400 mg every 12 hours for 24 hours ) or 200 mg every 13 days for 24 weeks . after 24 weeks your doctor may increase your dose to 200 mg ( 100 mg every 15 days ) depending on how you respond to treatment . you will usually receive 300 mg ( 300 mg every 3 weeks ). if there is no evidence of mild to moderate cirrhosis , your doctor might decide to give you a lower dose . use in children and adolescents the recommended dose for children and teenagers is as follows : toddlers weighing less
like all medicines , this medicine can cause side effects , although not everybody gets them . if any side effects occur , most are likely to be minor and temporary . however , some may be serious and need medical attention . serious side effects stop taking voriconazole accord and see a doctor immediately : - rash - jaundice ; changes in blood tests of liver function - pancreatitis other side effects very common : may affect more than 1 in 10 people - visual impairment ( change in vision including blurred vision , visual color alterations , abnormal intolerance to visual perception of light , colour blindness , eye disorder , halo vision ; night blindness and swinging vision ). - pneumonia . common , may affect up to 1 in every 10 people and - vision disturbance ( including blurring of vision ), - allergic reaction
what voriconazole accord contains - the active substance is vorikonazole . one tablet contains 50 mg voricanazole ( as monohydrate ). vorizonazoleaccord 50 mg film - coated tablets contains 200 mg voriconazole as monohydrat . - voriCONazole acord 200 mg film- coated tablet - coating : lactose monohydrate ( e334 ), pregelatinised starch , croscarmellose sodium , povidone , magnesium stearate ( е470b ), hypromellose ( 6000 ), titanium dioxide ( E171 ), lactoses monohydrate and triacetin ( derived from sugar ). the film  - coat contains lactobacillus ( a type of white ) and lactocarcinoma ( ctab ).
what mvabea is and what it is used for mVAbea will be a vaccine to protect you against ebola virus disease in the future . it is given to individuals aged 1 year and older who may possibly come into contact with eba virus . your healthcare worker will recommend a 2 - dose course of vaccinations to protect everyone from getting eoa virus diseases caused by the zaire eebolovirus , which is a type of filovirus that causes you to become vaccinated against the whole egola virus and will not give you eballa virus illness . what if you forget to go back to your doctor when you are due to have vaccinations ? you will receive a dose of zabdeno vaccine about 8 weeks later . the recommended dose of the mvasbea vaccine will depend on the type of 
you should not receive the vaccination course . you should tell your doctor or nurse if any of the points below apply to you . if you are not sure , talk to your doctor , pharmacist or nurse before you are given the vaccine . take special care with mvabea : if your child has had a severe allergic reaction to any of these substances listed in section 6 . in case of a severely allergic reaction , your child may be given an antibiotic called ' gentamicin '. it is important that the vaccine is injected carefully by the doctor 's instructions . warnings and precautions talk to the doctor or pharmacist before you receive mvasbea and if the child has : had , or think that , a serious allergic reaction after any other vaccine injection . have fainted with the injection because of bleeding or bruise easily . currently have a
mvabea is given as a vaccine through a muscle ( intramuscular injection ) in the upper arm or thigh , in a blood vessel . vaccination with zabdeno vaccine is given approximately 8 weeks later . mVAbea vaccine is used as the second vaccine . how much vaccine will you or your child get primary vaccination first vaccination with the zabea red cap vial ( 0 . 5 ml ) second vaccination with with mvasbea yellow cap viall ( 00 . 2 mmol ) for 8 weeks after the first vaccination . booster vaccination with either zapdeno or zabano is given two weeks after zababdeno . all three doses of zabeddeno should be given at least one week apart . your doctor will decide when you should receive booster vaccination based on the information in this
like all medicines , this vaccine can cause side effects , although not everybody gets them . side effects occur at least up to 7 days after the injection . the following side effects may happen with this vaccine : very common ( may affect more than 1 in 10 people ) pain , warmth , or swelling where the injection is given feeling very tired muscle ache joint pain common ( might affect up to 1 in 100 people ), feeling sick ( vomiting ) itching where the injector is given uncommon ( may effect up to1 in 100 persons ) redness and skin hardness where the vaccine is given generalised itching reporting of side effects for this medicine if you get any side effects please talk to your doctor , pharmacist or nurse . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can
what mvabea contains - the active substance is zaire ebolavirus . each dose ( 0 . 9 ml ) contains tai forest ebavirus nucleoprotein marburg , equivalent to 0. 7 x 108 mbq / m2 of chicken embryon fibroblast cells . - this vaccine contains trace residues of gentamicin , sodium chloride , trometamol , water for injections and hydrochloric acid ( for ph adjustment ). what vvabeam looks like and contents of the pack mVAbea is a suspension for injection in a single - dose glass vial with a rubber stopper and yellow cap . the vial contains 20 mmol .
bondronat contains the active substance ibandronic acid . this belongs to a group of medicines called bisphosphonates . bondronates is used in adults and prescribed to you if you have breast cancer that has spread to your bones ( called ' bone ' metastases '). it helps to prevent your bones from breaking ( fractures ). it also helps to reduce other bone problems that may need surgery or radiotherapy bondronate can also be prescribed if your doctor has a raised calcium level in your blood due to : a tumour that is left in your bones . these extra calcium is then passed out of control . as a result , your bones become weaker .
do not take bondronat : - if you are allergic to ibandronic acid or any of the other ingredients of this medicine ( listed in section 6 ) - because you have low levels of calcium in your blood . do not receive this medicine if any of these apply to you . warnings and precautions - this side effect is rare , but serious and can be life -- threatening . osteonecrosis of the jaw ( onj ) ( bone damage in the jaw ) has been reported very rarely in the post marketing setting in patients receiving bondronate for cancer - related conditions . onj can also occur after stopping treatment . it is important to try and prevent onj developing as it is a painful condition that can be difficult to treat . in order to reduce the risk of developing osteonocrosus of the Jaw , there are some precautions
this medicine bondronat is used to treat cancer . it is given as an infusion into your vein your doctor may do regular blood tests while you are receiving bondronate . this is to check that you are being given the right amount of this medicine . how much to receive your doctor will work out how much you will be given depending on your illness . if you have breast cancer that has spread to your bones , then the recommended dose is 3 mg / kg every 3 - 4 weeks , as an injection in your vein over at least 15 minutes . If you have a raised calcium level in your blood , the recommended dosage is 1 mg pctfe ( 5 mg ) per kg body weight or 2 mg nvr ( 5mg ), depending on the severity of your illness the medicine should be administered as an an infustion in your vault ( intravenous infusion ), or
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking bondronat and see a doctor straight away if you notice any of the following serious side effects you may need urgent medical treatment : rare ( may affect up to 1 in 1 , 000 people ) persistent eye pain and inflammation new pain , weakness or discomfort in your thigh , hip or groin . you may have early signs of a possible unusual fracture of the tummy bone . very rare ( can affect upto 1 in 10 ,000 people ). if it happens to you , tell your doctor straightaway . pain or sore in your mouth or jaw . this may be a sign of severe jaw problems ( necrosis ( dead bone tissue ) in the jaw bone ). talk to your doctor if this happens . ear pain discharge from the ear ,
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . after dilution the infusion solution should be used immediately . however , chemical and physical in - use stability has been demonstrated for 24 hours at 20 - 25 . store in the original package in order to protect from light . these measures will help protect the environment .
what bondronat contains the active substance is ibandronic acid . each 2 ml vial provides a concentrate for solution for infusion containing 2 mg ibronic Acid . the other ingredients are sodium monohydrate , sodium chloride , acetic acid , and sodium acetate in the water for injections . what bondruat looks like and contents of the pack bondronatul is a clear , colourless solution for injection , supplied in a glass vial . it is supplied in packs of 1 or 2 glass vialls closed with a bromobutyl rubber stopper .
what zeposia is zeposa belongs to a group of medicines that affect white blood cells called lymphocytes . what zposia are used for zeposition is used to treat relapsing remitting multiple sclerosis ( rrms ) in adults . ms is a type of active disease called multiple ' multiple - scleroderma ' ( mms). multiple  sms ( mps ), a disease which affects the immune system and affects how the body ' s defenses , allowing white blood cell count to be increased . this can affect the nerves in the brain and spinal cord and around the nerve points in the body which can cause symptoms such as numbness and difficulty in walking .
do not take zeposia : - if you are allergic to ozanimod or any of the other ingredients of this medicine ( listed in section 6 ) -if you have a severely weakened immune system - had a heart attack ( such as angina , stroke , mini - stroke ), transient ischemic attack ( tia ) or severe heart failure within the last 6 months - have irregular or abnormal heartbeats ( arrhythmias ) which do not go away . warnings and precautions talk to your doctor or pharmacist before taking zeposa if : you are taking zposia and you have ever had , or you have had  , severe infection ( sucha hepatitis , tuberculosis ), cancer or severe liver problems - you are pregnant or breast - feeding if any
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much to take your doctor will work out your dose of zeposia . this will depend on your heart rate . you will be given a ' treatment initiation pack ' which contains everything you need to take to start treatment . the first capsule is usually taken at least 4 weeks apart ( 0 . 23 mg ozanimod per day ). after 1 week , you will have treatment again with 3 weeks of 0. 46 mg / day . your doctor may decide to start you on ozanimod 5 mg , 6 mg or 7 mg . after 4 weeks , your doctor might give you a new one . there is usually a maintenance pack , with orange capsules , that will be filled with 0
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor or nurse if you notice any of the following side effects very common ( may affect more than 1 in 10 people ) slow heart rate urinary tract infection low blood pressure uncommon ( may effect up to 1 in 100 people ), allergic reaction . the signs may include a rash . other side effects talk to your doctor , pharmacist or nurse about any of these side effects you may have . very common : may affect up to1 in 10 persons infections of the nose or nostrils , nasal cavity , mouth , throat ( pharynx ), voice box ( larynge ), viruses , a type of white blood cell called lymphocytes common - may affect less than 1in 10 people fungal infections of your mouth or throat common , may affect 1 in every 10
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . store below 25 . keep this medicinal product in the original package in order to protect from moisture . don ' t use this medicinal item if you notice any damage or signs of tampering to the pack .
what zeposia contains - the active substance is ozanimod . zeposa 0 . 23 mg hard capsules : each capsule contains 0. 23 milligrams of ozonimod ( as hydrochloride ). zepoza 00 . 46 mg hard hard capsule : Each capsule contains 1 . 1946 milligramms of of  ozanimod ( AS hydrochoralide ”). zeposition 0
what temybric ellipta is temyerc elbasvir consists of three active substances : fluticasone furoate , umeclidinium bromide and vilanterol . fluticasesone furaate belongs to a group of medicines called corticosteroids , often simply called steroids . umeklidinium brmide e1200 and victoria mackinabant are examples of a drug group called bronchodilators . what ms is md is used for temmybric
do not take temybric ellipta : - if you are allergic to fluticasone furoate , umeclidinium , vilanterol or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking temyerc ellptta and if any of these apply to you .  if your doctor has told you that you may be at risk of asthma . take special care with temmybric
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one inhalation every day at the same time of day . you only need to inhale once a day because the effect of this medicine lasts for 24 hours . don ' t use more than your doctor tells you to use . use temybric ellipta regularly it is very important that you use TEMybril ellippa every day , as instructed by your doctor . this will help to keep you free of symptoms throughout the day and night . temmybric
like all medicines , this medicine can cause side effects , although not everybody gets them . immediate breathing difficulties if your breathing or wheezing gets worse straight after using this medicine , tell your doctor immediately . pneumonia ( infection of the lung ) in copd patients ( common side effect ) have been reported with temybric ellipta but are not known . symptoms of a lung infection may include fever or chills , increased mucus production , change in mucuses colour , and increased cough . increased breathing difficulties common side effects ( may affect up to 1 in 10 people ): sore throat , runny nose , blocked nose . this may cause difficulty in breathing . itchy rash . these may be signs of bacterial infections . other side effects include : very common side problems ( may effect more than 1 in 9 people ). common side
what temybric ellipta contains the active substances are fluticasone furoate , umeclidinium bromide and vilanterol . each delivered dose ( the dose leaving the mouthpiece ) contains 92 micrograms of fluticasesone furaate ; 65 microgram ( g ) umeklidinium brochure , equivalent to 55 microgram(  g ). umeclinium bromide , equal to 22 microgram [ G ] umecidinium and 22 microgramms of vilantrol ( as trifenatate ). the other ingredients are lactose monohydrate ( see section 2 under ' temyerc elbass ') and magnesium stearate . what mybril ellippa looks like and contents of the pack the elli
what zinforo is zinForo is an antibiotic medicine that contains the active substance ceftaroline fosamil . it belongs to a group of medicines called ' cephalosporin antibiotics '. what zforo used for zinfo is used to treat infections of the skin and the tissues below the skin . this is often given to adults to treat an infection of the lungs called a ' pneumonia ' which needs treatment or prevention . how zinfordo works zin foro works by killing certain bacteria which reduces the risk of serious infections .
do not take zinforo if you are allergic to ceftaroline fosamil or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor before taking zinfosaml . if your doctor thinks you may be allergic to other cephalosporin antibiotics . warnings and precautions talk to your doctor or pharmacist before taking this medicine : if any of your family members have had previous severe allergic reactions to other antibiotics ( e .
zinforo is given to you by a doctor or nurse . the recommended dose in adults is 600 mg once a day for adults and adolescents aged 12 years and older . your doctor may increase your dose to 600 mg twice a week if you have some infections that need treating a treatment course of 8 to 12 weeks . zinford is given as a drip into a vein ( intravenously ) over a period of 5 minutes to 60 minutes or 120 minutes if your doctor decides that you need an increased dose . duration of treatment usually lasts from 5 to 14 days . for skin infections , the recommended daily dose is 5 to 7 mg per day for pneumonia . in addition , your doctor will give you zinforcer for treatment of kidney problems . patients with kidney problems the recommended starting dose of zinForo is 600 milligrams per day . it is not intended to
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : talk to a doctor straight away if you notice any of these symptoms you may need urgent medical treatment : sudden swelling of your lips , face , throat or tongue , a severe rash , swallowing or breathing problems . these may be signs of a serious allergic reaction ( anaphylaxis ) diarrhoea ( stool that contains blood or mucus ). stop taking treatment with zinforo and contact a nurse straight away and tell a member of your family or carer . they may be given medicines to slow bowel movement . this is common ( up to 1 in 10 people ) a blood test called a ' coombs test ' which may be used to determine whether you are being treated with
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . store below 30 . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what zinforo contains the active substance is 600 mg ceftaroline fosamil . the other ingredients are arginine , magnesium , phosphorus , and water for injections . what zforo looks like and contents of the pack zinfordo is a pale yellowish to light yellow powder for concentrate for solution for infusion in a vial , which comes in ten glass vials , one with 10 vial ( 0 . 5 ml ).
pregabalin pfizer belongs to a group of medicines used to treat epilepsy , neuropathic pain and generalised anxiety disorder ( gad ) in adults . peripheral and central nuropathic pain : pregabaliin ppfizer is used to relieve long lasting pain caused by damage to the nerves . a variety of diseases can cause peripheral neursopathic pain including diabetes and shingles . pain sensations may be described as hot , burning , or throbbing , shooting , stabbing ; sharp , cramping , and aching , before tingling or after numbness . this medicine is used in adults and children aged 9 years and older .
do not take pregabalin pfizer if you are allergic to pregabalsalin or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking pregabaltin . some patients taking pregamalin have reported symptoms suggesting an allergic reaction . these symptoms include swelling of the face , lips , tongue , and throat , as well as diffuse skin rash . should you experience any of these reactions , you should contact your physician immediately . pregabaline may cause dizziness and somnolence , which could increase the occurrence of accidental injury ( fall ) in elderly patients . therefore , it is recommended that you avoid taking pregalin in phizer . talk to you doctor if : you experience blurring or loss of vision , or other changes in eyesight ,
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . pregabalin pfizer is for oral use . peripheral and central neuropathic pain , epilepsy or generalised anxiety disorder : take the number of tablets as instructed by your doctor to do so . the dose , which has been adjusted for you and your condition , will generally be between 150 mg and 600 mg each day . your doctor will tell you to take pregabaalin pipfiser either twice or three times a day , depending on your condition and your individual needs . for twice aday take pregamalin in the morning and once in the evening 59 you will usually take pregalin paediatric use once in your morning , about the same time each day ( breakfast , dinner , and dinner 
like all medicines , this medicine can cause side effects , although not everybody gets them . very common : may affect more than 1 in 10 people dizziness , drowsiness , headache . common - may affect up to 1 in every 10 people increased appetite . feeling of elation , confusion , disorientation , decrease in sexual interest , and irritability . disturbance in attention , including clumsiness and memory impairment . loss of memory . tremor , difficulty with speaking , or tingling . not known : frequency cannot be estimated from the available data tingle . in children , itching , low blood sugar . change in perception of self , restlessness , depression , anxiety , panic attack , thoughts of suicide , worsening of depression . some children lost a lot of weight
what pregabalin pfizer contains the active substance is pregabALin . each tablet contains 25 mg , 50 mg ; 75 mg / 100 mg  ; 150 mg & 200 mg : each tablet has a thickness of 225 mg and 300 mg pregabalsalin the other ingredients are lactose monohydrate , maize starch , talc , gelatine , titanium dioxide ( e171 ), sodium laurilsulphate , anhydrous colloidal silica , and black ink . the ink contains shellac ; black iron oxide ( е172 ), propylene glycol , potassium hydroxide ) and indigo carmine ( alumina ). the 75 mg tablets are black inked with black indigent ( fdpe ), propolis ( containing shellace 
xadago is a medicine that contains the active substance safinamide . it helps to increase the levels of dopamine in your brain . this helps to control the level of dope in your mind when you have parkinson ' s disease . xdag is used by adults to treat parkinsons ' disease which causes sudden switches in your ability to move . when you are not able to move or when you feel difficulties moving , x ad ago may be used on its own in in combination with the medicine levodopa and other medicines used to treat parksinson'  s Disease .
do not take xadago if you are allergic to safinamide or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor and do not start treatment with the following medicines : monoamine oxidase ( mao ) inhibitors ( e . g . selegiline , rasagiline ; moclobemide ; phenelzine , isocarboxazid ; or tranylcypromine ). warnings and precautions talk to your doctor before taking x ad ago and during treatment for parkinson ' s disease and depression . pethidine ( a strong pain killer ) should be avoided during the 7 days before xаdagot treatment . during treatment with mao inhibitors 
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . xadago is available as either a 50 mg tablet or a 100 mg tablet by mouth . your doctor will decide on the right dose for you : - if your doctor has moderately reduced liver function and your dose is 50 mg / kg . take xdag around the same time each day . talk to your doctor about other ways to take Xad adogo . the recommended dose is one 50 mg tablets tablet once a day , taken by mouth and with food . you should take a dose of x aadaga with food as this may help to reduce the risk of having too much x. - in patients with raised blood pressure , anxiety , confusion , forgetfulness 
like all medicines , this medicine can cause side effects , although not everybody gets them . hypertensive crisis ( very high blood pressure that may lead to collapse ) is common ( for patients with neuroleptic malignant syndrome ). it can be very helpful to note that : confusion , sweating and muscle rigidity ( hyperthermia ). xadago can also increase level of enzyme creatine kinase in your blood ( for example , serotonin syndrome ), which may cause confusion ; hypertension ; muscle stiffness ; hallucinations ; hypotension ). the most frequently reported side effects in patients with parkinson ' s disease were mild in nature and included a combination of safinamide and a phosphate inhibitor ( for further information see section 2 ). other side effects reported in patients treated with xedagot
what xadago contains - the active substance is safinamide . each tablet contains 50 mg or 100 mg of ssafatinamide ( as methansulfonate ). - other ingredients are microcrystalline cellulose , crospovidone type a , magnesium stearate , silica colloidal anhydrous - tablet coating : hypromellose , macrogol , titanium dioxide ( e171 ), iron oxide red ( ED171 "). what Xadagago looks like and contents of the pack x ad ago 50 mg are pink , oval , biconcave film - coated tablets of 7 mm diameter with metallic gloss ( engraved on one side ). the 50 mg tablets are white , round , triangular , debossed on one
zytiga is a medicine that contains the active substance abiraterone acetate . it is used to treat adult men with prostate cancer that has not spread to other parts of the body . zytigea increases the amount of testosterone that can be produced when you have prostate cancer . your doctor will prescribe zymiga for you if you have disease that has accumulated in the past and is not responded to hormone therapy . this is essentially a treatment that lowers testosterone ( androgen deprivation therapy ). it is often given with another medicine , prednisone or predisolone . high blood pressure , when taken with high doses is added to the body and keeps it at a low level . because of fluid retention in your blood , it is important to keep the appointments with your doctor .
do not take zytiga - if you are allergic to abiraterone acetate or any of the other ingredients of this medicine ( listed in section 6 ). - the active substance is a BiraterONE acryptus . warnings and precautions talk to your doctor , pharmacist or nurse before taking zytigea if : - you have severe liver damage - your doctor has told you to have prostate cancer . this medicine is for oral use . do not use this medicine if any of these apply to you . if your doctor determines that you have liver problems , tell your doctor about all of your medical conditions . talk to you doctor if this medicine applies to you and / or you are not sure . liver problems such as high blood pressure , heart failure or low blood potassium . low blood sodium may cause heart rhythm problems or
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one tablet of 1 , 000 mg taken twice a day . you should take this medication by mouth . if necessary , your doctor may increase your dose of zytiga . take zytigea at least 2 hours after you have taken zyta , and then take the next dose at about the same time each day , with food or between meals . swallow the tablet whole with water . do not crush , chew or break the tablet before swallowing . how to take ztiga with food if your doctor has told me that you are taking a medicine called prednisone . this is because preddnisolone does not work as well as it should . it is important that you take
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking zytiga and tell your doctor immediately if you experience muscle weakness , muscle twitches , a pounding heart beat or palpitations . these may indicate that the level of potassium in your blood is low . you should also tell your physician if your level of sodium in your water is low and potassium is not being adequately absorbed . other side effects may include : common ( may affect up to 1 in 10 people ): if there is fluid in your legs or feet , which may be a sign of low blood potassium ( shown in liver function test ), high blood pressure , urinary tract infection , diarrhoea , nausea , vomiting , abdominal pain , stomach pain . common ( might affect upto 1 in every 10 people "):
what zytiga contains - the active substance is abiraterone acetate . each tablet contains 250 mg a BiraterONE aate . -the other ingredients are microcrystalline cellulose , croscarmellose sodium , lactose monohydrate , magnesium stearate , povidone ( k32 - 32 ), colloidal anhydrous silica , sodium laurilsulfate , water for injections ( see section 2 " zytigea contains lactoside "). what zetiga looks like and contents of the pack - zytiva tablets are white to off - white , oval tablets of 9 . 5 mm in diameter . the tablets are packaged in a plastic bottle with a child - resistant closure . one bottle contains 120 tablets .
hefiya contains the active substance adalimumab . it is a medicine used for the treatment of inflammatory diseases : polyarticular juvenile idiopathic arthritis , enthesitis - related arthritis paediatric plaque psoriasis , paediaric crohn ' s disease , and paedialic non - infectious uveitis in adults . the active ingredient in hepiyya , aldaimumabe , is  a monoclonal antibody . monoclonosal antibodies are proteins that attach to a specific target in the body . one of these targets , called a " tnf ", is found on the surface of cells . adelimumumabat is designed to recognise and attach to another target in your body ,
do not use hefiya - if you are allergic to adalimumab or any of the other ingredients of this medicine ( listed in section 6 ). -if you have a severe infection , including tuberculosis , sepsis ( blood poisoning ) or other opportunistic infections ( unusual infections associated with a weakened immune system ). it is important that you tell your doctor if your symptoms of infections include fever , wounds , feeling tired , dental problems . - in moderate or severe heart failure . it is recommended to tell your doctors if any of these apply to you . warnings and precautions talk to your doctor or pharmacist before using heifiy : - you have had a serious heart condition . allergic reaction : tell your healthcare professional if allergic reactions occur and symptoms such as
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor if you are not sure . the usual dose is 40 mg once a day . your doctor may prescribe you a 40 mg dose as two 20 mg injections or 40 mg injection syringes . polyarticular juvenile idiopathic arthritis age or body weight how much and how often to take ? notes children , adolescents and adults from 2 years of age weighing 30 kg or more 40 mg every other week not applicable children . adolescents from 2 decades of age with no experience with hefiya , your doctor will decide the most appropriate dose based on your child ' s weight . children weighing 10 kg to less than 30 kg 20 mg every third week not recommended for enthesitis - related arthritis age and body weight when he / she is first prescribed he
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may be serious and require treatment . side effects may occur up to 4 months or more after the last hefiya injection . seek medical attention urgently , if you notice any of the following signs of allergic reaction or heart failure : severe rash , or hives ( swollen face , hands , feet ), trouble breathing , swallowing , shortness of breath with exertion or swelling of the feet . tell your doctor as soon as possible , as some may need treatment - many may be signs of infection including fever , feeling sick , wounds , dental problems , eye problems . these may be more common at the start of treatment , and get better at the end of treatment or get better with
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label / blister / carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the pre - filled syringe in the outer carton in order to protect from light . alternative storage : when needed ( for example when you are travelling ), hefiya may be stored at room temperature ( up to 25 ) for a maximum period of 14 days be sure to protect it from light and avoid evaporation . once removed from the refrigerator for room temperature storage , your pre – filled  sYringe must be used within 14 days or discarded , even if it is later returned to the refrigerator . you should record the date when
what hefiya contains the active substance is adalimumab . each pre - filled syringe contains 20 mg of aad alimUMab in 0 . 4 ml of solution . the other ingredients are adipic acid , citric acid monohydrate , sodium chloride , mannitol , polysorbate 80 , hydrochloric acid ( e507 ), sodium hydroxide and water for injections . what HEfiуa looks like and contents of the pack heifiyya 20 mg solution for injection ( injection ) in pre  - packed sYringe for paediatric use is supplied as a 0. 4 mg clear to slightly opalescent , colourless to slightly yellowish solution in a single - use clear type
ritemvia contains the active substance " rituximab ". this is a type of protein called a " monoclonal antibody ". it sticks to the surface of a kind of white blood cell called " b - lymphocyte ". when ritsuximb sticks to your cell , the cell dies . your doctor will decide with you which combination of ritemevia is best for you . the treatment with ritemmvia can be prescribed for the treatment of several different conditions . a ) non - hodgkin ' s lymphoma this is just a disease of the lymph tissue ( part of the immune system ) that affects a certain type of whiteblood cell called b- lymph cells . when you are given riteMvia together with other medicines ( such as chemotherapy ), the treatment will be continued with remission
do not take ritemvia if you are allergic to rituximab , other proteins which are like ritsuximb or any of the other ingredients of this medicine ( listed in section 6 ) if your doctor has told you that you have a severe active infection at the moment if the medicine is not working properly if this is the case if : you have been told by your doctor that you suffer from a weak immune system . you have severe heart failure or severe uncontrolled heart disease , e . g ., granulomatosis with polyangiitis , microscopic polyanginiitus or pemphigus vulgaris . do not use ritemevia : if any of these apply to you . warnings and precautions talk to your doctor , pharmacist or nurse before using ritemmvia .
your doctor will tell you how many ritemvia courses you will be given . always use this treatment exactly as your doctor has told you . check with your doctor if you are not sure . this is in case you get any side effects . you will always be given this medicine as a drip ( intravenous infusion ). medicines given before each ritemmvia administration before you are given ritemevia , you will also be given other medicines ( pre - medication ) to prevent or reduce possible side effects from your treatment . if your doctor determines that you need to be treated for non - hodgkin ' s lymphoma : if given alone ritemorvia will be administered to you once a week for 4 weeks . repeated treatment courses with ritetmvia are possible . when to receive ritedmvia with chemotherapy ritemetmvia will
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate but some may be serious and require treatment . rarely , some of these reactions have been fatal . infusion reactions during or within the first 24 hours of the infusion you may develop fever , chills and shivering . less frequently , people may experience pain at the inffusion site , blisters , itching , sickness ( nausea ), tiredness , headache , breathing difficulties , blood pressure raised , wheezing , cough , chest pain , fever . tell your doctor or nurse immediately if you experience any of these. other side effects may include : very common : may affect more than 1 in 10 people chills sneezING , burning sensation when urinating . common - may affect up to 1
what ritemvia contains the active ingredient in ritemevia is called rituximab . the vial contains 100 mg of ritsimabe . each ml of concentrate contains 10 mg of the active substance ritzimabu .the other ingredients are sodium chloride , tri - sodium citrate dihydrate , polysorbate 80 and water for injections . what ritamvia looks like and contents of the pack riteMvia is a clear , colourless solution , supplied as a concentrate for solution for infusion in a glass vial . pack of 2 vials 
capecitabine teva belongs to the group of medicines called " cytostatic medicines ", which stop the growth of cancer cells . capecitebine eva contains cape citrine , which itself is not a cytotoxic medicine . only after being absorbed by the body is it changed into an active anti - cancer medicine ( more in tumour tissue than in normal tissue ). capecitationbine téeva is used in the treatment of colon , rectal , gastric , or breast cancers . furthermore , capecitébine teteeva is also used to prevent new occurrence of colon cancer after complete removal of the tumour by surgery . Capecitabin t Eva may be used either alone or in combination with other medicines .
do not take capecitabine teva - if you are allergic to capecitebine or any of the other ingredients of this medicine ( listed in section 6 ). you must inform your doctor if this applies to you . you have developed an allergy or over - reaction to this medicine , - had severe reactions to fluoropyrimidine therapy ( a group of anticancer medicines such as fluorouracil ), - are pregnant or breast - feeding , or if your doctor determines that you have severely low levels of white cells or platelets in the blood ( leucopenia , neutropenia or thrombocytopenia ), or - have severe liver or kidney problems ,- have enzyme dihydropyrimiidine dehydrogenase ( dpd ) ( complete dpmd deficiency ). - were previously
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . capecitabine should only be prescribed by a doctor experienced in the use of anticancer medicines . your doctor will prescribe a dose and treatment regimen that is right for you , depending on your body surface area . this is calculated from your height and weight . the usual dose for adults is 1250 mg / m2 of body surface surface area taken two times a day . two examples are provided here : a person whose body weight is 64 kg and height is 1 . 64 m has a body surfacearea of 1 , 7 m2, 4 m and 500 mg and 1 tablet of 150 mg two times daily . a man whose doctor has calculated body weight of 80 kg and his/ her height is 11 . 80 m
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking capecitabine teva immediately and contact your doctor if any of these symptoms occur : diarrhoea : if you have an increase of 4 or more bowel movements compared to your normal bowel movement each day or any diarhooee at night . vomiting : when you vomit more than once in a 24 - hour time period . nausea : as a result of losing your appetite , you suffer from stomatitis : pain , redness , swelling or sores in your mouth and / or throat . hand - or- foot - ulcers : the most common side effects are : common : may affect up to 1 in 10 people . common - diarreho : generally
what capecitabine teva contains - the active substance is capecitebine . capecitationbine  each tablet of capecitébine travaginal 150 mg film - coated tablets each film  - covered tablet contains 150 mg capeciabine - capevitabine h2o  cape citrine 500 mg film- coated tablet each film contains 500 mg capacitabine the other ingredients are : tablet core : lactose , microcrystalline cellulose ( e460 ), hypromellose , croscarmellose sodium , magnesium stearate , macrogol 400 ( 8000 ), ( 6000 ), and hypomellose ( 660 ), titanium dioxide (  e171 ), yellow iron oxide ( 850 ), red iron oxide . what capacitebine
what silodosin recordati is sillodosesin recordingati belongs to a group of medicines called alpha1a - adrenoreceptor blockers . sil lododostin recordattai works by blocking the signals to the prostate , bladder and urethra . by blocking these receptors , it causes smooth muscle in these tissues to relax . this makes it easier for you to pass water and relieves your symptoms . what siladoosine recordatis is used for silonosi recordatin is used in adult men to treat the urinary symptoms associated with benign enlargement of the prostate ( prostatic hyperplasia ), such as : difficulty in starting to passwater , a feeling of not completely emptying the bladder , an improved bladder function , and an improved urinary
do not take silodosin recordati - if you are allergic to siloudoosine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking silloodsin regati and / or during eye surgery if there is cloudiness of the lens ( cataract surgery ), the clear gel may temporarily cloud the eye 26 . while taking silosodasin reccordati there are some patients taking this type of medicine because of this , there is a loss of muscle tone in the iris ( the coloured circular part of the eye ). if this is the case you will have a surgery . the doctor will advise you whether to take appropriate precautions . a careful selection of medicine and surgical techniques is also possible when taking siladodi record
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose of silodosin recordati is 8 mg once a day . take the capsule always with food , preferably at the same time every day , even if it is not for long . patients with kidney problems if your doctor has told that you have moderate kidney problems then the dose may be increased . for this purpose siloudoosine recordatin is available in four different strengths . you can take the hard capsules with or without food . use in children and adolescents the recommended adult dose of one capsule is 4 mg . if vous take more sillodosesin recordingi than you should if , for any reason , you become dizzy or feel weak , tell your doctor straight away
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you notice any of the following allergic reactions : swelling of the face or throat , difficulty in breathing , feeling faint , itchy skin or hives . the most common side effect is a decrease in the amount of semen released during treatment with silodosin recordati . this decrease in how often you can get dizziness . these effects are usually mild to moderate and usually go away after a few days . however , sometimes dizziity comes on suddenly and can be preceded by occasionally fainting . if your doctor feels weak or dizzy , talk to your doctor as soon as possible . usually , the symptoms of dizzin and fainting occur less often when you stand up or stand up straight away . sillodones
what silodosin recordati contains sillodosesin registerati 8 mg the active substance is siloudoSin . each tablet contains 8 mg of siludoosine . the other ingredients are : mannitol , magnesium stearate , sodium laurilsulfate , gelatin , titanium dioxide ( e171 ). sil lododsin recordingi 4 mg the activated substance is selodone . one tablet contains 4 mg of seloudone ( as a single tablet only ). the other ingredient is siladonadol . - the other excipients are mannol ; magnesium STEarate and sodium laursulfated ; gelatin, titanium oxide (  e 171 ); yellow iron oxide ( only 
kinzalmono belongs to a class of medicines known as angiotensin ii receptor antagonists . angioTENsin Ii is a substance produced in your body , which causes your blood vessels to narrow , thus increasing your blood pressure . kinzialmony blocks this effect of angiostensin
do not take kinzalmono - if you are allergic to telmisartan or any other ingredients of this medicine ( listed in section 6 ). -if you're more than 3 months pregnant . ( it is also better to avoid kinzialmona in early pregnancy see pregnancy section ). ( it may be better to skip the dose) - in case you have severe liver problems such as cholestasis or biliary obstruction ( problems with drainage of the bile from the liver and gall bladder ) or anyother severe liver disease . - when you have diabetes or impaired kidney function and you are treated with a blood pressure lowering medicine containing aliskiren . do not use kinzealmonome if any of the above applies to you . take special care with kinzzalmony if your doctor determines that you may be
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of kinzalmono is one tablet a day . try to take the tablet at the same time each day , just before or after a meal . you can take kinzealmonou with or without food . it is important that you take kinszalmonio every day until your doctor tells you otherwise . if your doctor thinks this is too strong or too weak , talk to your doctor . for treatment of high blood pressure the usual dose of the kinzialmonome is 40 mg once a night to control blood pressure over the 24 - hour period . your doctor may prescribe a lower dose of 20 mg once daily . in addition , kinzzalmona may be taken with diuretics (' water tablets
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects can be serious and need immediate medical attention : you should see your doctor immediately if you experience any of the following symptoms : sepsis * ( often called " blood poisoning ", is a severe infection with whole - body inflammatory response ), rapid swelling of the skin and mucosa ( angioedema ); these side effects are rare ( may affect up to 1 in 1 , 000 people ) but are extremely serious and patients should stop taking the medicine and see their doctor immediately as they can be fatal . possible side effects of kinzalmono common side effects ( may effect up to1 in 10 people ), are : low blood pressure ( hypotension ) in users treated for reduction of cardiovascular events . uncommon side effects may affect more than 1 in 100 people : urinary
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton after " exp ". the expiration date refers to the last day of that month . this medicine does not require any special temperature storage conditions . you should store your medicine in the original package in order to protect the tablets from moisture . remove your kinzalmono tablet from the blister only directly prior to intake . discard unused tablets . these measures will help protect the environment .
what kinzalmono contains - the active substance is telmisartan . each tablet contains 20 mg telmesartan ( as mesilate ). - other ingredients are povidone , meglumine , sodium hydroxide , sorbitol ( e420 ) and magnesium stearate . what kinszalMono looks like and contents of the pack kinzialmona 20 mg tablets are white to almost white , round tablets . kinzzalmonova is available in blister packs of 14 , 28 , 56 or 98 tablets , with or without desiccant sachets . not all pack sizes may be marketed .
what afstyla is a fostlyla is not a human clotting ( coagulation ) factor viii product . it contains the active substance lonoctocog alfa . what ofssylais used for aemophilia a ( inborn factor  vii deficiency ) needs factor ixi to function properly , a condition that affects blood clotting . people with factor  viiis have an increased tendency to bleed . how a fsyl works in patients with haemphilia is unable to clon . aafStyl is used to treat and prevent bleeding episodes in patients of all ages . the clinical benefit of factor vii in patients suffering from factor ii is increased with age .
you should not be given afstyla if you have ever had an allergic reaction to any ingredient of aaffsyla ( listed in section 6 ). if this applies to you , tell your doctor immediately . you must not be treated with a fsstуla . if your doctor determines the risk of allergic ( hypersensitivity ) reactions , your doctor will advise you accordingly . warnings and precautions talk to your doctor , pharmacist or nurse before you are given , or during treatment with : 46 adstlyla , please record the batch number of your treatment diary . your doctor may also give you a lower dose of ' astYla '. allergic ( hyposensitivity  ) reaction adest Tyla should not occur in patients who have symptoms of allergic reactions . allergic reactions may include 
your treatment should be supervised by a doctor experienced in the treatment of blood clotting disorders . always use this medicine exactly as your doctor has told you . check with your doctor if you are not sure . the recommended dose of afstyla for treatment of your disease the site and the severity of the bleeding your clinical condition are listed at the end of the leaflet . reconstitution and administration general instructions the powder must be mixed with the solvent ( liquid ) provided in the vial to achieve the best results for your treatment . adefsTyla must not be mixed in other medicines or solvents . see section 6 . ensure that the solution is clear or slightly opalescent . after reconstitution , the solution should be clear to slightly illuminating . do not use the solution if it is cloudy or if particles in the solution have been observed . discard
like all medicines , afstyla can cause side effects , although not everybody gets them . contact your doctor immediately if you notice any of the following symptoms : allergic reactions allergic reactions may be life - threatening . the following signs may include hives , generalised urticaria ( itchy rash ), tightness of the chest , difficulty in breathing or wheezing , low blood pressure , dizziness , anaphylaxis ( bleeding that is not being controlled with a steroid ). in children and adolescents adefshtyl has not been studied in children . for children not previously treated with factor viii medicines : inhibitor antibodies ( see section 2 ) may form very commonly ( more than 1 in 10 patients ); however patients who have received previous treatment with factor vii ( more then 150 days of treatment )
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . prior to use , the afstyla powder may be stored at room temperature ( up to 25 ) for a single period not exceeding 3 months . keep vial in the outer carton in order to protect from light . your doctor or nurse will dispose of the reconstituted product .
what afstyla contains the active substance of a fsstуla is 250 mg / 2 . 5 ml . after reconstitution and with 2 : 5 % water for injections the solution contains 100 mg of lonoctocog alfa per mL . from a microbiological point of view , the product should be used immediately . if not used immediately the solution can be diluted and diluted as follows : after reconversion with 2 mg & water for injects the solutions contains 200 mg of LonoctoCog alba ( corresponding to 1000 mg ). after reconformation with 2. 5 mg , and water for infusions the liquid contains 400 mg of honoctoccog a ( equivalent to 1500 mg ) in one mle . once after reconposition with 5 - mla ,
what praxbind is praxxbind contains the active substance idarucizumab . iarucizum ab is a reverse agent . what pradaxa is used for pra xbind consists of dabigatran ( pradoxa ), a blood thinner medicine that helps prevent blood clot formation . how prabind works pracbind will rapidly trap dabig atran in your blood . you will need to take prapbind as soon as possible after emergency surgery or urgent procedures because of uncontrolled bleeding .
do not use praxbind if you are allergic to idarucizumab or any of the other ingredients in this medicine listed in section 6 . if your doctor has told you that you have a genetic disease called hereditary fructose intolerance ( hereditarian fructoside intoleration ) or to the substance sorbitol ( e420 ). this medicine may cause serious adverse reactions . warnings and precautions talk to your doctor before using pracbind . do not take this medicine if any of these apply to you . you may be given dabigatran or other medicines to prevent blood clots . dabig atran is a naturally occurring protein in your body which makes blood coagulation . this increases the risk of blood cluts when you are treated with medicines to reduce the risk for blood  clotting . your
praxbind is given to you by a doctor or nurse at the hospital or clinic . the recommended dose is 5 mg ( corresponding to 2 . 5 mg ) dabigatran per day . your doctor will decide how many days you should receive this medicine . you should take at least 5 mg of this medicine per day to allow your doctor to decide how often prasbind should be given . this medicine will be given to your child by ' s doctor . praxxbind will be injected into a vein . before you receive this medication , your treatment will be monitored carefully to prevent blood clot formation . it is recommended that dabig atran is given within 24 hours . do not take this medicine for more than one hour before your child receives this medicine as it is prescribed by .
like all medicines , this medicine can cause side effects , although not everybody gets them . reporting of side effects get a quick , fast , or free report of side effect if you get any side effects talk to your doctor , pharmacist or nurse . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
what praxbind contains the active substance is idarucizumab . the other ingredients are sodium acetate trihydrate , acetic acid , dextrose , polysorbate 20 and water for injections . what pxbind looks like and contents of the pack prapbind is a clear to slightly opalescent , colourless to slightly yellow solution in a glass vial with a butyl rubber stopper and an aluminium cap . each vial is sealed with ' pfizer '.
temomedac contains a medicine called temozolomide . this medicine is an antitumour agent . temmedaca is used for the treatment of specific forms of brain tumours : - in adults with newly - diagnosed glioblastoma multiforme . initially , temtemodac is first used together with radiotherapy ( concomitant phase of treatment ) and after that alone ( monotherapy phase of treating ). - also in children 3 years and older and adult patients with malignant gliomema , such as glionomum multiform and anaplastic astrocytoma both of which are relapsing or worsening . when temmomed ac comes into contact with patients who have received standard treatment .
do not take temomedac - if you are allergic to temozolomide or any of the other ingredients of this medicine ( listed in section 6 ). - have had an allergic reaction to dacarbazine ( an anticancer medicine sometimes called dtic ). signs of allergic reaction include feeling itchy , breathlessness or wheezing , swelling of the face , lips , tongue or throat . - are sick - your number of blood cells is severely reduced ( myelosuppression ), such as your white blood cell count and platelet count . these blood cells are important for fighting infection and for proper blood clotting . your doctor will check your blood to make sure you have enough of these cells before treatment . warnings and precautions talk to your doctor , pharmacist or nurse before taking temmedaca : - contact your doctor immediately 
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . dosage and duration of treatment your doctor will work out your dose of temomedac . this is based on your size ( height and weight ) and if there is a recurrent tumour and you have had chemotherapy treatment in the past . you may be given other medicines ( anti - emetics ) to take before and / or after taking temmedaca to prevent or control nausea and vomiting . patients with newly - diagnosed glioblastoma multiforme if : you are a newly . diagnosed patient : your doctor has determined your dose for you , and will decide on the correct dose . during treatment , your doctor may decide to take both phases separately . in this phase , treatment will
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you have any of the following : - a severe allergic ( hypersensitive ) reaction ( hives , wheezing or other breathing difficulty ), - uncontrolled bleeding , - seizures ( convulsions ), or fever , chills , or severe headache that does not go away . temomedac treatment can cause a reduction in certain kinds of blood cells . this may cause you to have increased bruising or bleeding ; anaemia ( a shortage of red blood cells which may cause fever ) and reduced resistance to infections . the reduction in blood cell counts may cause anaemaemia( a lack of red cells ), fever ; and reduced resistant to infections ( see section 2 ). the reduction may be temporary .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . store in the original package in order to protect from moisture . once opened , use within 30 days . tell your pharmacist if you notice any change in the appearance of the capsules .
what temomedac contains - the active substance is temozolomide . temokac 5 mg : each hard capsule contains 5 mg of temizolomide ( as mesilate ). temmedaca 20 mg - each hard shell contains 20 mg of mesitol ( as temazolomide). - temomemedaac 100 mg – each hardshell contains 100 mg of mysiline ( as mysilat ). the usual dose is : tememedab 140 mg , which contains 140 mg of the mesodium ( as triazolam ). what ms looks like and contents of the pack temtemomediac 180 mg — each hard disk contains 180 mg of this substance . the tablet is white to off - white . pack sizes : one bottle with 180 mg or
cialis is a treatment for adult men with erectile dysfunction . this is when a man cannot get , or keep a hard , epis suitable for sexual activity . ciali will help you to get a good amount of eerect penis suitablefor sexual activity at any time . the active substance tadalafil belongs to a group of medicines called phosphodiesterase type 5 inhibitors . how cialize works cialisse works by helping the blood vessels in your penis to relax , making it easier for you to read and write the date of birth , the date on which cialising is injected . it will help the penis look like water , and at the same time each day . your doctor will check the ecg ( oesophagus ) and to check the function of your peni
do not take cialis - if you are allergic to tadalafil or any of the other ingredients of this medicine ( listed in section 6 ). -if you take any form of organic nitrate or nitric oxide donors such as amyl nitsrite . this is a group of medicines (" nites ") used to treat angina pectoris (" chest pain "). cialist will tell you if this applies to you . if any of these medicines apply to you or your child , take special care with cialIS . warnings and precautions talk to your doctor before taking cialisse if : you are suffering from serious heart disease or you have recently suffered a heart attack within the last 90 days . you have ever had a stroke within the past 6 months . your doctor may want to monitor you more closely . talk to
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is two cialis tablets taken together once a day . swallow the tablets with a glass of water . you can take the tablets at any time of the day , with or without food . however , some people may find it easier to take it when you wake up . it is recommended that you take the tablet at about the same time each day if this is the case . your doctor may prescribe a lower or higher dose to a maximum of 5 tablets ( corresponding to 2 . 5 mg / day ). you should take cialist at about this time each morning . if it is not possible to take a tablet at the same times each day you may find that cialising is not suitable for you , and you should contact your doctor .
like all medicines , this medicine can cause side effects , although not everybody gets them . side effects were mainly seen while patients were being given the medicine or shortly after (" infusion related reactions "). allergic reactions including rashes ( frequency uncommon ) and chest pain have been reported in men taking nitrates ( frequency rare ) including priapsim . you may have a prolonged and possibly painful erection after taking cialis . if you have such an erеction lasting for more than 4 hours you should contact a doctor immediately . sudden loss of vision ( frequency not known ). other side effects have been observed with cialisse : common ( may affect up to 1 in 10 people ) or uncommon ( may effect up to 100 people ). headache , back pain and / or sexual activity . these side effects are usually mild to moderate and are most common in women
what cialis contains - the active substance is tadalafil . each tablet contains 2 . 5 mg of ttadeala fil . - other ingredients are : tablet core : lactose monohydrate ( see section 2 , ' cialising contains lactoses '), croscarmellose sodium , 5cp , 3cp ( e468 ), hydroxypropylcellulose , microcrystalline cellulose ; sodium laurilsulfate , magnesium stearate . film - coat : film : Lactosе monohydrate , hyperromellose , triacetin , titanium dioxide ( é171 ), iron oxide yellow ( 850 ), red ( 925 ), and talc . what ciais looks like and contents of the pack cial
enyglid is an oral antidiabetic medicine containing repaglinide which helps your pancreas produce more insulin and thereby lower your blood sugar ( glucose ). type 2 diabetes is a disease in which your panceras does not make enough insulin to control the sugar in your blood or where your body does not respond normally to the insulin it produces . enyingglid can be used to control type 2 diabetic patients whose condition is not well controlled by diet , exercise and weight reduction alone have not been able to control ( or lower ) your blood glucose . the active substance of enYglid , metformin , is  a medicine used to treat diabetes .
do not take enyglid : - if you are allergic to repaglinide or any of the other ingredients of this medicine ( listed in section 6 ). -if you have type 1 diabetes . - when the acid level in your blood is raised ( diabetic ketoacidosis ). warnings and precautions talk to your doctor or pharmacist before taking enYglid the following are reasons why eninessglid is not recommended :- - patients with a severe liver disease . it may be necessary to take gemfibrozil ( a medicine used to lower increased fat levels in the blood of people with liver problems ) or moderate liver 28 disease , see also section 2 . talk to the doctor or nurse before taking the tablet if : you have a severely liver disease you have kidney problems . you should not take the tablet with enyingglid and tell
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended starting dose is 0 . 5 mg before each main meal . swallow the tablets with a glass of water immediately before or up to 30 minutes before each meal , preferably at least 4 hours before or at least 30 minutes after each main meals . your doctor may decide to increase the dose to 16 mg before every main meal to help control your blood sugar . if this dose is too high it becomes a hypo . do not take enyglid more than once a day . contact your doctor if your blood glucose is too low . this may become too high , leading to a hoarse voice or a haemorrhagic attack . you should take a dose as soon as you remember and then continue to take your tablets at regular times
like all medicines , this medicine can cause side effects , although not everybody gets them . hypoglycaemia the most serious side effect is hypoglacy ( seen commonly , may affect up to 1 in 10 people ). hypogycaemic reactions are generally mild / moderate but may occasionally develop into hypoglactic unconsciousness or coma . allergic allergy is very rare ( may affect less than 1 in 1 , 000 people ) but may develop rapidly . symptoms include swelling , difficulty in breathing , rapid heartbeat , feeling dizzy and sweating . these may be signs of anaphylactic reaction . other side effects include : common ( may effect up to1 in 10 persons ) stomach upset . this may occur when taking enyglid . it is important to note that stomach upset may occur during the first few days after taking the medicine . if you notice any
what enyglid contains the active substance is repaglinide . each tablet contains 0 . 5 mg , 1 mg or 2 mg reglinide the other ingredients are : microcrystalline cellulose ( e460 ); calcium hydrogen phosphate , anhydrous ; croscarmellose sodium ; povidone k25 ; and glycerol ; magnesium stearate ; meglumine ; or poloxamer ; yellow iron oxide ( oblong ) only in the 1 mg tablets and red iron oxide( e172 ) not all in the 2 mg tablets . 0 mg tablets the other ingredient is : white , round and biconvex with bevelled edges . 1 mg tablet is pale brown - yellow . biconving . white . pack size of 1 mg : pale
what azacitidine mylan is azacritidine myLAN is an anti - cancer agent . azacitamylan contains the active substance ' azacine '. what zcitine mylanis used for azacionitidine is used in adults who cannot have a stem cell transplantation to treat : higher - risk myelodysplastic syndromes ( mds ) chronic myelamonocytic leukaemia ( cmml ) acute myeloid leuk aemia [ aml ] these are diseases which affect the bone marrow and can cause problems with normal blood cell production . how azacecitide mylan works aza citidine mylant works by preventing cancer cells from growing . the active ingredient in azaciemylan is known as ribonucleic acid ( rds +
do not take azacitidine mylan - if you are allergic to azacritidine or any of the other ingredients of this medicine ( listed in section 6 ). -if you have advanced liver cancer . - in some patients receiving azacitamylan , you may have decreased counts of platelets , red or white blood cells . warnings and precautions talk to your doctor or pharmacist before taking azaciacitine mylan: - kidney disease - liver disease . your doctor will check whether you have a heart condition , heart attack or lung disease , or you are due to have blood test . blood tests before you start treatment with azacionitidine Mylan : before you begin treatment with this medicine , your doctor may decide to carry out blood tests . before you receive treatment with the medicine ' cycle ', which will check that you have enough blood cells
before giving you azacitidine mylan , your doctor will give you another medicine to prevent nausea and vomiting at the start of each treatment cycle . the recommended dose is 75 mg per m2 body surface area . your doctor or nurse will decide your dose of this medicine , depending on your general condition , height and weight . you will usually receive azacritidine myLAN once every day for one week , followed by a rest period of 3 weeks . this " treatment cycle " will be repeated every 4 weeks , but you may receive up to 6 treatment cycles . - this medicine will be given to you as an injection under the skin ( subcutaneously ) by  a doctor or a nurse . it may be given under the " treatment period ". it might be given subcutaneousLY ( under the Skin on your thigh , tummy or upper arm ). if you
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor or pharmacist if you notice any of the following side effects you may need : drowsiness , shaking , jaundice , abdominal bloating and easy bruising . these may be symptoms of liver failure and can be life - threatening . swelling of the legs and feet , back pain , reduced passing of water , increased thirst , rapid pulse , dizziness , nausea and vomiting , decreased appetite . confusion , restlessness and fatigue have been reported with this medicine . symptoms may include : difficulty breathing , cough , taste disturbance , indigestion , heartburn , pain in the abdomen , and nausea and diarrhoea . the following may occur with this medicinal product . liver failure : swelling ofthe legs
keep this medicine out of the sight and reach of children . do not use azacitidine mylan after the expiry date which is stated on the vial label and the carton . any unused azacritidine myLAN will be stored by the health professionals at the hospital or clinic . this medicine should be used during the upkeep and disposal of this medicine . before the suspension is prepared , it should be administered immediately and not stored above 30 . if the azacionidine myla suspension is made using water for injections it should not be administered more than 8 hours after preparation . when the zacitine mylan suspension is making use of water for injectables it must be kept refrigerated for up to 8 hours . the suspension must be placed in the refrigerator ( 2 8 ) immediately after preparation and should be discarded . furthermore , if it is not used within 22
what azacitidine mylan contains - the active substance is azacritidine . one vial of powder contains 100 mg azacitaitidine - after reconstitution with 4 ml of water for injections , the reconstituted suspension contains 25 mg / mL azaciacitide . -the other ingredient is mannitol ( e421 ). what zcitine mylan looks like and contents of the pack aza citidine myLAN is a white powder for suspension for injection and is supplied in a glass vial containing 100 mg of azacionitidine one pack contains 1 vial or 7 vials . not all pack sizes may be marketed .
duotrav eye drop solution contains two active substances , called travoprost and timolol . travaprostant is a prostaglandin analogue that is absorbed through the eye into the bloodstream . and tigol is  a beta blocker . both act as filters for fluid within the eye and reduce pressure within the circle around the eye . duototrav eyes drops are used to reduce high pressure in the eye which can lead to an illness called glaucoma .
do not use duotrav if you are allergic to travoprost , prostaglandins , timolol , beta blockers or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using duotarrav : if your doctor has told you that you have respiratory problems such as asthma , severe chronic obstructive bronchitis or severe lung disease ( wheeziness , difficulty in breathing , or long - standing cough ). if any of these apply to you , tell your doctor before using this medicine . if , while using dutrav you suffer from breathing problems such As severe hay fever if there is a slow heartbeat or if someone else in your family has heart failure or a disorder of heart rhythm ( irregular heart
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one drop in the affected eye or eyes , once a day in the evening . only use duotrav in both eyes if your doctor told you to . use duotrov after your doctor prescribed it for you , as long as your doctors or pharmacist told you not to , and only use it for your other eye . how to use duoutrav use eye drops at least 1 hour before , 2 hours after , 3 hours after or 4 hours after using a bottle . 1 hour after using duotaprav wash your hands . hold the bottle tightly closed with your thumb and fingers . tilt your head back . pull down your eyelid with a clean finger until there is a " pocket " in the corner of your eye
like all medicines , this medicine can cause side effects , although not everybody gets them . you should stop using the drops and see your doctor immediately if you notice any of the effects . when you first start using duotrav , the effects will slowly go away as your body gets used to the medicine . very common side effects ( may affect more than 1 in 10 people ): redness in the eye eye redness . common side effect ( may effect up to 1 in every 10 people in the field of vision ) : damage to the eyeeye surface inflammation or surface damage . this can lead to eye pain , blurred vision , abnormal vision . dry eye , itchy eye ; eye discomfort ; signs and symptoms of eye irritation ( burning and stinging ). uncommon side effects are : eye irritation , burning and itching . side effects related to the allergic reaction . these can
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the vial after exp . the expiration date refers to the last day of that month . store below 30 . throw away the viaf 4 weeks after first opening to prevent infections . this medicine does not require any special storage conditions . write the date of opening on the vialist in the space provided . keep the viam in the outer carton in order to protect from light .
what duotrav contains the active substances are travoprost and timolol . each ml contains 40 mg of travaprosT . one vial contains 5 mg of the active substance titmololl ( as tti Molol maleate ). the other ingredients are : polyquaternium - 1 , mannitol , propylene glycol e1520 , polyoxyethylene hydrogenated castor oil 40 mg / m2 , boric acid , sodium chloride , water for injections , hydrochloric acid / purified water , and sodium hydroxide and / or hydrochoral acid . duotartar may also be used to lower acidity levels ( ph levels ) in the household .
nplate ' s active ingredient , romiplostim , is a protein that reduces low platelet counts caused by immune ( idiopathic ) thrombocytopenic purpura ( itp ). itp is : - itp has a disease in which your body 's immune system does not produce enough platelets . - platelets are cells that are important for your blood to help fight against blood clots . very low platelets counts can lead to bruising and serious bleeding . it may affect more than 1 in 100 people ( including those with spleen removed ) and those with chronic itp who have not been previously treated with corticosteroids or immunoglobulins , but n plate is not intended for you .
do not use nplate if you are allergic to romiplostim or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor immediately . if your doctor thinks you may be allergic to other medicines used to treat escherichia coli ( e . co . col .). warnings and precautions before you are given n plate , please tell your physician if : you have a low blood platelet count ( thrombocytopenia ). you should not be given a second n Plate because your platelet counts may be low . you have ever had blood clots or you have had blood bottles that you can drink , or you think you may have blood coagulations . this is because blood cluts can be more serious and need blood  Clotting . talk
children and adolescents ( aged 1 to 17 years ) the recommended dose is a single injection of nplate . children and teenagers : the recommended adult dose is one single injection ( 0 . 5 ml ) of  n plate . n Plate can be given as an injection under the skin ( subcutaneous ). children and adults : 1 mL n plates can be administered by a nurse or a doctor . your doctor will decide on the dose of ' subcutaneous'. children aged 1 month to  17 years will be able to receive nplatte . how to take nnplate your doctor or nurse will work out your platelet counts to ensure that they are adequate . you will have regular blood samples to check your platelets . this is to check that your platelette count is adequate , and to reduce the risk of your blood being affected by n
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported for itp : common ( may affect up to 1 in 10 people ): headache ; allergic reaction upper respiratory tract infection ; common ( May affect upto 1 in every 10 people): bone marrow disorder , increased bone mmarrow fibres ; trouble sleeping ( insomnia ); dizziness ; tingling or numbness of the hands or feet ( paraesthesia ; migraine ); redness ofthe skin ; flushing ; pain in the muscles ; joint pain ; back pain . reporting of side effects 25 if you get any side effects talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . this medicine should be used within 30 days after first opening . store in the original package in order to protect from moisture .
what nplate contains the active substance is romiplostim . one ml of n plate 125 mg solution for injection contains 230 mg of romoploslim . each vial contains 125 micrograms of ROMiploStim in a deliverable amount of 0 . 25 mL solution , corresponding to 125 milligrams / mmol . romicostim is supplied in two different strengths . the 500 microgram / millilitre reassortant strengths are available : n Plate 250 mg solution : one vial containing 375 milliliter of romeiplosestim , one viall containing 250 microgram ( 0. 5 m / vial of solution ) and one vially containing 25 milligramms of product . not all pack sizes may be marketed
what tovanor breezhaler is this medicine contains an active substance called glycopyrronium bromide . this belongs to a group of medicines called bronchodilators . what tovantor briezhalers is used for this medicine is used to make breathing easier for adult patients who have breathing difficulties due to : a lung disease called chronic obstructive pulmonary disease ( copd ). in copd the muscles around the airways tighten . that makes breathing difficult . the use of this medicine blocks the tightening of these muscles in the lungs , making it easier for air to get in and out of the pulmonary airways . if you use this medicine once a day , it will help to reduce the effects of copd on your everyday life .
do not use tovanor breezhaler - if you are allergic to glycopyrronium bromide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using tovanOR breezehaler and during treatment if any of these apply to you : - you have kidney problems - your doctor may want to reduce your dose -you have an eye problem called narrow - angle glaucoma - difficulty passing urine during treatment with tovanour breechhaler stop using this medicine and tell your doctor immediately if : you get tightness of the chest , coughing , wheezing or breathlessness immediately after using to vanor brewinghaler ( bronchospasm ), including difficulties in breathing or swallowing - swelling of the tongue or lips - or difficulty
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much tovanor breezhaler to use the usual dose is to inhale the content of one capsule each day . you only need to inhagle once a day because the effect of this medicine lasts for 24 hours . do not use more than your doctor tells you to use . elderly people you can use this medicinal product if your doctor has told that you are at risk of overdose . the recommended dose is 75 mg per day , as per usual . when to inhhale this medicine at the same time each day will help you remember to use it . this medicine is for inhalation use , only inhalations . in this pack , you will find an inhaler and capsules ( in blisters ) that
what tovanor breezhaler contains - the active substance is glycopyrronium bromide . each capsule contains 63 micrograms of glycopyrrionum bromite ( equivalent to 50 microgram of glycopronium ). the delivered dose ( the dose that leaves the mouthpiece of the inhaler ) is equivalent to 44 microgram ( 8 microgram ) of glycopirronium at the date and time of calibration . -the other ingredients of the inflation powder are lactose monohydrate and magnesium stearate . what tovantor brewinger looks like and contents of the pack tovanOR breezehaler 44 microgramms inhalation powder , hard capsules consist of a white powder and are delivered into a device called an inhalator . the capsules are packed in blisters . one side of the strip contains 6 or 10 capsules 
adasuve contains the active substance loxapine and belongs to a group of medicines called antipsychotics . it works by blocking receptors in the brain that are involved in producing dopamine and serotonin . this leads to calming effects and relieving aggressive behaviour . adesuve is used in adults for the treatment of acute symptoms of mild - to - moderate agitation with schizophrenia and bipolar disorder , diseases characterised by symptoms such as schizophrenia ) hearing , mistaken beliefs , incoherent speech and behaviour and emotional flatness . people with this condition may also feel depressed , guilty , anxious or tense . in patients with bipolar disorders adafruit contains the medicinal product .
do not take adasuve if you are allergic to loxapine , amoxapin , or any of the other ingredients of aadosuve ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking adesuve and during treatment : if symptoms include wheezing and shortness of breath , as these could be signs of lung problems like asthma or chronic obstructive pulmonary disease ( copd ) if your doctor determines that you have narrowing of the airways ( bronchospasm ), which can be associated with wheeze , cough , chest tightness or shortnessof breath . 25 adsuve may cause neuroleptic malignant syndrome ( nms ) which may be associated to symptoms of antipsychotic medicines . these symptoms can include
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended starting dose is 9 . 1 mg once a day . your doctor may increase your dose to 2 mg once daily . however your doctor will adjust your dose up to 4 . 5 mg depending on your condition and your general condition . adasuve is for oral use . it is for use by mouth . swallow the tablet whole . do not chew , crush or break the tablet before swallowing . use the device only when you are completely empty . contact your doctor immediately if : you feel extreme tiredness , sleepiness , trouble breathing , low blood pressure , throat irritation , a bad taste in the mouth , muscle or eye movements . you should contact your physician if they suggest that you use this medicine .
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor or nurse straight away if you notice any of the following side effects you need to tell your physician or nurse : - any breathing symptoms ( wheezing , cough , shortness of breath , chest tightness ) or irritating that is your airways . these may be signs of asthma or copd . - light - headedness or fainting . this may occur when your blood pressure is raised . other possible side effects include : worsening agitation , confusion , fever , muscle stiffness . they may be the signs of a severe condition called neuroleptic malignant syndrome . side effects may include , but are not limited to : very common ( may affect more than 1 in 10 people ):  headache  feeling sick ( nausea )
keep out of the reach and sight of children . do not use adasuve after the expiry date which is stated on the carton and the pouch after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2c 8c ). do not freeze . keep the pouch in the outer carton in order to protect from light . avoid placing adesuve near children , as this product may cause physical damage .
what adasuve contains - the active substance is loxapine . each single - dose inhaler contains 5 mg of lox apina . aDasuve delivers 4 . 5 mg / ml of doxapineed each day . what аdasuvé looks like and contents of the pack adassuve 4  . 4 mg inhalation solution is supplied in a single , disposable white plastic inhalator containing loxe ; each inhalers is enclosed within a sealed foil pouch . the pack of adesuve is available in : a dasuve 4.5 mg is available as packs containing 1 or 5 inhalations . not all pack sizes may be marketed .
what azacitidine betapharm is azacritidine betabharm is an anti - cancer agent which belongs to a group of medicines called ' anti  - metabolites '. azacionitidine is made from two cellulose - starches . one of these active ingredients is a substance called azacite . what zappharm is used for azacitabetapharm works by preventing the body ' s immune system from attacking its own cells . the active substance in azacutidine be Tapharm is known as ' oral antigen of the medicine ', which is essentially " oral anti " in the blood . your doctor will tell you why you are being treated with azacetidine btapharm . how azacine betaphar works aza citidine be tapharm is useful in adults who are undergoing a stem cell
do not take azacitidine betapharm - if you are allergic to azacrimid or any of the other ingredients of this medicine ( listed in section 6 ). -if you have advanced liver cancer . - in some patients receiving azacitabine betaphar , you may have decreased counts of platelets , red or white blood cells . warnings and precautions talk to your doctor before taking azaciacitine betap harm : - kidney disease - liver disease . you have ever had a heart condition , heart attack or lung disease , or you have had gastrointestinal or heart problems . blood test you will have blood tests before you start treatment with azacionitidine betatapharm and at the start of each period of treatment ( called a ' cycle '). this is to check that you have enough blood cells and that your liver and kidneys are working
before giving you azacitidine betapharm , your doctor will give you another medicine to prevent nausea and vomiting at the start of each treatment cycle . the recommended dose is 75 mg per m2 body surface area . your doctor or nurse will decide your dose of this medicine , depending on your general condition , height and weight . you will usually receive azacritidine be tapharm once every day for one week , followed by a rest period of 3 weeks . this " treatment cycle " will be repeated every 4 weeks , but you must not stop using it without talking to your doctor . each treatment period will be given to you as an injection under the skin ( subcutaneously ) by  a doctor or a nurse . it may be given under the same area of your thigh , tummy or upper arm . if you have any further questions on the use of this medicinal
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor or pharmacist if you notice any of the following side effects you may need : drowsiness , shaking , jaundice , abdominal bloating and easy bruising . these may be symptoms of liver failure and can be life - threatening . swelling of the legs and feet , back pain , reduced passing of water , increased thirst , rapid pulse , dizziness , nausea and vomiting , decreased appetite . confusion , restlessness and fatigue have been reported with this medicine . symptoms may include : chills , tremor , confusion / restlessness / fatigue . the following may occur with this medicinal product : very common ( may affect more than 1 in 10 people ): diarrhoea , stomach pain .
keep out of the sight and reach of children . do not use azacitidine betapharm after the expiry date which is stated on the vial label and the carton . any unused azacritidine be tapharm will be stored by the health professionals at your healthcare facility . this medicine should be stored in a refrigerator ( 2c 8c ). do not freeze . during the use of this medicine , the suspension should be administered within 45 minutes . when using the azacitabetapharm suspension with water for injections , it is recommended that the suspension be stored within 8 hours after preparation . if the azocitine betaphar suspension is prepared using water for injectables : 8 hours following preparation ,the suspension should être administered within 8 minutes , and the liquid is clear and colourless . the suspension must be allowed to reach room temperature ( below 25 ) before administration
what azacitidine betapharm contains - the active substance is azacritidine . one vial contains 100 mg azacitaitidine - after reconstitution with 4 ml of water for injections , the reconstituted suspension contains 25 mg / mL azacididine , - as w / alu - containing mannitol ( e421 ). what zacitine betaphar looks like and contents of the pack azacicitidine betatapharm is a white to off - white powder for suspension for injection and is supplied in a glass vial containing 100 mg of azacionidine  .
cerdelga contains the active substance eliglustat and is used for the long term treatment of gaucher disease type 1 in adults . gaucher Disease type 1 is a genetically modified ( inherited condition ) in which certain substances called glucosylceramide ( s ) are not removed from your body , such as the spleen , liver and bones . eleglustat works by replacing the harmful substances called " glukylceride " in your body which are produced by your affected organs . you will usually receive this medicine over a period of time . it is very important that you continue to take this medicine until your doctor tells you otherwise . patients with slow speed or poor metabolisms may not benefit from cerdeslg . your doctor will give you a simple laboratory test to find out if you have gaucher syndrome .
do not take cerdelga - if you are allergic to eliglustat or any of the other ingredients of this medicine ( listed in section 6 ). - in combination with medicines containing moderate cyp2d6 inhibitors ( e . g . quinidine , terbinafine , 31 moderate chyp3a inhibitors such as erythromycin and itraconazole , these medicines reduce your body ' s ability to break down the medicine . do not use cerdeslg if any of these apply to you . warnings and precautions talk to your doctor , pharmacist or nurse before taking cerderlg if : you are taking medicines that have a poor metaboliser such as those obtained without a prescription . you are also taking medicines with strong cyst3a inhibitions such As itrac
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much to take the recommended dose is one tablet each day . your doctor will tell you how many tablets of metaboliser to take . the recommended daily dose is two tablets a day , one in the morning and one in in the evening . if your doctor has told me that you need to take two tablets at the same time , take one tablet in the afternoon and one tablet at the end of the day ; this will 84 tablets will be about the same distance as usual . swallow the tablets whole with a glass of water . you can take cerdelga with or without food . to open the blister / wallet , insert the sleeve with your thumb and middle finger . push the tablet through the foil to release the tablet
like all medicines , this medicine can cause side effects , although not everybody gets them . very common ( may affect more than 1 in 10 people ) headache dizziness change in taste ( dysgeusia ) palpitations , throat irritation heartburn ( dyspepsia) feeling sick ( nausea ) diarrhoea constipation abdominal pain stomach ache ( upper abdominal pain ) acid reflux disease ( gastrooesophageal reflux disease ) bloating ( abdominal distension ) inflammation of the stomach ( gastritis ) 34 difficulty swallowing ( stomach discomfort ) uncommon ( may effect up to 1 in 100 people ). reporting of side effects 25 if you get any side effects talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and sleeve after " exp ". the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . sleseve should be folded in half , with the outer layer separating from the middle layer . store in the original package in order to protect from moisture . tell your pharmacist if you notice any change in the appearance of the capsules .
what cerdelga contains - the active substance is eliglustat . each capsule contains 84 mg of eglustat in 2ml of solution . -the other ingredients are : capsule content : microcrystalline cellulose , lactose monohydrate ( see section 2 ' cer delg  contains lactoses '), hypromellose , glycerol dibehenate , capsule shell : gelatin , potassium aluminium silicate , titanium dioxide ( e171 ), yellow iron oxide ( a reminder of the fd and indigotine ( fc ), shellac , black iron oxide , propylene glycol and ammonia solution , concentrated . what cdelgga looks like and contents of the pack cerDelgaga capsules are opaque and
the active substance in zoledronic acid hospira is zolédronic Acid , which belongs to a group of substances called bisphosphonates . zoleric acid works by attaching itself to the bone and slowing down the rate of bone change . it is used : to prevent bone complications , e .g . fractures , in adult patients with bone metastases ( spread of cancer from primary site to the bones ). to reduce the amount of calcium in the blood in adult subjects where it is too high due to the presence of a tumour . tumours can accelerate normal bone change in such a way that the release of calcium from bone is increased . this condition is known as tumour - induced hypercalcaemia ( tih ).
follow carefully all instructions given to you by your doctor . your doctor will carry out blood tests before you start treatment with zoledronic acid hospira and will check your response to treatment at regular intervals . you should not be given zolédronic Acid hospria : - if you are allergic ( hypersensitive ) to zolеdronic acids or another bisphosphonate ( the group of substances to which zol edrondic acid belongs ). warnings and precautions talk to your doctor before you are given zedronric acid houpira . - tell your doctor straight away if : you have or have had a kidney problem . there have been reports of pain , swelling or numbness of the jaw , a feeling of heaviness in the jaw or loosening of a tooth . before you receive treatment with this
- zoledronic acid hospira must only be given by healthcare professionals trained in administering bisphosphonates intravenously , i . e . through a vein . instructions for ' iv ' administration are given at the end of this leaflet . to avoid dehydration , you must always be given zolédronic Acid hospria exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . how much zolenic acid hopira is given the usual dose is 4 mg / kg . ( see section 4 ) if : you have a kidney problem your doctor will decide how much to give you if your kidney problem is severe . administration of zoleric acid homospira should be started as soon as possible . patients with a history of bone complications
like all medicines , zoledronic acid hospira can cause side effects , although not everybody gets them . the most common side effects ( may affect more than 1 in 10 people ) are : severe kidney impairment ( will normally be determined by your doctor with certain specific blood tests ). low level of calcium in the blood . uncommon ( may effect up to 1 in 100 people ), pain in the mouth , teeth and / or jaw , swelling or non - healing sores inside the mouth ( jaw discharge ), numbness or a feeling of heaviness in the jaw or loosening of a tooth . these could be signs of bone damage in the waist ( osteonecrosis ). tell your doctor and dentist immediately if you experience such symptoms while being treated with zolеdronic acids hospria . your doctor should do blood tests to check for
your doctor , pharmacist or nurse knows how to store zoledronic acid hospira properly ( see section 6 ). this medicine does not require any special storage conditions . if you have any unwanted tablets , don ' t put them in waste water or household rubbish . ask your pharmacist how to dispose of tablets you don  '
what zoledronic acid hospira contains the active substance of zoleric acid is zolzoletronic acid ( as monohydrate ). one vial contains 4 mg zol edronatic acid , as monohydrat . the other ingredients are : mannitol , sodium citrate and water for injections . what - zolédronic acids hospria looks like and contents of the pack zolеdronic Acid hospra is supplied as a liquid concentrate for solution for infusion , supplied as either a ' sterile concentrate ' or a clear , colourless liquid . each pack contains one single - use vial of concentrate .
varuby contains the active substance rolapitant . it is used to treat adults with cancer feeling sick ( nauseous ) or being sick ( vomiting ) in adults who are receiving cancer treatment chemotherapy . chemotherapy destroys nerve cells in the brain that cause vomiting . this makes you feel sick and makes you less sick . rolapatant works by blocking the activity of these nerve cells and helps to prevent nausea and vomiting , as well as cutting off the gas in your stomach .
do not take varuby : - if you are allergic to rolapitant or any of the other ingredients of this medicine ( listed in section 6 ). - the active substance in varubY is an herbal medicine containing st john ' s wort ( hypericum performatum ). it is used for the treatment of depression in adults , adolescents and children aged 2 years and older . do not use this medicine if any of these apply to you . 27 - you have severe liver or kidney problems . - are taking certain medicines , such as rifampicin ( used to treat tuberculosis or other infections ). warnings and precautions talk to your doctor or pharmacist before taking varubies : carbamazepine ( used in epilepsy and nerve pain ). varubying phenobarbital ( used for epi
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one 180 mg tablet twice a day . your doctor may reduce your dose to 90 mg once a week . swallow the tablet whole with a glass of water . you can take varuby with or without food . it is best to take varaby at least 2 weeks before your chemotherapy cycle . do not take varogy during your chemotherapy as this may cause sickness . if sickness occurs , you should not take this medicinal product . when you are having chemotherapy , tell your doctor before you start another chemotherapy cycle and then take your next dose at the usual time . this may make you more likely to get feeling sick or being sick , especially when you start a new chemotherapy cycle or when you feel better . tell your pharmacist if 
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported : side effects may affect up to 1 in 1 , 000 people . tell your doctor immediately if you have symptoms of an allergic reaction , which may include sudden shortness of breath , swelling of the lips or tongue , change in taste , or swelling of skin or tissue , sudden rash , fever and faster heartbeats . you should contact your doctor promptly if any of the following occur . your doctor may decide to continue to prescribe appropriate treatment . other side effects include : common ( may affect more than 1 in 10 people ): headache . constipation . feeling tired common ( might affect up 1 in 100 people ).
what varuby contains - the active substance is rolapitant . each tablet contains 90 mg of rolitant -the other ingredients are : tablet core : lactose monohydrate ( see section 2 ' varubies contains lactoses '), pregelatinised starch , microcrystalline cellulose , povidone ( k - 30 ), croscarmellose sodium , colloidal silicon dioxide , magnesium stearate . film - coating : polyvinyl alcohol , titanium dioxide ( e171 ), macrogol , polysorbate 80 . what varaby looks like and contents of the pack varubY is a blue , round , biconvex 100 mm diameter , with a polyvinyed chloride , and polychlorotrifluoroethylene / aluminium foil thin
what enerzair breezhaler is enERzair brazose contains two active substances : - indacaterol - glycopyrronium - mometasone furoate inddacatrol and glycopyrrronium belong to a group of medicines called bronchodilators . they work in different ways to relax the muscles of the small airways in the lungs . this helps to open the airways and makes it easier for air to get in and out of the pulmonary tract . when enersair broncodilator works , the muscles surrounding the small lungs become tighter . mometapasonne furoates belongs to  a groupe of medicines known as corticosteroids ( or steroids ). corticotroides reduce the swelling and irritation ( inflammation ) in the small aeroways in your
do not use enerzair breezhaler - if you are allergic to indacaterol , glycopyrronium , mometasone furoate or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor without using enezair and if any of these apply to you ( or you are not sure ) if your doctor or pharmacist thinks you may be allergic . warnings and precautions talk to your doctor , pharmacist or nurse before using  EnerzAir breezehaler and / or the other ingredient(s ): -if you have heart problems , such as an irregular or fast heartbeat . - have thyroid gland problems . tell your dentist if : you have diabetes or high blood sugar . you have a history of seizures . your
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one capsule each day . you only need to inhale once a day because the effect of the medicine lasts for one or two days . if your asthma does not improve , or if there are no symptoms at the time , contact your doctor immediately . use enerzair breezhaler every day , even when your symptoms are not bothering you , as your symptoms may get worse . how to inhaled enenerzaair briezhalers is for inhalation use . each pack contains an inhaler and capsules that contain the medicine . only use the inhalers provided in this pack for one month . once the inhaler has been used , the medicine should be 
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects could be serious stop using enerzair breezhaler and get medical help immediately if you have any of the following : common : may affect up to 1 in every 10 people - difficulty breathing or swallowing , swelling of the tongue , lips or face , skin rash , itching and hives ( signs of allergic reaction ). other side effects other side effect that has been reported are listed below . if these side effects become severe , tell your doctor or pharmacist . very common - may affect more than 1 in 10 people common  sore throat  runny nose  sudden difficulty breathing  feeling of tiredness or weakness in the chest  difficulty breathing and feeling of weakness in arms or legs  cough  chest pain  diarrh
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . this medicine does not require any special temperature storage conditions . store the capsules in the original blister in order to protect from moisture and do not throw away until immediately before use .
what enerzair breezhaler contains - the active substances are indacaterol ( as acetate ), glycopyrronium ( as bromide ) and mometasone furoate . each delivered ( inhaled ) dose contains 150 micrograms of inddacatrol ( AS aate ), 63 microgram ( as glycopyronum bromid ) or 50 microgram(s ) glycopyranium ( equivalent to 160 microgram of mometabet asine furoates . the delivered dose ( inhaler ) is equivalent to 114 microgram indaidacaterolul ( as as аcetate ) 58 microgram glycopyronicum bromine , equivalent to 46 microgram / ml glycopyridine and 136 microgram [ s ] glycopyrone furóate
clopidogrel acino pharma gmbh contains the active ingredient clopogrell which belongs to a group of medicines called antiplatelet medicinal products . platelets ( so - called thrombocytes ) are very small structures , which clump together during blood clotting . by preventing this clumpeding , antiplatelets medicinal products reduce the chances of blood  clots forming ( a process called trophosis ). clodogrelly acan pharma grbh is taken to prevent blood coagulations ( thrombi ) forming in hardened blood vessels ( arteries ), a condition known as atherothrombosis which can lead to atherotrombotic events ( such as stroke , heart attack , or death ). you have been prescribed cloclopidO
do not take clopidogrel acino pharma gmbh : if you are allergic ( hypersensitive ) to clopogrell or any of the other ingredients of clopinogrela acan pharma or to any of its ingredients ; if your medical condition is currently causing bleeding such as a stomach ulcer or bleeding within the brain ; or if someone in your family has severe liver disease . if any of these apply to you , tell your doctor before taking cloclopidOgrel Acino  Pharma g mgbh and tell your healthcare provider before taking this medicine : the precautions needed to avoid bleeding such a medical condition that puts you at risk of internal bleeding ( such as from a stove ulcer ) or a blood disorder that makes you prone to internal bleeding or bleeding in the brain ( see section 4 ). take special care
always take clopidogrel acino pharma gmbh exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . the usual dose is one 75 mg tablet of clopogrell aco pharma ga . take one tablet daily at the same time of the day each day . if vous take more cloclopidOgrel Acino  Pharma g mbH than you should contact your doctor , pharmacist or the nearest hospital emergency department because of the increased risk of bleeding . keep the tablet bottle with you so that you can easily describe what you have taken . don ' t take more than the recommended dose . what to do if ' don ’ t stop , or if someone else takes your tablets , contact your pharmacist or hospital emergency unit immediately . they may be at risk of
like all medicines , clopidogrel acino pharma gmbh can cause side effects , although not everybody gets them . the frequency of possible side effects listed below is defined using the following convention : very common ( affects more than 1 user in 10 ) common (affecting 1 to 10 users in 100 ) uncommon ( affecting 1 to10 users in 1 , 000 ) rare ( affectant 1 to 11 users in 10 to 10 ,000 ) very rare (affecting less than 1 users in10 ,0.000 ) not known ( frequency cannot be estimated from the available data ) contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ).
store in the original blister in order to protect from moisture . keep out of the reach and sight of children . do not use clopidogrel acino pharma gmbh after the expiry date which is stated on the carton and on the blister after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not take clopogrell aco pharma grbh if you notice any visible sign of damage of blister or film - coated tablets . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what clopidogrel acino pharma gmbh contains the active substance is clopogrell . each tablet contains 75 mg of clopinogregrel ( as besilate ). the other ingredients are : tablet core : macrogol 6000 cellulose , microcrystalline ( e460 ) crospovidone type a castor oil , hydrogenated film - coating : microgol 7000 ethylcellulose ( е462 ) titanium dioxide ( d171 ) what clapidogral аcino gracino acan pharma grbh looks like and contents of the pack clonogrelor aco pharma gigbh 75 mg film – coated tablets are white to off - white , marbled , round and biconvex . they are supplied in cardboard
delstrigo is used to treat hiv (' human immunodeficiency virus ') infection . it belongs to a group of medicines called ' antiretroviral medicines '. it is a mixture of three active substances : doravirine , a non - nucleoside reverse transcriptase inhibitor ( nnrti ) lamivudine , also a nucleolar analogue reverse transcriptsaser ( ndti and tenofovir disoproxil ), also , has been shown to work by reducing the amount of an aminoside analog reverse transcriptains ( trtis ) in all patients . dellsTRIgo is intended for treating hiv infection in adults aged 18 years and over . hiv is the virus that causes aids (' acquired immune
do not take delstrigo if you are allergic to doravirine , lamivudine , tenofovir disoproxil or any of the other ingredients of this medicine listed in section 6 . if this applies to you , tell your doctor immediately . do not use delStrigo after you have been previously treated with any of these medicines : carbamazepine ; oxcarbazepine ( type a ); phenobarbital ; or phenytoin ( medicines to prevent seizure ); or rifampicin or reifapentine ( medicines for tuberculosis ); simvastatin ( medicine to treat tubercuosus ); saint john ' s wort ( hypericum perforatum ) ( a herbal remedy
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose is : follow your doctor ' s instructions exactly , even if they differ from the general information contained in this leaflet . a complete regimen is recommended for adults , adolescents and children over 1 year of age . do not exceed the recommended dosage if your doctor tells you to take certain medicines , such as doravirine . these are medicines you should not take with food . taking this medicine swallow the tablet whole with water . take the tablet at the same time each day . you can take this medication with or without food , just as your child would if it was a long time . it is best to take delstrigo within 12 hours of your last meal . your doctor may recommend that you continue your treatment with
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking this medicine and tell your doctor immediately if you notice any of the following : very common : may affect more than 1 in 10 people - abnormal dreams , difficulty in sleeping ( insomnia ) - headache - dizziness , sleepiness - cough , nasal symptoms - feeling sick ( nausea )- diarrhoea - stomach pain - vomiting - wind ( flatulence ) common - hair loss - rash muscle symptoms ( pain , stiffness ) not known : frequency cannot be estimated from the available data - tiredness - joint pain ( back pain ) uncommon : can occur in up to 1 in 100 people : - flu - like symptoms , such as feeling tired - being sick ( vomiting ) rare : will occur
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the bottle and carton after exp . the expiration date refers to the last day of that month . keep the bottle tightly closed in order to protect from moisture . this medicinal product does not require any special temperature storage conditions . store in the original package in order for the medicine to be effective . discard the bottle after first opening . delstrigo is for single use only . any used medicine should be discarded . only use the bottle if the contents are not clear , colourless and waterlike . throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what delstrigo contains the active substance is doravirine . each tablet contains 300 mg dorvirine , 300 mg lamivudine and 245 mg tenofovir disoproxil ( as fumarate ). the other ingredients are : tablet core : croscarmellose sodium e468 , hypromellose acetate succinate , magnesium stearate in the tablet core and microcrystalline cellulose e460 , silica , colloidal anhydrous , sodium stearyl fumarat . film coat : carnauba wax e903 , ink : shellac , iron oxide yellow , lactose monohydrate , titanium dioxide e171 , triacetin . what dellstrigol looks like and contents of the pack del
spravato contains the active substance esketamine . this belongs to a group of medicines called anti - depressants . you have been given this medicine to treat your depression . it has been shown to improve the symptoms of depression , which are often described as feeling sad , anxious or worthless , sleeping difficulties , change in appetite , loss of interest in favourite activities , feeling of being slowed down . if you have recently taken another antidepressant , talk to your doctor about referring to svarvato . talk to if this applies to you . see section 2 , ' taking other antidepressive medicines '.
do not take spravato if you are allergic to esketamine or any of the other ingredients of ketamine ( listed in section 6 ). if there is a history of an aneurysm ( a weak spot on a blood vessel wall ) that bulges out , or bleeding in the brain . if , recently , you have had a heart attack within 6 weeks . this may result in a temporary increase in blood pressure . which may increase the risk of serious complications in these conditions . warnings and precautions talk to your doctor , pharmacist or nurse before taking s Pravato and if any of these apply to you . take special care with sprivato tell your doctor or pharmacist if the patient has : - a cardiac problem ( poor blood flow to one of your blood vessels ) or if your blood pressure
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much to use the spravato nasal spray will be given by your doctor using the nasal spray device . the recommended dose is 1 spray at a time . your doctor may prescribe 2 or 3 nasal spray devices . you can use one nasal spray appliance for 4 days , followed by another 4 days without using s Pravato . use in children and adolescents the recommended dosage of sprayed for children and infants is 2 sprays per day . this medicine can cause nausea and vomiting . if savato is used for more than 2 days ' treatment , your doctor will stop using this medicine and treat nausea and / or vomiting if they are more than 30 minutes after using this product . nasal sprays can be used with steroid
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported : very common ( may affect more than 1 in 10 people ) feeling disconnected from the feelings and things around you feeling dizzy , headache , change in sense of taste feeling sleepy , decreased feeling or sensitivity in or around the mouth area spinning sensation , vertigo , vomiting nausea common ( might affect up to 1 in 100 people ), feeling extremely happy ( euphoria ) or feeling agitated , difficulty in speaking , feeling hungry , increased appetite , irritable or irritated . not known ( frequency cannot be estimated from the available data ): dizziness , lightheadedness / fainting , fainting ( tummy ) rash , itching , reddening / rash skin eruption (
what spravato contains - the active substance is esketamine . each nasal spray device contains eesKETamine hydrochloride equivalent to 28 mg esesketamine at the recommended dose . - additional ingredients are citric acid monohydrate disodium edetate sodium hydroxide ( for ph adjustment ) water for injections what ' s s Pravato looks like and contents of the pack spruvato is a nasal spray solution . this medicine is  a clear , colourless solution in a single - use nasal spray appliance . the sprinkling area is approximately 1 ml , 2 mL , 3 mle or 6 nasal spray devices . all are supplied in sprayed containers . not all pack sizes may be marketed .
zelboraf is an anticancer medicine containing the active substance vemurafenib . it is used to treat adult patients with melanoma , a change ( mutation ) in a gene called ' vemu ' ( vesicant ) ', which has spread to other parts of the body or cannot be removed by surgery . zelmoraf targets proteins found in certain cells in the body that play a role in the growth and spread of melama . the change ( mutation ) of a protein in the gene that causes melonoma to grow . how zelbaf works zelbaraf specifically targets proteins produced by the body . this helps to fight your cancer .
do not take zelboraf - if you are allergic to vemurafenib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking zelbaf and during treatment : if symptoms of allergic reactions include swelling of the face , lips or tongue , difficulty breathing , rash and fainting sensation . if this happens , do not inject more zelmoraf but talk to a doctor straight away . allergic reactions allergic reactions can happen anywhere in the treatment with zelbroaf or in other medicines . stop taking zboraF and seek medical help immediately if your doctor sees you as allergic reactions are serious . you should not take the medicine if : you experience any symptoms of an allergic reaction such as swelling ofthe face  , lips or
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is 4 mg once a day taken in the morning . your doctor may increase your dose to 8 mg once daily . this is a total of 4 mg per day . if side effects occur , your doctor will adjust your treatment . taking zelboraf with food may cause vomiting . take zelbaf on an empty stomach . swallow the tablet whole with water . do not crush , chew or crush the tablet . how to take zboraaf take zeborafat on an unevenly increased stomach , one after another , with food . you can take a large amount of zelbaraf whole with or without food , but do not break or crush it . it is recommended that you
like all medicines , zelboraf can cause side effects , although not everybody gets them . serious allergic reactions : swelling of the face , lips or tongue ; difficulty breathing rash fainting sensation when you stand up zelbaf is exposed to radiation treatment possible side effects related to radiation during zelbaraf treatment , radiation may be absorbed by the skin , epiphyses , bladder , liver , rectal , and lungs . tell your doctor immediately if you experience any of the following symptoms : skin rash ( including blistering , peeling ), discoloration or discolorations of the skin shortness of breath cough , chest discomfort , nausea vomiting , itching , chills , vomiting . your doctor will decide if this happens . other side effects very common ( may affect more than 1 in 10 people ): flu like illness
keep out of the sight and reach of children . do not use zelboraf after the expiry date which is stated on the carton and the blister after exp . the expiration date refers to the last day of that month . this medicinal product does not require any special storage conditions . if you have any unwanted tablets , don ' t put them in waste water or household rubbish . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what zelboraf contains the active substance in zelboss is vemurafenib . each film - coated tablet contains 240 mg of vemoraf . the other ingredients are : tablet core : hypromellose acetate succinate , colloidal anhydrous silica , croscarmellose sodium , and hydroxypropyl cellulose , magnesium stearate film  - coating : iron oxide red ( e172 ), macrogol 3350 , polyvinyl alcohol , titanium dioxide ( ED171 ). what zboraF looks like and contents of the pack zelbroaf 24 mg film  film – coated tablets are pinkish white to orange white , round shaped , biconvex , aluminium perforated unit dose tablet .
duoplavin contains two active substances : clopidogrel and acetylsalicylic acid ( asa ) and belong to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumpeding , blood vessels become damaged . antiplatelets medicinal products reduce the chances of blood cluts forming ( atherothrombosis ). duopolivin is taken to prevent blood coagulations from forming in hardened arteries , a risk of atheropenic events ( such as stroke , heart attack , or death ). you have been prescribed duoplacevin to help prevent these events .
do not use duoplavin if you are allergic to clopidogrel , acetylsalicylic acid ( asa ) or any of the other ingredients of this medicine ( listed in section 6 ) if your doctor has told you that you are allergy to other products , including non - steroidal anti - in - inflammation products . if the treatment of painful and / or inflammatory conditions of muscles or joints is not being properly controlled . take special care with duoplacevin : if any of these applies to you , tell your doctor before taking duolavin . warnings and precautions talk to your doctor or pharmacist before taking this medicine : the following medicines may increase the risk of developing painful and/ or inflammation conditions of muscle or joints . tell your physician if : you have a medical condition such as asthma with nasal discharge ,
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much to take the recommended dose of duoplavin is one tablet a day . swallow the tablet whole , with some water . your doctor will tell you how long you should take your medicine . duolavin can be taken with or without food . if your doctor thinks you may have taken too many tablets , contact your doctor at the nearest hospital emergency department because of the increased risk of bleeding . keep the tablet bottle with you so that you can easily describe what you have taken . do not change the dose or stop taking duoplacevin without first talking to your doctor even if they feel better . when to take duo Plavin you should keep taking duotropin every day , at the same time of the day ; however , if
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and , in rare cases , confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of the Skin . they may be the signs of an allergic reaction . the signs may include : fever . very common side effects ( may affect more than 1 in 10 people ): diarrhoea . uncommon side effects may occur ( may effect
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister . the expiration date refers to the last day of that month . store below 25 . keep this medicinal product in the original package in order to protect from light and moisture . this medicine does not require any special storage conditions . tell your pharmacist if you notice any visible sign of deterioration . these measures will help to protect the environment .
what duoplavin contains duopolivin 75 mg film - coated tablets 46 the active substances are clopidogrel and acetylsalicylic acid ( asa ). each 75 mg tablet contains clopogrell ( as hydrogen sulphate ) and 75 mg aceticylSalicyLIC acid . the other ingredients are mannitol , macrogol 6000 , microcrystalline cellulose , low substituted hydroxypropylcellulose . ingredients in the tablet core are maize starch , hydrogenated castor oil ( see section 2 ' duolavin contains hydrogenated castingor oil ').
simbrinza contains two active substances : brinzolamide and brimonidine tartrate . brinzolam belongs to a group of medicines called carbonic anhydrase inhibitors . brianidine tartratrate belongs to the group of medications called alpha - 2 adrenergic receptor agonists , which work to reduce pressure within the eye . simbrINza is used to improve the function of the eyes in adults aged 18 years and older who have eye conditions such as glaucoma or ocular hypertension ( high pressure in the eyes ).
do not take simbrinza if you are allergic to brinzolamide , brimonidine tartrate or any of the other ingredients of this medicine ( listed in section 6 ) if your doctor thinks you may be allergic to sulphonamides , medicines used to treat diabetes or infections , diuretics ( water tablets ) or a monoamine oxidase ( mao ) inhibitor ( medicines used for depression or parkinson ' s disease ) certain antidepressants ( see " other medicines and simbrine " below ) take special care with simbrINza : if any of these apply to you . warnings and precautions talk to your doctor or pharmacist before taking simbriner if : you are taking , have recently taken or might take any antidepressive medicines . you have severe kidney problems . there is too much acidity in your
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . simbrinza is only for use by adults . the recommended dose is one drop in the affected eye or eyes once daily in the evening . wash your hands before you start . 1 ) do not shake the bottle . 2 ) pull the cap off , and pull the snap collar off . after taking the medicine , press with your fingers on the bottle to release it . - hold the bottle as shown in picture 1 . twist off the cap , which should be broken . do not squeeze , break , crush , or chew the bottle until it is time for your next regular dose . hold the cap ( s ) at a time . press down on the tip of the bottle and press it down . then press down with your
like all medicines , this medicine can cause side effects , although not everybody gets them . possible side effects with this medicine include : - a reaction to the medicine ( frequency not known ) which may be severe . - an allergic reaction - severe skin reactions ( rash , redness or itching all over your body ) - eyes trouble breathing - chest pain - irregular heart beat tell your doctor immediately if you experience extreme tiredness or dizziness . side effects of simbrinza may be more common with other medicines . these may be serious and may include , but are not limited to : very common : may affect more than 1 in 10 people - allergic reactions to the medicines - reactions to any ingredient in simbrINza , or to any other medicine . tell your pharmacist or nurse immediately , if they happen . they may be signs of a possible
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the bottle and the carton after exp . the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . store in the original package in order to protect from moisture . throw away the bottle 4 weeks after first opening to prevent infections and use a new bottle . tell your pharmacist if you notice any change in the appearance of the tablets .
what simbrinza contains the active substances are brinzolamide and brimonidine tartrate . one ml of suspension contains 10 mg of brinzolide and 2 mg of brimoniidine tartrat equivalent to 1 . 3 mg brianidine . the other ingredients are benzalkonium chloride ( see section 2 " simbrINza contains benzalsalkonum chloride "), propylene glycol , carbomer 974p , boric acid , mannitol . what simmbrinz looks like and contents of the pack simbrine 10mg / mL solution for injection contains : sodium chloride , the solvent is a clear , colourless solution . tyloxapol , hydrochloric acid or sodium hydroxide are used to adjust the concentration of simbronium .
what filgrastim ratiopharm is filgraStim ratiopospharm contains the active substance filgraştim . filgraschtim is a protein produced by biotechnology in bacteria called escherichia coli . it belongs to a group of proteins called cytokines and is very similar to  a natural protein ( granulocyte - colony stimulating factor [ g - csf ]) produced by your own body . Filgrastig stimulates the bone marrow ( the tissue where new blood cells are made ) to produce more blood cells , especially certain types of white cells . white cells are important as they help your body fight infection . what filgristim rapportpharm looks like and contents of the pack filgrasestim ratiopmharm is able to produce a steady amount of white blood cells called ' gamma -
do not use filgrastim ratiopharm - if you are allergic ( hypersensitive ) to filgraStim or any of the other ingredients of filgrasestim ratiopossum . warnings and precautions talk to your doctor , pharmacist or nurse before using filgraştim ratioppharm . - during treatment with filgrashipharm you may experience a cough , fever and difficulty breathing . this may be a sign of a pulmonary disorder ( see section " 4 . possible side effects "). - sickle cell disease 57 you may get left upper abdominal pain or pain at the tip of your shoulder . it could be , in rare cases , a so - called spleen disorder ( seen in patients with spd ) which can cause side effects . your doctor will do regular blood tests while you are being treated with filgristim rapportp
your doctor will tell you how much filgrastim ratiopharm you need to take . always take filgrar ratioparm exactly as your doctor has told you . check with your doctor , pharmacist or nurse if you are not sure . how much to take your doctor or nurse will tell how long you need filgrastor ratiopport . you will usually start filgraste ratiopr and your doctor may then slowly increase or decrease your dose . your doctor and nurse will regularly check if and when you need more filgrastat ratioparch treatment . when you are having filgrasum ratiopram after chemotherapy the usual dose is 0 . 5 million international units ( miu ) per kilogram of body weight . this may be given as a 30 million international unit ( mius ). you will normally have your treatment once a week for about 14 days . in some disease types however , longer treatment
follow all instructions given to you by your doctor , pharmacist or nurse carefully , even if they are different from what is in this leaflet . follow all the instructions given in the leaflet of the sickle cell disease leaflet in this section under " how to use filgrastim ratiopharm ". 57 if you get left upper abdominal pain or pain at the tip of your shoulder . it could be a consequence of a spleen disorder ( see section 4 . possible side effects "). your doctor will do regular blood tests whilst you are using filgraStim ratioppharm . this is to check the number of neutrophils and other white blood cells in your blood . your doctor may change the dose , interrupt , or completely stop treatment . taking other medicines please tell your doctor or pharmacist if your child is taking or have recently taken any other medicines , including medicines obtained without 
keep out of the reach and sight of children . do not use filgrastim ratiopharm after the expiry date which is stated on the carton and on the label of the vial after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . filgraStim ratioppharm should be used if it appears that the solution is cloudy or if there are particles in it . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what filgrastim ratiopharm contains - the active substance is filgraStim . each ml of solution for infusion contains 60 million international units [ miu ] ( 600 microgram ) of filgraştim , corresponding to 30 million international unit [ miU ] [ mi U ]). each vial of 0 . 5 mL contains 30 million internaţional units [ Miu ], 600 microfilm , 30 million [ mizu ]( 300 micrograms ) filgraraztim in 0, 5 . 0ml . filgragrastig ratioph : 48 miu in a vial containing 0x 48 million international operations [ mio ][ miu [ miuge ] of filgranstim in an 0e . 8 mle ]. - also the solvent is water for injections .
what riluzole zentiva is rILuzola contains the active substance rilsuzolone . it works by blocking receptors in the nervous system . what reiluze  Zentiva for is used r Iluzolе zentivea is used in patients with amyotrophic lateral sclerosis ( amyO ), a form of motor neurone disease where attacks of the nerve cells responsible for sending instructions to the muscles lead to weakness , muscle waste and paralysis . the destruction of nerve cells in motor neurones disease may be caused by too much glutamate ( a chemical messenger ) in the brain and spinal cord . rilluzol zentapa works by stopping the release of glutamates and this may help in preventing the nerve cell from being damaged .
do not take riluzole zentiva - if you are allergic to rilsuzola or any of the other ingredients of this medicine ( listed in section 6 ). - warnings and precautions talk to your doctor before taking rILuzolе zentivea : - you have any liver disease , or increased blood levels of some enzymes of the liver ( transaminases ). this is because rilluzoling zentaprapine may harm an unborn baby . - tell your doctor if any of these apply to you . tell your doctors if : you have or have had any liver problems . you have yellowing of your skin or the whites of your eyes ( jaundice ), itching all over , feeling sick , being sick - your kidneys are not working very well . this may be accompanied
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one tablet a day . try to take the tablet at the same time each day , so that it is easier for you to remember to take it . you can take the tablets with or without food . take the dose by mouth , approximately 12 hours after the last dose of your tablet . if your doctor decides that you should take more riluzole zentiva than you should contact your doctor, pharmacist , or your nearest hospital emergency department immediately for advice . keep the tablet bottle with you so that you can easily describe what you have taken . do not take a double dose to make up for a forgotten tablet , just carry on with the next tablet as usual . contact your pharmacist if a child has taken more
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever ( increase in temperature ). riluzole zentiva can cause a decrease in the number of white blood cells . your doctor will take a blood sample to check the number , quantity and number of red or white blood cell s . this is to check if this medicine is working properly . white blood counts can be very important in fighting infections . tell your doctor if they occur . you may experience the following symptoms : yellowing of your skin or the whites of your eyes ( jaundice ), itching all over , feeling sick or being sick . these may be signs of liver disease ( hepatitis ). your doctor may do regular blood tests before and during treatment with rilsuzola zentap
what riluzole zentiva contains - the active substance is rilsuzola . - each tablet contains anhydrous dibasic calcium phosphate , micro crystalline cellulose , anhydrOUS colloidal silica , magnesium stearate , croscarmellose sodium , all in the tablet core ; hypromellose , macrogol 6000 , titanium dioxide ( e171 ). what ricuzolе zentivea looks like and contents of the pack the tablets are white to off - white , biconvex , oval shaped and debossed with " r " on one side and " 202 " on the other side . the tablets come in blisters of 28 , 56 , 99 , 112 or 168 tablets . not all pack sizes may be marketed 
emgality contains the active substance galcanezumab . this is a medicine that blocks the action of a protein called calcitonin gene - related peptide ( cgrp ), which is involved in migraine and has been shown to increase levels of cggrp in the blood . egality is used to prevent migraine in adults who have at least 4 migraines per month and who are at risk of getting migraines . the active ingredient of emmgality has been linked to an increase in the frequency and frequency of migraine headache . it also helps improve your quality of life .
do not use emgality if you are allergic to galcanezumab or any of the other ingredients of this medicine ( listed in section 6 ). if your doctor thinks you may have a serious cardiovascular disease . warnings and precautions talk to your doctor , pharmacist or nurse before using emmgality and if any of these apply to you . if there is anything you do not understand , ask your doctor or pharmacist . this medicine has not been studied in pregnant women . serious cardiovascular diseases are rare . however , there is a small risk of serious cardiovascular disorders . allergic reactions e mgality can cause serious allergic reactions and some of these reactions can be life - threatening . you should be aware that up to 40 minutes after taking egality to identify a severe allergic reaction . such signs are listed in the side effects listed in appendix v
always use emgality exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the usual dose of egality is 240 mg once a week . your doctor will decide on the correct dose . emmgality will be injected under your skin ( subcutaneous injection ). your doctor may decide that you can have your empgality injection later on after proper training . detailed instructions for use are provided at the end of this leaflet . you can inject e mgality yourself or your caregiver may inject a higher or lower dose if your doctor determines that it is appropriate . however , if the doctor determine that the correct dosing is appropriate for you , please read and follow the instructions carefully . do not exceed 240 mbq ( two syringes ) or inject if a child
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects allergic reactions to emgality are rare . they may appear as rash or itching . these are serious allergic reactions ( may affect up to 1 in 1 , 000 people ). difficulty breathing or swallowing , low blood pressure , dizziness or light - headedness , swelling of the neck , face , mouth , lips , tongue or throat , severe itching of the skin , with a red rash with raised bumps . other side effects include : very common side effects ( may effect more than 1 in 10 people ) headache , skin redness / rash , raised bump in the area where you have applied emmgality . reporting of side effects 23 if you get any side effects talk to your doctor or pharmacist . this includes
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . after reconstitution : chemical and physical in - use stability has been demonstrated for 7 days at room temperature ( up to 30 ). this medicine does not require any special storage conditions . write down the date you open the bottle and use this leaflet in the space provided . return the bottle to your pharmacist if you notice any change in the appearance of the capsules . this medicine is for single use only . discard any unused medicine via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what emgality contains the active substance is galcanezumab . each pre - filled pen contains 120 mg of galcanazumablich in 1 ml solution . the other ingredients are l - histidine , l- histhidine hydrochloride monohydrate , polysorbate 80 , sodium chloride , water for injections . what  emmgality looks like and contents of the pack egality is a solution for injection in a clear glass syringe . colourless to slightly yellow , the syingringe is engraved with the company logo and the code " gxcj4 ". single - dose pen in packs of 1 , 2 and 3 single  dose pens . not all pack sizes may be marketed .
defitelio is a medicine that contains the active substance defibrotide . it is used to treat a condition called hepatic veno - occlusive disease ( hvvd ) in which the blood vessels in the liver become damaged and blocked by blood clots . this medicine is used only in adults , and is not recommended if other medicines are not available prior to a stem cell transplantation . defibroTide can be released from blood vessels and prevent the blood cluts from reocclusively . you must use this medicine exactly as your doctor has told you .
do not use defitelio : - if you are allergic to defibrotide or any of the other ingredients of this medicine ( listed in section 6 ) - when used with other medicines to prevent blood clots - in combination with tissue plasminogen activator warnings and precautions talk to your doctor or nurse before using defitalia . this is because defitliio is not approved for use in adult patients . talk to the doctor if this applies to you . warnings about bleeding tell your doctor immediately if : you experience heavy bleeding ( for example , if it is necessary to have a blood transfusion after surgery ) you have problems with blood circulation you have : always have  a constant blood pressure ( over 1 hour ) taking other medicines , including medicines that prevent blood bleeding , such as acetyls
your doctor will decide on the best dose for you . detailed instructions for use and follow - up of the treatment with defitelio are given at the end of the leaflet . defit elilio is for use with stem cells transplantation . it is given into one of your veins through an ' intravenous infusion ' ( drip ). this treatment can be repeated every 21 days . if your symptoms do not improve after 18 weeks , your doctor may decide to reduce your dose . speak to your doctor or nurse first . when to receive defitelfellia if you need to go to a hospital or doctor , as this medicine is for oral use . take the pack with you , or your child ' s doctor . do not take a double dose to make up for a forgotten dose , whichever is earlier .
like all medicines , defitelio can cause side effects , although not everybody gets them . when defit elilio is used , the side effects listed below are listed below . some of these side effects may be serious . if they occur , they may need medical attention . report any reported side effects immediately to your doctor . very common : may affect more than 1 in 10 people - low blood pressure . common - may affect up to 1 in every 10 people ( frequency not known ). - bleeding in general bleeding - the nose bleeding , or the brain bleeding . not known ( frequency cannot be estimated from the available data ) - in the gut vomiting - blood bleeding ' s effects on the lungs bleeding ; blood in the urine ; the mouth bleeding  problems with the skin coagulopathy ( disturbance of blood clotting )
keep this medicine out of the sight and reach of children . do not use defitelio after the expiry date which is stated on the carton and on the vial label after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . keep the vially in the outer carton in order to protect from light . defitеlia should be used immediately after its preparation . however , it is recommended to be used within 24 hours after reconstitution . this product may be stored at 2  8 , but not above 25oc . discard the viatula if it is cloudy . throw away any unused medicine via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what defitelio contains - the active substance is defibrotide . each 2 . 5 ml vial contains 200 micrograms of defibrototide at the date and time of calibration . - each mL solution contains 80 microgram ( mg ) of debiotide in each 0 . 25 mlitre vial .- the other ingredients are sodium citrate dihydrate , hydrochloric acid ( for ph - adjustment ), sodium hydroxide ( for further information on dissolved compounds and water for injections ). what deFITelilo looks like and contents of the pack defitеli0 is a clear , colourless solution . it is supplied in 2 mla glass vials for infusion . one pack contains 10 vial ( 2 , 5 . 4 mml concentrate ).
daklinza contains the active ingredient daclatasvir . it is used to treat hepatitis c ( an infectious disease that affects the liver , caused by the hepatis  c virus ). this medicine works by stopping the hpatiti cvirus from multiplying in the body . this will allow the virus to multiply in your blood . daklingza is used with other medicines to treat adults with heptis
do not take daklinza - if you are allergic to daclatasvir or any of the other ingredients of this medicine ( listed in section 6 ) or take it by mouth . - take the following medicines : phenytoin , carbamazepine , oxcarbazepine and phenobarbital ( used to treat epileptic seizures ) rifampicin / riffabutin - used rfapentine ( antibiotics used to prevent tuberculosis ) dexamethasone ( a steroid used to relieve allergic and inflammatory diseases ) medicines that contain st .
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the usual dose of daklinza is one 60 mg tablet a day . swallow the tablet whole with water . do not chew , crush or split the tablet as this may cause a very unpleasant taste . when you take daklines with some other medicines , your doctor may need to change your dose of dklinz . this is to make sure that you take all of these medicines as directed by your doctor . your doctor will tell you how long you should continue to take daknza . talk to your doctor about how long your treatment will last . daklineznez is taken in combination with some others , sometimes with or without food . it may take some time before you start to feel an improvement in the treatment . you may need some time to take both of these
like all medicines , this medicine can cause side effects , although not everybody gets them . daklinza is taken with sofosbuvir and ribavirin . the side effects reported very commonly ( may affect more than 1 in 10 people ) were headache and fatigue . common ( may effect up to 1 in10 people ), difficulty sleeping dizziness migraine nausea ( feeling sick ) diarrhoea abdominal pain joint pain aching or tender muscles when daklinning is taken in combination with soofosbvir and also rib virin the frequency of these effects is not known ( frequency cannot be estimated from the available data ). very common side effects ( may impact more than1 in 10 persons ) headache fatigue common side effect ( may effects up to1 in10 persons ). difficulty sleeping dakliness when taking daklines in combination With sofavir and in combination mit rib
what daklinza contains the active substance is daclatasvir . each film - coated tablet contains 30 or 60 mg of daclatabasVir ( as dihydrochloride ). the other ingredients are : - tablet core : anhydrous lactose , microcrystalline cellulose , croscarmellose sodium , silicon dioxide , magnesium stearate . - coating : hyperromellose , titanium dioxide . macrogol 400 , indigo carmine aluminium lake , yellow iron oxide ( e172 ). 51 what daknza looks like and contents of the pack round , biconvex , oval shaped tablet with " bms 30 " debossed on one side . the film  - coat is white . with " brms 60 " deBossed in blue on one
proquad is a vaccine to prevent measles , mumps , rubella and chickenpox ( varicella ) viruses . when a person is given the vaccine , the immune system ( the body ' s natural defences ) will make antibodies against the meases , bumps , and mops caused by rubella or varicellella viruses , which are then destroyed by the immune systems . the antibodies help protect against diseases caused by these viruses : proquade helps to prevent the occurrence of meales / mums caused by Rubella and poultry caused by chickenpuff ( varicela ). the vaccine will help protect you against 12 months after you have been vaccinated . proquaa is given to individuals who have already received at least 9 doses of national vaccine .
do not use proquad if you are allergic to any varicella vaccine ( e . g . measles , mumps , rubella vaccine ) or any of the other ingredients of this vaccine ( listed in section 6 ) neomycin if your child has a blood disorder or type of cancer that affects the immune system . warnings and precautions talk to your doctor , pharmacist or nurse before using proquade if the child : has , or has ever had , any of which may weaken or weaken . has ever been told that your child ' s immune system may not work properly . before treatment with medications that weaken the immune systems ( such as low - dose corticosteroid therapy , used to treat asthma ) as replacement therapy . have or have had a weakened immune system due to a disease
proquad is given by injection under the skin in the thigh or upper arm . injections will be given into the muscle , in the upper thong area or upper arms area , at the same injection site . the recommended dose is : - if you have a blood clotting disorder or low levels of platelets , the vaccine will be injected under the Skin . - to prevent bleeding , it is recommended that proquade is given into a muscle by injection . not everyone gets enough of proquadu into , or into - blood vessel . your doctor will tell you if proquaD needs to be given at the site of injection , by a doctor or nurse .
like all vaccines and medicines , this vaccine can cause side effects , although not everybody gets them . allergic reactions such as hives have been reported rarely in patients receiving this vaccine . these reactions include difficulty in breathing or swallowing . if you have an allergic reaction , tell your doctor immediately . other side effects that have been observed with proquad are : uncommon ( may affect up to 1 in 100 people ): seizures with a fever rare ( may effect up to1 in 1 , 000 people ). bronchiolitis ( difficulty breathing , cough ) and unsteadiness with walking . the following side effects have been seen with proqud : common ( may occur with up to one in 10 people ); injection site complications ( such as pain , redness or itching ); headache ; hiccups ; chest pain ; difficulty in sleeping ; cough ;
what proquad contains - the active substances are : measles virus1 , edmonston strain ( 3 . 00 micrograms per ml ) and mumps virus1 ( jeryl lynn TM - level b ) strain ( approximately 4 . 30 microgram s )*; rubella virus2 , ( ph - 1 ) ( strain 3 .00 microgram per mm sprinkling ); varicella virus3 , and merck strain ( ppv 3 .99 microgram * derived from tissue culture in cells containing plaque - forming units ( cns ), including 1 , 2 , 3 , 4 , 5 , 6 , 7 , 8 , 9 , 10 , 12 , 25 , 56 , 100 , 200
jylamvo is made from two human proteins , one of which is naturally present in your body . it is an anticancer medicine that helps to prevent unwanted reactions . jyinglamva is an immunosuppressive agent with an anti - inflammatory effect jYlamve is used to treat rheumatic and skin diseases : o in adults with active rHeumatoid arthritis , including polyarthritic forms affecting all joints o severe juvenile idiopathic arthritis . the active ingredient in jia is a set of treatments lasting for 3 months , in patients who are already taking non - steroids anti  - in inflammatory drugs ( nsaids ) or who are insufficient o severely o disabling psoriasis . in adults , the initial phase of treatment with photo
do not take jylamvo if you are allergic to methotrexate or any of the other ingredients of this medicine ( listed in section 6 ) if your doctor has told you that you have a severe kidney impairment if the doctor has given you a liver impairment based on blood disorders ( e . g . bone marrow hypoplasia , leukopenia / thrombocytopenia ) or significant anaemia 34 if this medicine has been shown to increase the risk of developing a weakened immune system if : you have recently had a serious infection such as tuberculosis or hiv if any of these apply to you , tell your doctor . warnings and precautions talk to your doctor or pharmacist before taking jYlamva if: you suffer from ulcers in the stomach or intestines
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . jylamvo can cause severe side effects or even death if the treatment is continued . your doctor will decide if and when you should return the medicine . adults with rheumatoid arthritis , or with severe juvenile idiopathic arthritis ; with severe psoriasis ; and with severe petechiase . severe soriatic arthritis jYlamva is used as a long - term treatment . use in children and adolescents jyermanid is also used for the treatment of rhumatic and skin diseases ( jia ), p storiasi and psieatic arthritis when jyinglamme is used alone .
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately : - wheeziness , difficulty in breathing , swelling of the eyelids , face or lips , rash or itching ( especially affecting your whole body ) other side effects may include : breathing problems - a feeling of illness - dry , irritating cough - shortness of breath , and difficulty in breath - chest pain ( fever ) - getting up from spitting or coughing blood - serious peeling with blistering or burning sensation - redness of the skin , burning sensation or burning pain ( a burning sensation in the chest ) common side effects ( may affect up to 1 in 10 people ):  breathing problems including feeling of sickness , dry - irritating cough with shortness or breath ; difficulty in breathe ; chest
keep this medicine out of the sight and reach of children . do not use the medicine after the expiry date which is stated on the carton and the bottle after exp . the expiration date refers to the last day of that month . store below 25 . keep the bottle tightly closed in order to protect from moisture . once the bottle is opened , the medicine should be used immediately . to prevent accidental spillage , use within 3 days . any unused medicine or waste material should be disposed of in accordance with local requirements for cytotoxic products .
what jylamvo contains - the active substance is methotrexate . each ml of solution contains 2 mg of methotréxate ( as macrogol 400 mg ). - its other ingredients are glycerol , orange flavour , sucralose , ethyl parahydroxybenzoate ( e218 ), sodium methyl parahydroxybenzoate ( ( a ), citric acid , tri - sodium citrate , purified water . see section 2 " jYlamva contains ethiyl parhydroxybenzobiate , and sodium hydroxybenzbenzoates ". what ylmvo looks like and contents of the pack jyermvo is a brown glass bottle , supplied in a 60 mL amber plastic cap with a child - resistant closure . the bottle also
what enurev breezhaler is this medicine contains an active substance called glycopyrronium bromide . this belongs to a group of medicines called bronchodilators . what enturev brezhalers is used for this medicine is used to make breathing easier for adult patients who have breathing difficulties due to : a lung disease called chronic obstructive pulmonary disease ( copd ). in copd the muscles around the airways tighten . that makes breathing difficult . the use of this medicine blocks the tightening of these muscles in the lungs , making it easier for air to get in and out of the pulmonary system . if you use this medicine once a day , it will help to reduce the effects of copd on your everyday life .
do not use enurev breezhaler - if you are allergic to glycopyrronium bromide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using enUREv brewinghaler as it may cause kidney problems . - an eye problem called narrow - angle glaucoma ( difficulty passing urine ). during treatment with enurév briezhalar stop using this medicine and tell your doctor immediately if : - you experience tightness of the chest , coughing , wheezing or breathlessness immediately after using  Enurev brezhalers ( signs of bronchospasm ), such as difficulties in breathing or swallowing . the doctor may want to monitor you more closely , - swelling of the tongue , lips or face ,
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one capsule inhalation twice a day in the morning and evening . you only need to inhale once a morning because the effect of this medicine lasts for 24 hours . do not use more than your doctor tells you to use . elderly people you can use this medicinal product if your doctor told you to . if necessary , you can inhaling this medicine at any time of the day , any time before or after food or drink . how to inhaled enurev breezhaler - this medicine is for inhalations use , either in the evening or at the same time each day . this will help you to remember to use it . when to inhales the medicine as this helps you to
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects may be serious . they are uncommon ( may affect up to 1 in 100 people ) irregular heart beat high level of blood sugar ( hyperglycaemia ). typical symptoms are excessive thirst and hunger ( frequent urination ), rash , itching or hives ( difficulty breathing or swallowing ), dizziness ( possible signs of allergic reaction ) swelling mainly of the tongue , lips , face or throat ( possible sign of angioedema ). if you get any of these side effects you should tell your doctor immediately . other side effects include : some side effect may be more serious and include , but are not limited to : very common ( may effect more than 1 in 10 people ). common ( might affect upto 1 in every 100 people and be severe ). very common
what enurev breezhaler contains - the active substance is glycopyrronium bromide . each capsule contains 63 micrograms of glycopyrrionum broMIDe ( equivalent to 50 microgram of glycopronium ). the delivered dose ( the dose that leaves the mouthpiece of the inhaler ) is equivalent to 44 microgram ( 8 microgram ) of glycopirronium at the start of the treatment . -the other ingredients of the extracting powder are lactose monohydrate and magnesium stearate . what  Enurev brezhale looks like and contents of the pack enurév brieyhaler 44 microgramms inhalation powder , hard capsules are transparent and contain a white powder . they are presented in a device called an inhalers . the capsules have been designed to deliver the active substances into blister
what riximyo is rximyyo contains the active substance " rituximab ". this is a type of protein called a " monoclonal antibody ". it sticks to the surface of a kind of white blood cell called " b - lymphocyte ". when ritsimabe sticks to your cell , the cell dies . what he or she needs to treat your condition is important for your health . your doctor may need to change your dose or stop the treatment . the recommended dose of ritchimy0 in patients with a ) non - hodgkin ' s lymphoma this is just a disease of the lymph tissue ( part of the immune system ) that affects a certain type of whiteblood cell called b- lymph cells . rrixmyo may be given
do not take riximyo if you are allergic to rituximab , other proteins which are like ritsimabe , or any of the other ingredients of this medicine ( listed in section 6 ). if your doctor has told you that you have a severe active infection at the moment . if there is a weak immune system . in particular , if the patient has severe heart failure or severe uncontrolled heart disease , with granulomatosis with polyangiitis , microscopic polyanginiitus or pemphigus vulgaris . do not receive rximya if any of these apply to you . warnings and precautions talk to your doctor , pharmacist or nurse before you are given rrixIMyo and during treatment with r6imyyo tell your doctor straight away 
riximyo will be given to you by a doctor or nurse who is experienced in the use of this treatment . they will watch you closely while you are being given this medicine . this is in case you get any side effects . you will always be given rximyyo as a drip ( intra - venous infusion ). medicines given before each ruximya administration before you are given  RiximYo , you will be provided with other medicines ( premedication ) to prevent or reduce possible side effects from your treatment , and will continue to give you your treatment as recommended . for non - hodgkin ' s lymphoma if you are having rrixIMyo alone riskimyok will be taken once a day for 4 weeks . repeated treatment courses with rXimy if necessary
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate but some may be serious and require treatment . rarely , some of these reactions have been fatal . infusion reactions during or within the first 24 hours of the infusion you may develop fever , chills and shivering . you may experience pain at the inffusion site , blisters , itching , sickness ( nausea ), tiredness , headache , breathing difficulties , blood pressure raised , wheezing , cough , chest pain , diarrhoea , nausea , tiredness and a hoarse voice . other side effects may include : very common : may affect more than 1 in 10 people chills . common - may affect up to 1 in every 100 people chill - mild infusion -
what riximyo contains the active ingredient in rximyok is called rituximab . the 10 ml vial contains 100 mg of ritsimabe ( 10 mg / mL ). the 50 mml solution contains 500 mg of the active substance ritzimabid ( 10mg /ml ). - the other ingredients are sodium citrate , polysorbate 80 , sodium chloride , water for injections , potassium hydroxide and hydrochloric acid ( see section 2 " risimya contains sodium "). what if you see if the solution is clear , colourless to slightly yellowish solution for infusion . risseimyyo is available in glass vials containing 2 m , 3 mg or 1 vial of 2 g .
topotecan actavis contains the active substance topoten . topotent actavisent is used to treat small cell lung cancer that has come back after chemotherapy . it is used in adult patients with advanced cervical cancer if surgery or radiotherapy is not possible . in this case topotencecan actAVIs treatment is combined with medicines containing cisplatin .
do not use topotecan actavis - if you are allergic to topotencan or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using topotécan activis . if your blood cell counts are too low . your doctor may decide to reduce your dose of topoteractavis ( see section 4 , " possible side effects "). if any of these apply to you , tell your doctor before using this medicine . you should not use this medicine topotacan actAVIs , if : you have any kidney problems . do not take topotement actavises if anyone else is taking it . there is little information available on the use of to potecan actingavis in patients with severe kidney impairment . liver problems , as topot actedavis is not recommended
your doctor will decide how much topotecan actavis you receive , depending on the disease being treated . your doctor may perform blood tests before you start treatment and then assess your response to treatment . adults small cell lung cancer the usual dose is 1 . 5 mg per square metre of body surface area once daily for 5 days . this treatment cycle will normally be repeated every three weeks . cervical cancer the normal dose is 0 . 75 mg per mètre of bodysurface area once every 3 weeks , but this treatment cicle will normally normally be discontinued if cervical cancer is treated in combination with another anticancer medicines called cisplatin . if you are given csplatin you may be given another medicine called ' oral '. patients with impaired kidney function your doctor might decide to reduce your dose depending on your kidney function . when topotécan actAVIs is given topot acted
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following serious side impacts : - infections ( very common : may affect more than 1 in 10 people ):  fever  your general condition  local symptoms such as sore throat or burning sensation  severe stomach pain  or fever , diarrhoea  bowel inflammation ( neutropenic colitis )  topotecan actavis may reduce your ability to fight infections  lung inflammation ( rare : might affect up to 1 in 1 , 000 people ).  difficulty in sleeping ( insomnia ) or sleepiness ( insomniam ). reporting of side effects 25 if any of these side effects gets serious , talk to your doctor or pharmacist . this includes any possible side effects not listed in this
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial and carton after exp . the expiration date refers to the last day of that month . keep the viall in the outer carton in order to protect from light . storage after reconstitution and dilution chemical and physical stability of the concentrate has been demonstrated for 24 hours at 25  2 , in normal light conditions and 24 hours in 2 to 8 , protected from light and protected from direct sunlight . from a microbiological point of view , the drug product solution should be used immediately after difution in solutions for infusion ( nacl 0 . 9 % and glucose 5 %) has been observed for 4 hours at room temperature , on samples reconstituted and stored for 12 hours and 24 hour at 25oc , and then stored for 24
what topotecan actavis contains - the active substance is topotencan . each vial contains 1 mg or 4 mg topotencecan ( as hydrochloride ). after reconstitution 1 ml concentrate contains 1 g of topotécan -the other ingredients are mannitol ( e421 ), tartaric acid ( E334 ), hydrochoralic acid ( for example , sodium hydroxide ) and water for injections ( see section 2 ). what to potecan actingavis looks like and contents of the pack topotechcan activis is supplied in a protective sleeve with grey bromobutylic stopper and aluminium seals with plastic flip - off caps . the cap is placed in : a sachet containing 1 sachest or 5 sashes 1 
the active substance of rivastigmine hexal is rivassermine . rivascastigmin belongs to a class of substances called cholinesterase inhibitors . in patients with alzheimer ' s dementia or dementia due to parkinson 's disease , certain nerve cells die in the brain , resulting in low levels of the neurotransmitter acetylcholine ( a substance that allows nerve cells to communicate with each other ). rivazastigine works by blocking the enzymes that break down acetelcholine : aceTylcholcholineSterase and butyrylcholineSTErase . by blocking these enzymes , by blocking their action , the rivains ace tyllcholine is increased in the cerebral , helping to reduce the symptoms of dementia .
do not take rivastigmine hexal - if you are allergic to rivasserine ( the active substance in rivainstigmine himxal or any of the other ingredients of this medicine ) or to any of its constituents . - have had a previous skin reaction suggestive of allergic contact dermatitis with riv astigemine . do not taking rivstigmin heXal if any of these apply to you . take special care with rasmigmine hxal check with your doctor or pharmacist before taking r - 30 if : you have irregular or slow heartbeat you have an active stomach ulcer you have difficulties in passing urine you have seizures you have asthma or severe respiratory disease you have impaired kidney function you have impairment liver function you suffer from trembling or seizures you suffer with asthma or severely impaired kidney . you have
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how to start treatment your doctor will tell you what dose of rivastigmine hexal to take . treatment usually starts with a low dose . your doctor may slowly increase your dose depending on how you respond to treatment . the highest dose that should be taken is 6 . 0 mg twice a day . you should take this dose every day , preferably at the same time of the day ; if your weight is not well controlled , you should not take this medication for more than three days . do not take more than one dose at the time you have taken this medicine . take the next dose at your regular time . tell your doctor if it has not been fully taken . taking this medicine tell your caregiver that you are taking riv astigemine
like all medicines , this medicine can cause side effects , although not everybody gets them . you may have side effects more often when you start your medicine or when your dose is increased . usually , the side effects will slowly go away as your body gets used to the medicine . very common ( may affect more than 1 in 10 people ) feeling dizzy loss of appetite stomach problems such as feeling sick ( nausea ) or being sick ( vomiting ), diarrhoea common ( might affect up to 1 in 100 people ), anxiety sweating headache heartburn weight loss stomach pain feeling agitated feeling tired or weak generally feeling unwell trembling or feeling bloated feeling weak abdominal pain , being sick , vomiting , stomach pain rash feeling weak common ( will affect upto 1 in every 10 people people ). not known ( frequency cannot be estimated from the available data ) being sick( vomiting ) di
keep out of the reach and sight of children . do not use rivastigmine hexal after the expiry date which is stated on the carton and blister . the expir date refers to the last day of that month . store below 30 .
what rivastigmine hexal contains 64 the active substance is rivustigmine hydrogen tartrate . the other ingredients are hypromellose , magnesium stearate , microcrystalline cellulose , colloidal anhydrous silica , gelatin , yellow iron oxide red iron oxide ( e172 ) and titanium dioxide ( E171 ) shellac . each rivasse heXal 1 . 5 mg capsule contains 1 , 5 mg of riv astigemine . Each rivassimine hxal 3 mg capsule contain 3 mg of the active substances . one concentrate contains 3 mg rivostigine . - each rastagmine hemxal 4 . 4 mg capsule is 4 , 4 - 5 mg .
what cabometyx is cabrometyyx , a cancer medicine that contains the active substance cabozantinib , is used to treat adults with a type of kidney cancer called renal cell carcinoma , or liver cancer , when treatment with  a specific anticancer medicine , called sorafenib has not worked . how cabômetyX works cabombometychx blocks the action of proteins called receptor tyrosine kinases ( rtks ), which are involved in the development of new blood vessels that supply them . these proteins can be present in high amounts in cancer cells , and by blocking their action cabommetych may slow the rate at which they multiply and help to cut off the blood supply that the cancer needs . if you have any questions about how libometyingx
do not take cabometyx 45 - if you are allergic to cabozantinib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking cabrometyc : - patients with high blood pressure - patient with an aneurysm ( enlargement and weakening of a blood vessel wall ) or a tear in a wall surrounding a bleeding vessel wall which causes diarrhoea - recent history of significant bleeding - surgery within the last month - surgical procedures including dental surgery -inflammatory bowel disease ( including diarrection of the bowel ) - bleeding from the gums - pneumonia - an ulcer of the mouth - heartburn - prolonged bleeding from a puncture site - severe bleeding from an artery wall 
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . taking this medicine your doctor will monitor your treatment carefully to check that it is working properly and whether it is helping you to get better or reducing the risk of serious side effects . your doctor may adjust your dose , interrupt , or completely stop treatment with cabometyx , until your doctor tells you otherwise . the usual starting dose is 60 mg cabrometyX taken 2 hours before . take cabmetyc at least 1 hour before you take the medicine . swallow the tablet whole with some water . cabômetyyx can be taken with or without food . you can take a tablet with or just after food or between meals . how long to take - take robbie tyre for as long as your physician tells it 
like all medicines , this medicine can cause side effects , although not everybody gets them . you may experience side effects while taking cabometyx . your doctor may tell you to take other medicines to control your side effects ( see section 2 ). if you notice any of the following side effects you may need urgent medical treatment : symptoms may include pain in the abdomen , nausea ( feeling sick ), vomiting , constipation , fever ( this may be a gastrointestinal perforation - a hole that develops in your stomach and intestine that may lead to severe or uncontrollable bleeding . symptoms may be vomiting blood , black stomachs and vomiting blood may be associated with a higher risk of infection . other side effects may include : very common ( may affect more than 1 in 10 people ): diarrhoea , stomach pain , vomiting rash 
what cabometyx contains - the active substance is cabozantinib ( s )- malate . cabrometyX 20 mg : each tablet contains cabaozantsinibe (  ) ( as malate and as monohydrate ). each tablet also contains 20 mg of cabontinid ( as monotherapy ). cabombometchyx 40 mg - each tablet includes cabcabozzantininia ( ' s') ( also called malate " and 40 mg of " cab cabantinimib ). what ccabomettingyx looks like and contents of the pack cabômetyxx is a white to off - white tablet . it comes in blisters of 60 mg of tablet ( cabozotinibid (  s) ( mostly
pemetrexed hospira is a medicine used in the treatment of cancer . pemetreXed hopira will be given to you in combination with cisplatin , another anti - cancer medicine , as treatment for malignant pleural mesothelioma , a form of cancer that affects the lining of the lung , to patients who have not received prior chemotherapy . eds ., pemetreged houpira would be given in combinationwith cISSplatin for the initial treatment of patients with advanced stage of lung cancer  . Pemetrexéd homa can be prescribed to you if you have lung cancer at an advanced stage if your disease has responded to treatment or it remains largely unchanged after initial chemotherapy ; it is also available as a treatment for patients with progressive stage of long - term lung cancer
do not use pemetrexed hospira - if you are allergic ( hypersensitive ) to pemetreXed or any of the other ingredients of this medicine ( listed in section 6 ). -if you plan to breast - feed during or after treatment with pemetrexxed
the dose of pemetrexed hospira is 500 milligrams for every square metre of your body ' s surface area . your height and weight are measured to work out the surface area of your normal body . you should use this body surface area to workout the right dose for you . this dose may be adjusted , or treatment may be delayed depending on your blood cell counts and on your general condition . a hospital pharmacist , nurse or doctor will have mixed the pemetreced hompira powder with 9 mg / ml ( 0 . 9 %) sodium chloride solution before it is given to you , by infusion into one of your veins . the infusion will last approximately 10 minutes . when using pemetreexed also , it will be given in combination with cisplatin . it will depend on your heightand weight .
like all medicines , this medicine can cause side effects , although not everybody gets them . you must contact your doctor immediately if you notice any of the following : fever or infection ( common ): if your doctor has a temperature of 38oc or greater , sweating or other signs of infection ( since you might have less white blood cells than normal which is very common ). infection ( sepsis ) may be severe and could lead to death . if caught early , you may feel chest pain ( common in patients with a fast heart rate ) or pain , redness , swelling or sores in your mouth ( very common in children ). allergic reaction : - skin rash ( common with burning or prickling sensation ), fever ( common among children ) - allergic reactions : very common ( may affect more than 1 in 10 people )- sepson
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial label and carton . this medicine does not require any special storage conditions . reconstituted and infusion solution : the product should be used immediately . when prepared as directed , chemical and physical in - use stability of recombinant dna of pemetrexed was demonstrated for 24 hours at refrigerated temperature . the reconstructed solution is stable for parenteral medicines . any unused solution must be disposed of in accordance with local requirement .
what pemetrexed hospira contains the active substance is pemetreexed the active ingredient in pemetremetrex hospria 100 mg : each vial contains 100 milligrams of pemetreXed ( as pemetrexxed disodium hemipentahydrate ). pemetreced houpira 500 mg ; each viall contains 500 milligramms of pfu / ml of pemeterxeed( as pemeterxxes disodial hemimahydrate). pemeterced hospira 1 , 000 mg / 1 mL of pemetrixet ( aspemetrexd disipentehydrate ) after reconstitution , the solution contains 25 mg ph / millilitres of the active substances . further dilution by a healthcare provider is required
ganfort contains two active substances , bimatoprost and timolol , which work together to reduce pressure in the eye . bimatprostine belongs to a group of medicines called prostamides . it is a prostaglandin analogue . timimololl belongs to group of medications called beta - blockers . when the liquid enters the eye it becomes a clear , watery liquid which slowly disappears , helping to relax the liquid . this reduces pressure in and around the eye and reduces the risk of glaucoma . by doing so , ganford eye drops help to reduce high pressure inthe eye and lower the risk for glausa , and helps to get better .
do not use ganfort eye drops if you are allergic to bimatoprost , timolol or other beta - blockers , or any of the other ingredients of ganford . read the package leaflets carefully as well as the information provided in section 6 for the following conditions : - respiratory problems such as asthma , severe chronic obstructive bronchitis - severe lung disease - wheeziness , difficulty in breathing , long - standing cough - heart problems such  as low heart rate , heart block , and heart failure warnings and precautions before using ganFort : talk to your doctor , pharmacist or nurse before using this medicine . - coronary heart disease ( symptoms include chest pain , cough , wheezing , trouble breathing ) - liver problems ( signs include liver problems such As
always use ganfort exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . treatment should be started and supervised by a doctor who is experienced in the care of patients with disabilities . the bottle should only be used by eye patients who are able to swallow the product whole . instructions for use follow these instructions carefully and ask your doctor to explain them again before you use . ganford is for use in adults . only put the bottle into the neck once a day following the advice given by your doctor . 1 . wash your hands . tilt your head back and pull down the lower eyelid until there is a small pocket . 3 . gently squeeze the bottle to release one drop into each eye and a minute later . duration of treatment 4 . twist off the lid and close the eye 5 . turn the bottle upside down . use the
like all medicines , ganfort can cause side effects , although not everybody gets them . you can usually carry on taking the drops , but the side effects are usually less with each dose of ganford ( multi - dose or single - dosage ). very common side effects ( may affect more than 1 in 10 people ) - redness in the eye . common side impacts ( may effect up to 1 in 9 people , may affect up to 100 people ), - burning , itching , and stinging or irritation of the conjunctiva ( the clear layer at the front of the eye that covers the front part of the field of light ),- sensitivity to light , eye pain , sticky eyes , dry eyes - feeling of something in the eyes . reporting of side effects 25 if you get any side effects talk to your doctor or pharmacist . this includes any possible
keep out of the reach and sight of children . do not use ganfort after the expiry date which is stated on the carton and on the bottle after exp . the expiration date refers to the last day of that month . this medicinal product does not require any special storage conditions . after opening , ganford should be administered immediately and not stored in the refrigerator . if you notice any visible sign of tampering to the product , wash the bottle with soap and water and do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what ganfort contains - the active substance is bimatoprost . each ml contains 0 . 3 mg of timolol . one mL contains 5 mg of the active ingredient titmololl maleate equivalent to 6 . 8 mg . -the other ingredients are benzalkonium chloride ( a preservative ), sodium chloride , sodium phosphate dibasic heptahydrate , citric acid monohydrate . the ingredients are purified water , hydrochloric acid or sodium hydroxide . what gganfortation looks like and contents of the pack ganft is a clear , colourless to slightly yellow eye drop , provided in a plastic bottle . every pack contains 1 or 3 bottles with a screw - cap and either 3 or 4 bottles with or without 
gefitinib mylan contains the active substance gefitib , which blocks a protein called ' epidermal growth factor receptor ' ( egfr ). this protein is involved in the growth and spread of cancer cells . gefitINib melan is used to treat adults with non - small cell lung cancer . this cancer is a disease in which malignant ( cancer ) cells form in the tissues of the lung .
do not take gefitinib mylan if you are allergic to gefiteinib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking gefitINib Mylan : if your doctor has told you that you have any other lung problems . some lung problems may get worse during treatment with gefitineib , if vous have or ever had problems with your liver . children and adolescents do not give gefit inib in children under 18 years of age . other medicines and gefitdinib mythologise tell your doctor if : you are taking , have recently taken or might take any other medicines . tell your pharmacist if taking any of these : the following medicines may affect the way gefitib works : do not use phenytoin or carbamazepine
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one 250 mg tablet per day . swallow the tablet whole . do not crush , chew or break the tablet before swallowing . you can take the tablet with or without food . if necessary , your doctor may advise you to take antacids ( to reduce the acid level of your stomach ) 2 hours before or 1 hour after taking gefitinib mylan . If you have trouble swallowing the tablet , dissolve the tablet in a glass , stir and drink immediately . drink the liquid straight away . stir until the tablet breaks up into pieces . use any other liquids except water . add 20 ml of water to the mixture . take the next dose at the usual time . continue taking geFITin
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor straight away if you notice any of the following side effects you may need urgent medical treatment : allergic reaction ( symptoms include swollen face , lips , tongue or throat , difficulty to swallow , hives , or nettle rash , and difficulty breathing ). serious breathlessness ( sudden worsening breathlessness accompanied by a cough or fever ) this may be a sign of an inflammation of the lungs called ' interstitial lung disease '. this may affect up to 1 in 100 people taking gefitinib . severe skin reactions which may spread to other parts of the body . these reactions usually stop when gefiteinib is taken with food , drink , alcohol or a cut . common ( may affect more than 1 in 10 people )
what gefitinib mylan contains - the active substance is gefiteinib . each film - coated tablet contains 250 mg of gefitineb - - other ingredients are : tablet core : lactose monohydrate , microcrystalline cellulose , crospovidone ( type a ), povidone( k30 ), sodium laurilsulfate , magnesium stearate . film coating : polyvinyl alcohol , macrogol 4000 , titanium dioxide ( e171 ), red iron oxide ( erosion ), yellow iron oxide . what geFITini B mylan looks like and contents of the pack gefitINib minelan tablets are light - pink , biconvex film . tablet dimensions : 11 . 1 mm x 5 . 6 mm and debosse
reblozyl contains the active substance luspatercept and is used to treat myelodysplastic syndromes ( mds ). myelaodys plastic syndromes [ ms ] are caused by many different blood and bone marrow disorders , in which red blood cells become abnormal . signs and symptoms of a low red blood cell count ( anaemia ) can be severe and require red bloodcell transfusions . reglazyl can be prescribed to treat anaema in patients with mDS who need red blood platelets and can be given on its own if erythropoietin therapies are contraindicated or not tolerated . beta - thalassaemia in adults . this is a blood problem that is often passed down through the bloodstream and is inherited . it is usually passed down by the
do not take reblozyl if you are allergic to luspatercept or any of the other ingredients of this medicine ( listed in section 6 ) if i am or are pregnant ( see section " pregnancy and breast - feeding "). warnings and precautions talk to your doctor or pharmacist before taking this medicine if your doctor has told you that you have thalassaemia or have had your spleen removed if there was a blood clot during hormone replacement therapy if the result of a previous blood clut . your doctor will discuss preventive measures with you . medicines like rebzyl can increase the risk of forming ablood clotting . if this applies to you , tell your doctor . you have high blood pressure . before you start taking reglazyl your doctor may want to check your blood pressure more closely . while
your doctor will carry out blood tests to check that you are getting the correct dose of reblozyl . your doctor or nurse will give you rebzyl as an injection just under the skin . this will be done by your doctor , based on how much you weigh . the recommended dose for adults is 1 . 0 mg per kilogram of body weight . you will be given the injections once a week . however , this dose may be adjusted if your blood pressure is too low . use in children and adolescents rembozyl can be used in children with myelodysplastic syndromes . for adults the maximum single dose is 1. 75 mg per kg of bodyweight . in beta - thalassaemia the maximum solo dose is 1. 25 mg perkg of body poids . see section " instructions for use ". if you use more rezyl
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects possible : difficulty in walking or speaking , dizziness , loss of balance and coordination , numbness or paralysis in the face , leg or arm , or any other part of the body , blurred vision , which may be symptoms of a stroke caused by blood clots swelling in the area around the eyes , face / lips , mouth , tongue or throat allergic reactions including rashes and spit - ups . these may be signs of skin reactions . they usually go away in the first few days after starting treatment . it is not known how many days these side effects are due to reblozyl is given . if you notice any of the side effects above , tell your doctor straight away . very common : may affect more
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial label after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). store in the original package in order to protect from light . after reconstitution , reblozyl can be stored for up to 8 hours below 25 and for up tp 24 hours at 2  8 . this product is for single use only . any unused medicinal product or waste material should be disposed of in accordance with local requirements .
what reblozyl contains the active substance is luspatercept . each vial contains 25 mg or 75 mg of lusparcept , after reconstitution . one ml of solution contains 50 mg of of lucpaterception . the other ingredients are : excipients : citric acid monohydrate , sodium citrate ( e331 ), 80 sucrose , hydrochloric acid ( for ph adjustment ) and sodium hydroxide ( for further information on sodium hydroXide ( pharm adjustment ). what retizyl looks like and contents of the pack reblizyl is a white to off - white powder . reblezyl 25 mg powder for solution for injection contains 75 mg luspercept ( as hydrochlear ). after reconstituted mmol of solution for infusion each pack contains
fotivda contains the active substance tivozanib , which is a protein kinase inhibitor . tivolinib works by stopping the growth of the cancer , slowing down the growth and spread of cancer cells and forming new blood vessels . fotiva is used in adults with advanced kidney cancer who have not previously tried other treatments ( such as alpha or interleukin - 2 ) to treat your disease .
do not take fotivda if you are allergic to tivozanib or any of the other ingredients of this medicine ( listed in section 6 ). if your doctor has prescribed st . john ' s wort ( hypericum perforatum ) as a herbal remedy for depression and anxiety . warnings and precautions talk to your doctor or pharmacist before taking fotiva . high blood pressure . fotiv da may cause your blood pressure to rise . tell your doctor if this is the case if it is increased or if there is a problem with your blood temperature . your doctor may prescribe a medicine to lower your bloodpressure . it may also help you to take fotiveda to reduce your blood stress . you should not take Fotivdda as treatment for low blood pressure is usually required . there is an aneurysm (
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose of fotivda is 1340 mg for the first 21 days ( taking 7 capsules ) and 1 capsule ( 100 mg ) once a day for 4 weeks . your doctor may reduce your dose of foilda in order to reduce the risk of unacceptable side effects . severe side effects are common at the start of fotiveda therapy . if your doctor determines that higher doses are necessary , the doctor may lower the dose to 890 mg for each 21 - day period ( taking seven days ) or 7 days ( 1 capsule ) twice a week . you should take capsules twice - daily for 4 days . patients with liver problems if patients with kidney problems , lower doses may be necessary ( 1340  mg
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects high blood pressure is a very common side effect , which may affect more than 2 users . if this happens to you , tell your doctor immediately . high blood blood pressure can develop symptoms such as severe headaches , blurred vision , shortness of breath , changes in your mental state , feeling anxious , confused or disorientated . your doctor will monitor your blood pressure regularly while you are taking fotivda . as with all medicines this medicine may cause high blood temperature , your doctor may prescribe a medicine to treat your high blood tension . it is important that you take fotiva every day and for as long as your doctor recommends it . contact your doctor if you get any of the following side effects very common : may affect up to 1 in 10 people : headache 
what fotivda contains the active substance of fotiva 890 mg is tivozanib . each vial contains tivunib hydrochloride monohydrate equivalent to 890 micrograms of tivonib the other ingredients are : mannitol , magnesium stearate , gelatin , titanium dioxide ( e171 ), indigo carmine ( 6000 ), yellow iron oxide ( E172 ), propylene glycol . strong ammonia solution , talc , and titanium dioxide , tartrazine aluminium lake ( cadmium lake ). the printing ink contains shellac / propyl glycol and strong ammona solution indigolinium lake ( cabotequinas ). fotiv da is available in cartons containing 1340 mg capsules .
stribild contains two active substances : elvitegravir , an antiretroviral medicine known as an integrase inhibitor cobicistat , a booster ( pharmacokinetic enhancer ) of the effects of eelvisegravar emtricitabine , which is an antiregular medicine known als a nucleoside reverse transcriptaser ( nrti ) tenofovir disoproxil , another antirétroviral medication known as a nnrtose inhibitor ( strtis ) what strebild looks like and contents of the pack sTRIbild is a single tablet regimen for the treatment of human immunodeficiency virus ( hiv ) infection . stricbild is used for the prevention of hiv infection in adults
do not take stribild if you are allergic to elvitegravir , cobicistat , emtricitabine , or tenofovir or tenofoVir disoproxil . do not start taking this medicine for more than 6 months and may change your dose without talking to your doctor . warnings and precautions talk to your physician before taking sTRIbild : if treatment with any medicine containing tenoffovir disoproil is contraindicated or inadequate because it may affect your kidney function . tell your doctor before taking these medicines : alfuzosin ( used to treat an enlarged prostate gland ) amiodarone or quinidine ( used for irregular heartbeats ) 47 dabigatran ( used in adult men to prevent and treat blood clots ), carbamazepine
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose for patients 12 to less than 18 years is one 35 mg tablet by mouth once daily . your doctor may adjust the dose , depending on your condition and on your response to your medicine . if necessary , your doctor will inform you about the possibility to stop the treatment . you may need to take medicines or oral supplements ( antacids and laxatives containing minerals ( e .g . magnesium , aluminium , calcium , iron , zinc ) for at least 4 weeks . take the tablet at the same time each day , with food , at about the same times every day . for at most 4 weeks your doctor might advise you to stop taking stribild . do not stop taking your tablet without first
during hiv therapy there may be an increase in weight and in levels of blood lipids and glucose . this is partly linked to restored health and life style , and in the case of blood cholesterols sometimes to the hiv medicines themselves . your doctor will test for these changes . like all medicines , this medicine can cause side effects , although not everybody gets them . when treating hiv infection , it is not always possible to tell whether some of the unwanted effects are caused by stribild or by other medicines that you are taking at the same time or by the hivi disease itself . serious side effects tell your doctor immediately lactic acidosis ( excess lactic acids in the blood ) is a common side effect of some hiv medications . lactic Acidosity may occur more often in women , particularly if they are overweight . it is also common in people with liver disease . the
what stribild contains the active substances are elvitegravir , cobicistat , emtricitabine and tenofovir disoproxil . each sTRIbild film - coated tablet contains 150 mg of eelvisegraVir , 150 mg cobicistent , 200 mg emetricit abine , and 245 mg of the same active substance as ehnus ' s snr 245 / str 295 mg tenovir désoproxils 300 mg / 10ofovar disoproil fumarate , equivalent to 136 mg of 10ofovivir ). the other ingredients are croscarmellose sodium , hydrogenated cellulose , lactose monohydrate , magnesium stearate and talc . the other
zyprexa contains the active substance olanzapine . zyPrexa belongs to a group of medicines called antipsychotics and is used to treat the following conditions : schizophrenia , a disease with symptoms such as hearing , seeing or sensing things which are not there , mistaken beliefs , unusual suspiciousness , and becoming withdrawn . people with this disease may also feel depressed , anxious or tense . moderate to severe manic episodes , an area with symptoms of excitement or euphoria . the efficacy of zypréxa has been shown to prevent recurrence of these symptoms in patients with bipolar disorder whose manic episode has responded to olzapinе treatment .
do not take zyprexa if you are allergic ( hypersensitive ) to olanzapine or any of the other ingredients of this medicine ( listed in section 6 ). an allergic reaction may be recognised as a rash , itching , aswollen face , or swollenous lips or shortness of breath . if this has happened to you , tell your doctor . have eye problems such as certain kinds of glaucoma ( increased pressure in the eye ). ask your doctor for advice before taking zypa . warnings and precautions talk to your doctor before taking your first dose if : you are being treated for dementia or with serious side effects . medicines like these have been associated with unusual movements mainly of the face or tongue . you should tell your partner or caregivers if any of these apply to you or your carer . before
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will tell you how many zyprexa tablets to take and how long you should continue to take them . the daily dose of zyPrexa is between 5 mg and 20 mg . consult your doctor if your symptoms return but do not stop taking zypréxa unless your doctor tells you to . you should take your zy prexa tablet once a day following the advice of your doctor even if it is convenient for you to take your tablets at the same time each day . it does not matter whether you take them with or without food . zypa coated tablets are for oral use . swallow the zypräxa coated tablet whole with water . do not break or crush the tablets . to help you remember to take the zprex
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you have : unusual movement ( a common side effect that may affect up to 1 in 10 people ) mainly of the face or tongue ; blood clots in the veins ( an uncommon side effect which may affect more than 1 in 100 people ), particularly in the legs ( symptoms include swelling , pain , and redness in the leg ), which may travel through blood vessels to the lungs causing chest pain and difficulty in breathing . if your doctor notices any of these symptoms seek medical advice immediately .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . zyprexa must be used within six months after first opening . store in the original package in order to protect from moisture . keep this product in the outer carton in order for it to be stored and transported to the pharmacy .
what zyprexa contains the active substance is olanzapine . each zyPrexa tablet contains either 2 . 5 mg , 5 mg or 7 .  5 mg tablets or 10 mg tablets , or 15 mg tablets and 20 mg tablets each . the exact amount is shown on your zypréxa table pack . other ingredients are lactose monohydrate , hyprolose , crspovidone , microcrystalline cellulose , magnesium stearate , and hypromellose / titanium dioxide ( e171 ), and carnauba wax . what zprexа looks like and contents of the pack the different zypa tablet strengths are white to off - white . one pack of zypresa 2 , 500 iu , five 5 , 7 , 50 ius or 10
what prolia is prolivia contains denosumab , a protein ( monoclonal antibody ) that is similar to a natural protein ( s ) produced by your body . it helps to prevent bone loss caused by osteoporosis . treatment with prolium helps to make bone stronger and strengthen your bone . prolisis works by blocking the action of a hormone called oestrogen , which is an essential hormone needed to make the bones work . when you reach the menopause , the oesterogen level drops and bones become thin and fragile . this can lead to osteopossesis : people with osteopororosus can develop if their levels of testosterone or if they are treated with glucocorticoids . prevention of osteopochorosia may lead to symptoms that are not well controlled 
do not use prolia if you : have low calcium levels in the blood ( hypocalcaemia ). are allergic to denosumab or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor before using prolinia and if any of these apply to you too . if there is anything you do not understand , ask your doctor , pharmacist or nurse to explain . warnings and precautions talk to your doctor or nurse before using Proliia in particular : if your doctor thinks you may be at risk of developing a skin infection . symptoms may include a swollen , red area of skin , usually in your leg that feels hot and tender . this could be cellulitis , with symptoms that may include fever . these symptoms may be a sign of an allergy to
how much prolia is given one pre - filled syringe contains 60 mg or 6 mg . it is given as a single injection under the skin ( subcutaneous ) in the thighs , abdomen or upper arm . how much to use prolliа is available in different pack sizes and with stickers containing calcium and vitamin d supplements . they are all packed in the carton . do not use more than one pre- filled pen . if you miss an appointment to get prolina call your doctor right away to reschedule your appointment . what to do if your doctor tells you to . your doctor will tell you how to store prolisa . don ' t take more prolla than your doctor has recommended . you can get prollia any time before or after your first dose . prolioloa is intended for
like all medicines , this medicine can cause side effects , although not everybody gets them . prolia may cause skin infections such as cellulitis . tell your doctor immediately if you develop any of these symptoms during treatment with prolis : - a swollen or red area of skin on the right leg that feels hot and tender . these are symptoms of fever which may be severe . stop taking prolinia and seek medical help immediately : pain in the mouth and / or jaw , swelling or non - healing of sores in the jaw - discharge , numbness or a feeling of heaviness in the hands or feet which may indicate bone damage . this can be a sign of bone damage in the bone . as with all medicines this medicine may cause side effect , however , prolliam can cause pain in your mouth and
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and label after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2c 8c ). do not freeze . keep the vial in the outer carton in order to protect from light . before use , your pre - filled syringe may be kept at room temperature ( up to 25 ) for a single period not exceeding 30 days . record the date on the sYringe label in the space provided . this product does not require any special storage conditions . prolia is for single use only . you should not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what prolia contains - the active substance is denosumab . 1 ml solution for injection contains 60 mg of denosomab ( 60 mg in the methanol form ). - - other ingredients are acetic acid , glacial , sodium hydroxide , sorbitol ( e420 ), polysorbate 20 and water for injections . what prologia looks like and contents of the pack prolilia is a clear and colourless to slightly yellow solution for injecting in a pre - filled syringe with a needle guard .
ambirix is a vaccine used in infants , children and adolescents from 1 month up to 15 years to prevent two diseases : hepatitis a and hepatis b . ambirx is caused by infection with the heptic a virus that causes the liver to become swollen and inflamed by the virus . the virus can infect any infected person , including the unborn child . you can infuse the vaccine into your child ' s faeces , serum or saliva . symptoms start 3 to 6 weeks after you have received the vaccine . tell your doctor if you feel sick or have a fever , aches and pains after you leave hospital .
do not receive ambirix if you are allergic to ambirx or any of the other ingredients of this vaccine ( listed in section 6 ). signs of an allergic reaction may include itchy skin rash , shortness of breath and swelling of your face or tongue . if this is the case , tell your doctor immediately . you may experience an allergic response to any vaccine against hepatitis a or hepatis b diseases . your doctor will decide if the vaccine is suitable for you . warnings and precautions talk to your doctor , pharmacist or nurse before you are given ambirisk if : you have a severe infection with a high temperature ( over 38 ). if any of these apply to you , do not get the vaccine . the doctor may want to give you a minor infection such as a cold should not be a problem , but talk to the
ambirix will be given to you by a doctor or nurse . they will give you an injection into a muscle , usually in the upper arm . ambirx is given into  a vein . the injection will then be given into the thigh muscle . you will receive a total of two injections . each one should be given within 12 months of the first injection . if you miss an injection from the second injection , you will be told by your doctor or other healthcare professional . intervals between the first and second injections will normally be between 6 and 12 months . your doctor will decide when you should receive the first dose . extra doses may be given for future booster dosing . it is recommended that you receive two injection in the same day . this will be done in a hospital or clinic . depending on the dose and location of the injection syringe 
like all medicines , this vaccine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following serious side impacts you may need urgent medical treatment : allergic and anaphylactic reactions . the signs may include a rash , itchy , blistering and swelling of the eyes and face , difficulty in breathing or swallowing , a sudden drop in blood pressure and loss of consciousness . other side effects talk to your doctor if these side effects become serious . side effects reported during clinical trials with ambirix common ( may affect up to 1 in 10 people ) headache loss of appetite feeling tired or irritable pain in the joints or muscles . these may be signs of a drop in your blood pressure . common ( might affect upto 1 in 100 people ). these effects are usually mild and usually go away within a few days 
what ambirix contains 26 the active substances are : hepatitis a virus ( inactivated ) 1 , 2 720 elisa units hepatis b surface antigen , 1 : 1 x 720 ( ealisa unit ), heparin b , hepa - 2 ( mrc - 1 ) and human diploid ( pd - 0 . 5 - 3 ) cells . the other ingredients are , aluminium hydroxide , and hydrated , in 0. 05 % ( iu ) of the total number of cells ( saccharomyces cerevisiae ), aluminium phosphate , water for injections . what ambix looks like and contents of the pack suspension for injection in a pre - filled
bexsero is a meningococcal group b vaccine . bexsiel is given to protect against the bacteria neisseria mentingitidis group c . you will be given bexstero to help protect your child from 2 years of age against disease caused by the nisseisseriia maningitiidi group a bacteria . these bacteria often cause infections , including meningitis ( inflammation of the covering of the brain and spinal cord ) and sepsis ( blood poisoning ). the vaccine works by helping your body to make its own antibodies , which protect your kid against the disease .
do not receive bexsero if you are allergic to the active substance or any of the other ingredients of this vaccine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before receiving bexSero you have a severe infection with a high temperature ( over 38 ). if this applies to you , tell your doctor or nurse immediately . in case you are not sure , talk to you doctor / nurse before having bexsiero . a minor infection such as a cold should not be a problem , but talk to the doctor ' s advice . tell your healthcare worker if any of these apply to you ( or you are in doubt ), talk to them before vaccination . haemophilia tell your doctors if or you have any other problem that may stop your blood from clotting properly , such as the use
bexsero is given by a doctor or nurse as an injection of 5 micrograms into a muscle , preferably in the thigh or upper arm . you will receive injections every 2 weeks . your doctor or health care professional will decide how much you need . if you have been given more than 5 injections you will be given three injections of the vaccine . an additional injection ( booster ) may be given with the first injection given at least 2 months apart . the interval between injections is 1 month . depending on the dose you receive , the intervalbetween injections will be 2 months . it is recommended that you receive one injection of the booster every 12 weeks for 15 days . each 3 - week cycle starts with one injection . after the 3 , 4 - month cycle , your doctor will decide on the correct dose . please follow the instructions for your doctor ,
like all vaccines , this vaccine can cause side effects , although not everybody gets them . when bexsero is given to your or your child , the following side effects may occur : very common ( may affect more than 1 in 10 people ) pain / tenderness at the injection site ; redness of the skin at the injecting site , swelling of the flesh at the site of the injection ; hardness on the skin around the injection location . not known ( frequency cannot be estimated from the available data ) side effects with this vaccine are unknown ( may effect up to 1 in every 10 people in the field of contact ): - fever - numbness of skin at or near the injection area reporting of side effects for this vaccine if you get any side effects talk to your doctor , pharmacist or nurse . this includes any possible side effects not listed in this leaflet . you can
what bexsero contains the active substance is recombinant neisseria meningitidis group b nhba fusion protein 1 , 2 or 3 times 50 micrograms ( 0 . 5 ml ) of reconstituted néisseriia maningititididis group bo b group c nada protein 1 2 or3 times 50 milligrams of  regenerative nasopharyngitidas group a - b for fusion function 1 x 2 or  3 times the 50 millinog recombined nelseria meingitizidis - group d fhbp fusionprotein 1 2 to 3 times weekly 50 millies the remdesilicate nneissesia maleingitis group
nitisinone mdk contains the active substance nitsinone which belongs to a group of medicines called ' recombinant dna '. this medicine is used for the treatment of a rare disease called hereditary tyrosinemia type 1 in adults , adolescents and children aged 1 year and above . in this disease your body is unable to completely break down the amino acid tychrosine ( amino acids are building blocks of our proteins ), forming harmful substances . niitisINone , the active ingredient in this medicine , is tying the amino acids t4 , forming the harmful substances in your body . low tyerone and phenylalanine ( another amino acid
do not take nitisinone mdk if you are allergic to niitisINone or any of the other ingredients of this medicine ( listed in section 6 ) read the package leaflet of the medicine before you take it . read the information before you start taking this medicine , and during the course of pregnancy . warnings and precautions talk to your doctor or pharmacist before taking nITisinine mndk . your eyes will be checked before and during nitsinone treatment . if there are red eyes or any other signs in the eyes , contact your doctor immediately for an eye examination . eye problems may occur more frequently in adolescents and children due to inadequate dietary control . children and adolescents do not give this medicine to children under the age of 4 years because it has not been studied in this population . during the treatment , your doctor will take blood samples to check
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . treatment with this medicine should be started and supervised by a doctor experienced in the treatment of the disease ( hereditary tyrosinemia type 1 ). the recommended dose is 1 mg per kg of body weight once daily . your doctor will adjust the dose to 20 mg per day . this patient population is approximately the same as for adults . when swallowing the capsules , you should take a small amount of water or formula diet just before you take it . if your doctor decides to reduce the dose you will need to take , talk to your doctor . you should not take more than the recommended dosage . instructions for taking nitisinone mdk if , while taking this medicine , your doctor may advise you to take it at any time of the
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . after first opening , the viaL may be stored for up to 2 weeks below a temperature not above 25 .
what nitisinone mdk contains - the active substance is niitisINone . nitsinone mg : each capsule contains 2 mg of nITisinine . each capsule of ' nitéisinon mmdK 5 mg contains 5 mg of the active ingredient , nităisinONE . one capsule of " nitzinone "mdking 10 mg contains 10 mg of of the activated substance , including nitesinone the other ingredients are : capsule content : gelatin , titanium dioxide ( e171 ), black iron oxide ( E172 ), shellac glaze , printing ink : shellaca glaze what if nitchisino mk looks like and contents of the pack ntisinonne mpdk capsules are white to off
the name of this medicine is docetaxel accord . docetaxil is a substance derived from the needles of yew trees . it is derived in the herbal preparations of medicinal products called docetachl . Docetaxell belongs to the group of anti - cancer medicines called taxoids . o docetastel accord has been prescribed by your doctor for the treatment of breast cancer , special forms of lung cancer ( non - small cell lung cancer ), prostate cancer / gastric cancer ; head and neck cancer : for the diagnosis of advanced breast cancer you will be given docetacel accord in combination with doxorubicin , trastuzumab , and capecitabine . for the prevention of early breast cancer your doctor will prescribe docetcetaxele accord in the treatment or placement of other medicines .
docetaxel accord must not be used : if you are allergic ( hypersensitive ) to docetaxil or any of the other ingredients of docetcetaxell accord ( listed in section 6 ). if the number of white blood cells is too low . if your doctor has a severe liver disease . warnings and precautions before each treatment with docetastel accord , you will have blood tests to check that you have enough blood cells and sufficient liver function to receive docetacel accord ( see section 4 ). in case of whiteblood cells disturbances , your doctor may need to monitor you more closely . in case you have fever or infections , tell your doctor immediately . you may experience abdominal pain or tenderness , diarrhoea , rectal haemorrhage , blood in stool or in the urine . children and adolescents docetxl accord
docetaxel accord will be administered to you by a healthcare professional . usual dose the dose will depend on your weight and your general condition . your doctor will calculate your body surface area in square meters ( m2 ) and will determine the dose you should receive . method and route of administration docetaxil accord is given by infusion into one of your veins ( intravenous use ). the infusion will last approximately one hour during which you will be in the hospital . frequency of administration you should usually receive your infusion once every 3 weeks . the frequency of dosing may depend on the results of your blood tests , your general conditions and your response to docetal accord . in particular , please inform your doctor in case of diarrhoea , sores in the mouth , feeling of numbness or pins and needles , fever and give her 
like all medicines , this medicine can cause side effects , although not everybody gets them . your doctor will discuss these with you and will explain the potential risks and benefits of your treatment . the most commonly reported adverse reactions of docetaxel accord are : decrease in the number of red blood cells or white blood cells , alopecia , nausea , vomiting , sores in the mouth , diarrhoea and tiredness . these are the most common adverse events of doceaxel acord . docetaxil accord may be mixed with other chemotherapeutic agents during the infusion . allergic reactions are common ( may affect more than 1 in 10 people ) and are accompanied by flushing , headache , stomach upset , constipation , dry mouth . in some cases , it may affect other organs . other side effects of dotaxel
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial label after exp . the expiration date refers to the last day of that month . store below 25 . keep the vial in the outer carton in order to protect from light . after dilution , the medicine should be used immediately . if not used immediately the infusion bag may be stored in a refrigerator ( 2 to 8 ). do not freeze . once the inffusion solution has been prepared it should be administered within 6 hours of preparation ( up to 25 ). the infuzation solution for infusion may be kept in non - pvc bags up to 48 hours between 2 to8 . avoid direct sunlight and keep the inflow solution in the refrigerator ( 28 ). keep the container in the original carton in the dark . it should not be
what docetaxel accord contains - the active substance is docetaxil . each ml of concentrate for solution for infusion contains 20 mg of docetcetaxell . 1 mL concentrate contains 20 milligrams of dotaxel ; 4 mlitzes of concentrate contain 80 milligramms of doncetaxelly . 8 mla vial contains 160 millilitres of didcetaxem . - -the other ingredients are polysorbate 80 , ethanol anhydrous ( see section 2 ) and citric acid anhydrously ( see also section 2 for further information on citric acids and alcohol ). what docetaxel accord looks like and contents of the pack docetachel acord concentrate for concentrate for solutions for infuse is a clear pale yellow to brownish - yellow solution . the concentrate is essentially free of visible
intuniv contains the active substance guanfacine . this medicine belongs to a group of medicines that affect the brain . your doctor may decide to increase your dose . the active ingredient in this medicine is guangfacina . it is used to treat adults who are impulsive or hyperactive . you must not take this medicine because you have ' attention deficit hyperactivity disorder ', also known as adhd , when current stimulant medication is not working well enough or is not controlling your adhd symptoms . before you start taking the medicine , your doctor will recommend a treatment programme , which will consist of psychological therapy , educational therapy and social therapy . intunev may help to control your condition and to reduce the effects of adhd on your everyday life . adhd can also affect your everyday activities , including eating and drinking .
do not take intuniv : - if you are allergic to guanfacine or any of the other ingredients of this medicine ( listed in section 6 ) warnings and precautions talk to your doctor or pharmacist before taking this medicine if any of these apply to you : low or high blood pressure . heart problems . tell your doctor if your doctor thinks you may have heart problems or if : you have ever fainted recently had thoughts or feelings of suicide . you have any other psychiatric conditions you have had withdrawal symptoms ( such as increased heart rate or high pressure ). if at any time you have been given this medicine you should stop taking this medication and seek medical help immediately if these problems occur . children and adolescents intunev is not recommended for children and teenagers aged 6 to less than 18 years . it is not known how well it works in this
your treatment should be initiated and monitored by a doctor experienced in the treatment of adolescent behavioural disorders . always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . your treatment will be initiated by : a dose for 1 month . a starting dose for 2 months is 1 month ( 0 . 5 - 0. 12 mg / kg bodyweight ). the dose you receive will be calculated by your doctor calculated by bodyweight divided by the following formula : bodyweight per day . the recommended starting dose is 0 and 0 intuniv per day given once daily . this will be divided into two doses . each dose is given once weekly . you will receive treatment once every 1 month for 7 months . do not stop taking intunev without talking to your doctor first
like all medicines , this medicine can cause side effects , although not everybody gets them . if you feel unwell , tell your doctor immediately and stop your medicine . serious side effects tell your doctors or nurse straight away , if any of the following side effects occur : feeling drowsy , feeling dizzy ( hypotension ), slow heart beat ( bradycardia ), feeling faint , loss of conciousness ( syncope ), which is a serious withdrawal side effect from high blood pressure with symptoms such as headaches , being confused , nervousness , anger ( agitation ) or tremors ( hypertensive encephalopathy ). tell your healthcare professional immediately if they happen . other side effects include : very common ( may affect more than 1 in 10 people ) feeling dizziness ( hypotensives ), fainting
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . store in the original package in order to protect from moisture . keep the tablets in the blister pack in order not to damage or damage them .
what intuniv contains - the active substance is guanfacine hydrochloride . 1 mg of guangfacina / 2 mg guansfac hydrochleide / 1 mg / 3 mg GUanf acine / 4 mg guianfocine hydrochaloride with a maximum of 4 mg of Guanfucine . - other ingredients are : hypromellose 2208 ( e464 ), methacrylic acid - ethyl acrylate copolymer , lactose monohydrate , povidone type a , crospovidone kind a, microcrystalline cellulose .
ecalta contains the active substance anidulafungin . it is used to treat adults and children ( aged 1 year to less than 18 years ) with a type of fungal infection that affects the blood or other internal organs called invasive candidiasis . the infection is caused by fungal cells called candida . echinocandins are used to prevent serious fungal infections . they work by destroying damaged fungal cell walls . with ekalta , cases of fungls have incomplete or defective cell walls and are rendered fragile and unable to grow .
do not use ecalta - if you are allergic to anidulafungin , other echinocandins , or caspofungin acid , please read the section " other medicines and ecg ." do not take this medicine if any of the above apply to you . if not , tell your doctor before you are given ecleta and during your treatment . your doctor will check your liver function and if necessary , may adjust your treatment as you may be given anaesthetics . during your therapy with eCALta you may experience an allergic reaction such as itching , wheezing and blotchy skin . these may be signs of an infusionrelated reaction such a rash , hives , itching and redness , shortness of breath , cough , chest pain or
the treatment will be started and managed under the supervision of a doctor experienced in the care of patients with a demonstrated ability to double the dose . the recommended starting dose is 200 mg for every kilogram of your weight . adults ( from 1 month to less than 18 years of age ) the starting dose will be 3 . 0 mg for each kilogram of the patient , starting with 200 mg and then 1 . 5 mg for the 100 mg dose , depending on the patient' s weight ). the doctor will work out the right dose for you . how ecalta is given eCALta will be given to you in a slow infusion ( a drip into a vein ) over about 1 - 5 minutes . your doctor or nurse will calculate the loading dose based on the person ' 's weight and your response to the treatment . usually , your treatment will last for about
like all medicines , this medicine can cause side effects , although not everybody gets them . the most serious side effects are potentially life - threatening allergic reactions , such as difficulty breathing or wheezing , or an existing rash . stop taking ecalta and tell your doctor straight away if you notice any of the following serious side events : convulsion ( seizure ) flushing / rash ( pruritis ) itching hot flush hives sudden contraction of the muscles causing wheezeing . coughing or difficulty of breathing other side effects include very common side effects ( may affect more than 1 in 10 people ): dizziness headache coughing up blood rash uncommon side effects may affect up to 1 in 100 people : headache stomach discomfort , diarrhoea , nausea , vomiting , constipation , rash or
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2c 8c ). do not freeze . keep the vial in the outer carton in order to protect from light . use the reconstituted solution immediately or within 24 hours after reconstitution . however the infusion solution can be stored at room temperature ( up to 25 ) for up to 48 hours , or up to 72 hours at room temp ( upto 25c ) before administration .
what ecalta contains - the active substance is anidulafungin . each vial of powder contains 100 mg of anidULafungIN . -the other ingredients are mannitol , polysorbate 80 , tartaric acid , sodium hydroxide and hydrochloric acid . what  ekalta looks like and contents of the pack eCALta is supplied in a box containing 1 vial containing 100 mg powder for concentrate for solution for infusion . the powder is white to off - white .
adynovi contains the active substance rasaoctocog alfa pegol and is a pegylated human coagulation factor viii ( also called human clotting factor  vii ). factor  viiis is necessary for the blood to form clots and stop bleedings . in patients with haemophilia a ( lack of factor ixii ), it is missing or not working properly . aynovis is used for the treatment and prevention of bleeding in patients 12 years and older and older with haEmophilica  a , an inherited bleeding disorder caused by lack offactor viiI .
do not use adynovi if you are allergic to rurioctocog alfa pegol , octtocogg alfo or any of the other ingredients of this medicine ( listed in section 6 ) if your doctor thinks you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor , pharmacist or nurse before using aadchynovi as it may cause an anaphylactic reaction ( a severe , sudden allergic reaction ) to aynovis . allergic reactions may occur as rash 95 , and hives , wheals , generalised itching , swelling of lips and tongue , difficulty in breathing , when wheezing , tightness in the chest , overall feeling of being unwell , dizziness , confusion and / or faint
treatment with adynovi will be started by a doctor who is experienced in the care of patients with haemophilia a . your doctor will decide on the dose of aynovis to be used in your case . it is important to have a plan in place of treatment to prevent bleeding . adeynovin can be used on its own in adults , adolescents and children as a replacement therapy . for this reason , adamnovi is a life - long treatment . always use this medicine exactly as your doctor has told you . check with your doctor if you are not sure . prevention of bleeding the usual dose of the dose with  aadzynovi for adults is 40 to 50 iu per kg body weight , given every 2 weeks . treatment of bleeding how much apynovo is given the doctor will work
like all medicines , this medicine can cause side effects , although not everybody gets them . if severe , sudden allergic reactions ( anaphylactic ) occur , the injection must be stopped immediately . you must contact your doctor immediately if you have any of the following early symptoms of allergic reactions : - rash , hives , wheals , generalised itching , swelling of lips and tongue , difficulty in breathing , coughing , tightness in the chest , feeling of being unwell , dizziness and loss of consciousness . severe symptoms , including difficulty in breath or fainting requiring prompt emergency treatment , may occur .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . before first use , the powder vial may be kept at room temperature ( up to 30 ) for a single period not exceeding 3 months . if this medicine is not used within 3 months after it has been stored at room temp for reconstituted solution , it must be used within a maximum of 3 days . once refilled the powder has been prepared it should be used immediately . it should not be put back in the refrigerator . you must use adynovi if you notice it has not been stored outside of
what adynovi contains the active substance is rurioctocog alfa pegol ( pegylated human coagulation factor viii produced by recombinant dna technology ). each powder vial contains 250 , 500 , 1000 or 2000 iu rurileoctcog altfa pegol . the solvent vial should be 5 ml diluted in sterilised water for injections . solvent : mannitol , trehalose dihydrate , histidine , glutathion , sodium chloride , calcium chloride dihydrate and tris ( hydroxymethyl ) aminoomethane , polysorbate 80 , water for injecting tubes . what dynova looks like and contents of the pack aynovis is a white to off
rekovelle contains follitropin delta , a fsh - converting hormone ( flshs ), a type of feollicle stimulating hormone ( in utero ) stimulating hormone , which is similar to the natural hormone produced by your body , but is produced by means of biotechnology . it belongs to the family of hormones called gonadotropins . gonadotrophins are involved in the development of female infertility . rekowelle belongs to a group of medicines called assisted reproduction programmes . these include in vitro fertilisation ( ivf ) and intracytoplasmic sperm injection . the ovaries are responsible for the production of many egg sacs which are important for the reproduction of the baby .
do not use rekovelle this medicine - if your fertility problems are serious - you are allergic to follicle stimulating hormone ( fsh ) or any of the other ingredients of this medicine ( listed in section 6 ) - your tumour ( womb ) has reached the uterus , or the ovaries of your breasts ( pituitary gland or hypothalamus )- you have enlarged oocytes - or cysts on your ovulations ( polycystic ovarian disease ) which may be causing bleeding from the vagina ( an early menopause ) and malformations of the sexual organs which may make a normal pregnancy impossible - because of fibroids of the uv ( ovulating hormone ) that may make pregnancy impossible ( ovary hyperstimulation syndrome ) this medicine is
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will determine the correct starting dose of the rekovelle dose . this will be calculated by your doctor . the first treatment cycle is a single injection of a medicine called anti - mullerian hormone ( hcg ), which will be administered by your ovaries during stimulation with gonadotropins . how much rekelle is given your doctor may calculate your dose based on your body weight . if this is the case , your doctor can take a blood sample during the last 12 months of treatment . it is used to measure your bodyweight during treatment , and to adjust the roosting dose if needed . for the first cycle , the ' cycle ' will be repeated every two weeks . you will usually receive
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects linked to hormones used to treat infertility have been reported in patients using this medicine . some women have a high level of activity in the ovaries ( ovarian hyperstimulation syndrome ). symptoms may include pain or discomfort , swelling of the abdomen , nausea , vomiting , diarrhoea , weight gain or difficulty breathing . contact your doctor immediately if you get any of these symptoms . a side effect that may be common ( may affect up to 1 in 10 people ) headache and nausea ( ovulation hyperstyrostimulation syncope ) have been seen very commonly in women who were not stimulated enough during their adult pregnancy . these side effects may be serious . common ( might affect upto 1 in every 10 people in women 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial label and carton . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the viall in the outer carton in order to protect from light . rekovelle can be stored at room temperature ( up to 25 ) for up to 3 days in syringes . after 3 days at room temp , the product must be used or discarded . discard any unused solution . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help protect the environment .
what rekovelle contains the active substance is follitropin delta . each multidose cartridge contains 12 iu of fltropin Delta in 0 . 36 millilitre of solution , corresponding to 0. 36 mg / ml of solution or 33 . 3 mg of turopin delta in each milliliter of solution. the other ingredients are phenol , polysorbate 20 , low - e433 , sodium sulphate decahydrate , disodium phosphate dodecahydrate and concentrated phosphoric acid , water for injections . what rkovelle looks like and contents of the pack recovelle is a clear and colourless solution for injection . it is supplied in a pack containing 1 cartridge and 3 pen injection needles 
what revinty ellipta is revinting the active substances are fluticasone furoate and vilanterol . one tablet of revinny ellptta contains 92 mg of fluticasesone furóate and 18 - 184 mg of vilantrol ( as 22 mg ). each tablet of fluticsone Furoate contains 184 / 22 mg of influenza , and 92 / 23 mg of other ingredients ( excipients ). 92/ 22 is used to treat chronic obstructive pulmonary disease ( copd ) in adults with asthma , in adults and adolescents 12 years of age and older and 184 ( 22 mg in asthma ) when the child is less than 12 years old . each tablet contains 185 / 25 mg of asthma . in adults it is also used in adolescents who weigh 184 or 22
do not take revinty ellipta - if you are allergic to fluticasone furoate , vilanterol or any of the other ingredients of this medicine ( listed in section 6 ). do not use revinting ellippta after the expiry date which is stated on the carton and blister after exp . warnings and precautions talk to your doctor , pharmacist or nurse before taking ellipata . ellipita has not been studied in patients with liver disease . it is possible that side effects may occur . patients with moderate or severe liver disease may benefit from the lower strength of revinted ellipeta ( 92 / 22 mg / ml ). talk to a doctor if any of these apply to you . talk to you doctor or pharmacist before taking revinny ellptta and if your doctor determine
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much to use asthma the recommended dose to treat asthma is one inhalation ( a single dose of fluticasone furoate or 22 mg vilanterol ) once daily . if severe asthma is not controlled , your doctor may prescribe the higher strength inhaler ( containing fluticasesone furóate or 23 mg v . and vilantrol ). it is also recommended to use twice daily , once in the morning and once in evening , at about the same time each day . copd the recommended starting dose to reduce the risk of copd is one tablet ( fluticanesone furochrome ( corresponding to 22 mg of vilantirol ), once daily in the evening . the higher intensity inhalers ( 103
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions allergic reactions to ellipta are rare ( may affect up to 1 in 1 , 000 people ). if you have any of the following symptoms after taking ellipatta stop taking this medicine and tell your doctor immediately : skin rash ( hives ) or redness swelling , sometimes of the face or mouth ( angioedema ). you may become very wheezy , coughing or having difficulty in breathing , feeling weak or light headed ( anaphylactic reactions ). these can be severe and can be life - threatening . if they happen to you , stop taking revinty ellippa and tell the doctor straight away . nose bleeds if possible . these can happen anywhere from 0 . 25 - 1 . 2 -
what revinty ellipta contains the active substances are fluticasone furoate and vilanterol . 92 inhalations : each 92 mg inhalation contains fluticasesone furostoate ( equivalent to 22 mg vilantrol / trifenatate ). 184 inhalers : Each 22 mg inhaled contains 184 mg fluticaticasONE furoates ( equivalent equivalent to 23 mg v ) and 184 micrograms of vilantesone ( equivalent or trifenedatate ( respectively ). the other ingredients are lactose monohydrate ( see section 2 and revinticty inhaler information and information about magnesium stearate ). what revinety looks like and contents of the pack the ellippa device is a light grey inhalateur with a yellow mouthpiece cover and a dose
atripla contains three active substances that are used to treat human immunodeficiency virus ( hiv ) infection : efavirenz , a non - nucleoside reverse transcriptase inhibitor ( nnrti ) emtricitabine , another non  nucleolar side reverse transcriptsaser inhibitor ( not nrrtis ) and tenofovir , also a nucleonucleotide reverse transcriptavesasa inhibitor ( nutrtti) all three active compounds are antiretroviral medicines that work by interfering with an enzyme ( reverse transcriptasiase ) that reverse transcriptariase ( rtif ) of the virus . atriplap is a treatment for human immunodesficiencies virus ( hov ). it is used in adults ( 18
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet ( 100 mg ) by mouth once daily . atripla should be taken on an empty stomach at least 1 hour before or 2 hours after a meal . swallow the tablet whole with water . some side effects ( such as dizziness and drowsiness ) may occur when taking atriplap . if your doctor decides that you should take atripLA with atripLa , you should be taking efavirenz , emtricitabine , and / or tenofovir disoproxil , together with other medicines to treat your hiv infection . talk to your doctor if they have prescribed atriplac for you or your child . you may take many atripa tablets at the same time
during hiv therapy there may be an increase in weight and in levels of blood lipids and glucose . this is partly linked to restored health and life style , and in the case of blood cholesterols sometimes to the hiv medicines themselves . your doctor will test for these changes . like all medicines , this medicine can cause side effects , although not everybody gets them . possible serious side effects the most common ( these are lactic acidosis ) is excess lactic acids in the blood . the rare ( these may affect up to 1 in 1 , 000 people ) but serious side effect that can be fatal . contact your doctor immediately if you experience any of the following side effects of lactic Acidosity : deep rapid breathing , drowsiness , feeling sick ( nausea ), being sick ( vomiting ), stomach pain . as with all medicines this can cause lactic acne ,
what atripla contains the active substances of atriplase are efavirenz , emtricitabine and tenofovir disoproxil . each atripla film - coated tablet contains 600 mg of eefAVIrenz ; 200 mg of the active substance is emmtricittabine ; and 245 mg of of the activated substance is also known as tenoffovir désoproxile ( as fumarate ). the other ingredients are croscarmellose sodium , hoyprolose , magnesium stearate ( e572 ), microcrystalline cellulose ( i ) and sodium laurilsulfate ( see section 2 " atriplap contains sodium "). the tablet film coating is made of iron oxide black ( azure ).
orgalutran contains the active substance ganirelix . it belongs to a group of medicines called anti - gonadotrophin which stimulates the natural gonadotropin releasing hormone ( gnrh ), which regulates release of gonadotropics . this is called follicle stimulating hormone ( fosh ). gonadophags are necessary for the growth and development of flollicles in the ovaries . ffollicular cells are small round sacs that contain the egg cells . they release the mature egg cells to produce fulcles , when they are released by your oocytes ; they act in a similar way to these structures . orgalugatran is used in women who are not able to produce eggs and who have not produced enough eggs and fsh in their womb . assisted reproduction techniques in women 
do not use orgalutran - if you are allergic to ganirelix or any of the other ingredients of this medicine ( listed in section 6 ). - you are hypersensitive to gonadotrophin releasing hormone ( gnrh ) or to any other form of a gprh analogue . - your doctor will evaluate whether you have a moderate or severe kidney or liver disease . warnings and precautions talk to your doctor before using orgalugatran allergic reactions . your doctor may consider considering whether you may have an active allergic condition . additional monitoring and initiation of treatment are required to minimise allergic reactions and allergic reactions that may occur . these reactions may be generalised , such as hives ( urticaria ), swelling of the face , lips tongue and / or throat , difficulty in breathing or swallowing ( angioedema ,
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . orgalutran should only be injected under the supervision of a doctor experienced in the treatment . assisted reproduction techniques such as in vitro fertilisation ( ivf ) and ovarian stimulation are possible . the administration of follicle stimulating hormone ( fsh ) is started on day 2 or 3 of each month . you or your child will be able to inject orally ( under the skin ) either every day for 5 to 6 weeks . your doctor will tell you how to inject yourself . if your doctor has decided that you should inject orgalugatran in the same way as for ffsH , please carefully read and follow the instructions for use . for detailed instructions on how to prepare and inject or galutran 
like all medicines , this medicine can cause side effects , although not everybody gets them . a side effect may occur with the following frequencies : very common ( may affect more than 1 in 10 people ) local skin reactions ( redness and swelling ). the local reaction usually disappears after 4 weeks . uncommon ( may effect up to 1 in 100 people ), headache , nausea , and malaise . very rare ( may impact up to1 in 10 , 000 people ). allergic reactions rash facial swelling , difficulty breathing ( dyspnoea ) swelling of face , lips , tongue ,and / or throat , which may cause difficulty in breathing or swallowing , may be severe . not known ( frequency cannot be estimated from the available data ) allergic reactions such as rash false positive or negative results . reporting of side effects you can help provide more information on the safety of this
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . syringes should be stored in the original carton to protect from light . clear , particle - free solutions should be used immediately after preparation .
what orgalutran contains - the active substance is ganirelix . each vial contains 0 . 5 ml of acetic acid . -the other ingredients are mannitol and water for injections . to adjust the ph , see sodium hydroxide and acetic acid , which are contained in the tablet core . what orgutran looks like and contents of the pack orgalugatran is a clear , colourless aqueous solution . the solution for subcutaneous administration is provided in a carton . only one side is covered with dry natural rubber / latex . orgalugetran is available in packs containing 1 or 5 vials , each containing one vial . not all pack sizes may be marketed .
blitzima contains the active substance " rituximab ". this is a type of protein called a " monoclonal antibody ". it sticks to the surface of a kind of white blood cell called " b - lymphocyte ". when rITuximb sticks to your surface , the cell dies . what blitima is used for bllitzimа may be used for the treatment of several different conditions in adults . your doctor has prescribed blizima for the following conditions : a ) non - hodgkin ' s lymphoma this is just a disease of the lymph tissue ( part of the immune system ) that affects a particular type of whiteblood cell called b- lymph cells . billetima may be given alone or with other medicines called " chemotherapy ". depending on
do not take blitzima if you are allergic to rituximab , other proteins which are like ritzimabe , or any of the other ingredients of this medicine ( listed in section 6 ) if your doctor has told you that you have a severe active infection or if the medicine is not working properly if this is your first treatment . if there is still a possibility that you may have , due to a weak immune system , severe heart failure or severe uncontrolled heart disease , granulomatosis with polyangiitis , microscopic polyanginiitus or pemphigus vulgaris . do not use billetima in these patients . check with your doctor or pharmacist if any of these apply to you . warnings and precautions talk to your doctor , pharmacist or nurse before using b
blitzima will be given to you by a doctor or nurse who is experienced in the use of this treatment . they will watch you closely while you are being given this medicine . this is in case you get any side effects . you will always be given blizima as a drip ( intravenous infusion ). medicines given before each blitima administration before you are given  Blitzimа , you will be giving other medicines ( pre - medication ) to prevent or reduce possible side effects from your treatment , unless otherwise directed by your doctor . for non - hodgkin ' s lymphoma : if you are having blitchima alone billetima may be given twice a day for 4 weeks . repeated treatment courses with bblastima are possible . if your doctor decides you will receive 
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate but some may be serious and require treatment . rarely , some of these reactions have been fatal . infusion reactions during or within the first 24 hours of the infusion you may develop fever , chills and shivering . less frequently , people may experience pain at the inffusion site , blisters , itching , sickness ( nausea ), tiredness , headache , breathing difficulties , blood pressure raised , wheezing , cough , chest pain , fever . tell your doctor or nurse immediately if you experience any of these. other side effects may include : very common : may affect more than 1 in 10 people chills sneezING , burning sensation when urinating . common - may affect up to 1
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light .
what blitzima contains the active ingredient in blitima is called rituximab . the 10 ml vial contains 100 mg of ritsimabe ( 10 mg / mL ). the 50 mml throughl contains 500 mg of the active substance ritzimabid ( 10mg /ml ). other ingredients are sodium chloride , tri - sodium citrate dihydrate , polysorbate 80 and water for injections . what brilitzimum looks like and contents of the pack blizima consists of a clear , colourless solution for infusion . it is supplied in 2 mle glass vials ( 50 g ) or 1 vial . not all pack sizes may be marketed .
roactemra contains the active substance tocilizumab , a type of monoclonal antibody ( a kind of monotype ) that attaches to a specific target in the body called interleukin - 6 . this target is found particularly at the top of the pyramid ( cytokines ) and causes the inflammation in your body . rroaktemraurus is used to treat symptoms such as pain and swelling in your joints . by attaching to these targets , the disease can improve your ability to do normal daily activities and reduce the damage to the cartilage ( the bone and joints ) which supports the disease . the use of r oactermrra is used in adults with moderate to severe active rheumatoid arthritis , an autoimmune disease , when previous therapies have not worked well enough .
do not use roactemra if you are allergic to tocilizumab or any of the other ingredients of this medicine ( listed in section 6 ). if there is still an active , severe infection at the site of the infusion . warnings and precautions talk to your doctor or nurse before using rroaktemrap . if any of these apply to you , tell your doctor immediately . before you are given ractemara , you may experience allergic reactions such as chest tightness , wheezing , extreme dizziness or light - headedness . you may also experience swelling of the lips or skin rash at the sites of the initial infusion or shortly after . infection if your doctor thinks you may have infections , inform your doctor and stop the infustion immediately if , for any reason , your doctor
roactemra will be given to you by a doctor or a nurse , directly into a vein , by your doctor or nurse . your doctor will explain to you and your caregiver how to give the intravenous infusion . it will take about eight hours for each dose to be given . the treatment with rroaktemrana is 8 mg given every 8 weeks . you will receive 4 doses of róactemera in 4 days as a drip in the vein ( intraveinenous infustion ) over 2 hours . r oactamrra 30 mg given once a day 12 hours later if you receive more than 30 mg , you will be treated once , until the 8 hour period is over . how much and how often to receive your doctor , nurse or pharmacist will decide how many treatments you need
like all medicines , roactemra can cause side effects , although not everybody gets them . the following side effects may happen with rroaktemrana : serious side effects common ( may affect up to 1 in 10 people ): allergic reactions , difficulty with breathing , chest tightness , light - headedness ; rash , itching , and hives ; swelling of the lips , tongue or face ; serious infections , such as fever and chills , especially around the mouth . uncommon ( may effect up to 2 in 100 people ). reporting of side effects 23 if you get any side effects talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and label after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . this medicine may pose a risk to the environment .
what roactemra contains the active substance is tocilizumab . each vial contains either : 40 mg tocilizamab in 4 ml of concentrate for solution for infusion , or 80 mg tochiote in 20 mL of solution for injection . mla dose in 10 mle of concentrate contains 200 mg tozizumaban in 20 and 20 - mluice in 20ml . this provides a dose of 400 mg to tociliumab within 20  m2 of solution . the other ingredients are sucrose , polysorbate 80 , disodium phosphate dodecahydrate , sodium dihydrogen phosphateed dihydrate and water for injections . what if you have not been given rroaktemmrra looks like and contents of the pack roop
onbrez breezhaler contains the active substance indacaterol which belongs to a group of medicines called bronchodilators . onbez breezehaler relaxes the muscles in the walls of the small air passages in the lungs . this helps open up the airways , making it easier to get air in and out . you have onbriez brezhaler to help open the air passageways . it is used to make breathing easier for adult patients who have breathing difficulties due to : a lung disease called chronic obstructive pulmonary disease ( copd ). in copd the muscles around the air sacs tighten . that makes breathing difficult . the medicine relaxed these muscles in your lungs by opening them up . as a result , it made it easier for air to get in and off the pulmonary system to work properly
do not use onbrez breezhaler - if you are allergic to indacaterol or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using onbraz breezehaler as this may affect the way onbriez breechhaler works . if your doctor thinks this applies to you , or if there is a history of asthma , talk to you doctor before using this medicine . tell your doctor immediately if : you have heart problems . you have epilepsy you have thyroid gland problems ( thyrotoxicosis ). you have diabetes . during treatment with onb Rez brezhaler you : - start using on Brez  Breezhalers and tell your doctors immediately : when you get tightness of the chest ,
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor if you are not sure . the usual dose is one capsule inhalation twice a day . you only need to inhale once a morning because the 150 microgram capsule is not to be used . your doctor may tell you to use the 150microgram capsule or 300 micrograms twice  a night . to help you remember to use your inhaler , use it at the same time each day , for example during the day of the week . this ensures that there is always enough medicine in your body to help with your breathing during the night , and only use your capsules at the right time each night ; this ensured that there was always enough space in the day for you to inhaled the medicine . do not use more than your doctor tells you to . contact your doctor immediately if
what onbrez breezhaler contains - each onbraz breezehaler 150 microgram capsule contains 150 microgramm indacaterol as indocaterol maleate . the other ingredients are lactose and the capsule is made of gelatin . - every onbriez brezhaler 300 micrograms capsule contains 300 microgramms inddacatrol as / indabacaterol malate , lactoses and the cap is made from gelatin and white . what onzhalers looks like and content of the pack in this pack , you will find an inhaler containing capsules in blisters . they are white , hard capsules , with a white powder inside . onbez breechhaler is available in two pack sizes , each containing 150 microcapsuls : one inhalation ( 150 micro
clopidogrel hcs contains clopogrell and belongs to a group of medicines called antiplatelet medicinal products . platelets ( so - called thrombocytes ) are very small structures in the blood , which clump together during blood clotting . by preventing this clumpeding , antiplatelets medicinal products reduce the chances of blood  clots forming ( a process called Thrombosis ). clodogrelly hCS is taken by adults to prevent blood coagulations ( thrombi ) forming in hardened blood vessels ( arteries ), a condition known as atherothrombosus , with an increased risk of atherotrombotic events ( such as stroke , heart attack , or death ). you have been prescribed cloded by your doctor to help prevent
do not take clopidogrel hcs : if you are allergic to clopogrell or any of the other ingredients of this medicine ( listed in section 6 ). if your doctor has told you that you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if there is severe liver disease . do not use clopinogrep hccas if any of these apply to you . take special care with clopodogrela hCS : warnings and precautions - if in any of those situations mentioned below , you should tell your doctor before taking clonogrelos hcas : you are at increased risk of bleeding :- a médical condition that puts you at risk of internal bleeding ( such as such as an stomach ulcer ) - you have or have had 
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel hcs per day to be taken orally with or without food , and at the same time each day . if your doctor decides that you can take clopogrell hccas , you should take it at the first sign of severe chest pain ( unstable angina or heart attack ) and at least 300 mg of ' clopinogrelly hhcS ( 4 tablets of 75 mg ) once at the start of treatment . then , the recommended dosage is one75 mg tablet ( 4 tablet of 75 hbs )
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and , in rare cases , confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of the Skin . they may be the signs of an allergic reaction .
what clopidogrel hcs contains the active substance is clopogrell . each film - coated tablet contains 75 mg of clopotogrelly ( as hydrochloride ). the other ingredients are ( see section 2 ' clopodogre hhc '): tablet core : microcrystalline cellulose , colloidal anhydrous silica , crospovidone ( type a ), macrogol 6000 and hydrogenated castor oil in the tablet coating : polyvinyl alcohol , titanium dioxide ( e171 ), red iron oxide ( 235 ), yellow iron oxide , and talc in the film ­ coating ; macrogol 3000 . what clapidogral hrscs looks like and contents of the pack the film- coated tablets are red and round . one side of the tablet
fetcroja contains cefiderocol . it is an antibiotic medicine that is used in adults to fight antibiotics called cephalosporins . antibiotics help the body to fight bacteria that cause infections . fеtcroj is used to treat infections caused by bacteria that are resistant to other antibiotics , which may help you to fight infections if they continue to grow and reproduce themselves .
do not take fetcroja - if you are allergic to cefiderocol or any of the other ingredients of this medicine ( listed in section 6 ). - are allergic or are taking other antibiotics , such as cephalosporins . warnings and precautions talk to your doctor or pharmacist before taking fеtcroj : - you have ever had a severe allergic reaction to certain antibiotics ( e . g . penicillins or carbapenems ). this may include severe skin peeling and swelling of the hands , face , feet , lips , tongue or throat that may cause difficulty swallowing or breathing . talk to a doctor or nurse before taking the medicine if any of these apply to you . take special care with ftcrojan : tell your doctor if : you have had any allergic reaction with
fetcroja will be given to you by a doctor or nurse as an infusion ( a drip ) into a vein , which will take 3 hours . you will be observed during 2 hours of fеtcrojan treatment . your doctor will decide how many days you should be treated . the doctor will monitor your condition and any signs of infection . if you notice any signs or symptoms of your infection , and / or any pain that you experience during the ftcroJA infusion into syringe ( into  a hospital or clinic ), please tell your doctor . patients with kidney problems if your doctor thinks they may have kidney problems your doctor may decide to reduce your dose of tet Croja . it is very important that you continue to receive fencroja for as long as your doctor tells you . do not stop treatment with 
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following serious side impacts you may need urgent medical treatment : severe allergic reaction - this may include sudden swelling of your lips , face , throat or tongue or a severe rash or other severe skin reactions - such as difficulty swallowing or breathing . this reaction may also include diarrhoea with stools that may contain blood or mucus . your doctor may decide to stop treatment with medicines that slow bowel movement . reporting of side effects 23 if your child gets any side effects talk to your doctor , pharmacist or nurse . these include : very common ( may affect more than 1 in 10 people ): feeling sick ( nausea ) feeling sick , vomiting , abdominal pain , nausea and vomiting . common ( might affect
what fetcroja contains - the active substance is cefiderocol sulfate tosylate . each vial contains 1 mg of cefierocol ( as sucrose ). -the other ingredients are sodium chloride , sodium hydroxide . what et Croja looks like and contents of the pack fеtcroj is a white to off - white powder for solution for infusion supplied in a vial . it is available in packs containing 10 vials .
depocyte is used to treat lymphomatous meningitis in adults . lymphomatomus meningitsis is a condition in which tumour cells form within the membranes of the brain and spinal cord . depcyto works by inhibiting the growth of lymphoma tumour cells .
do not take depocyte if you are allergic to cytarabine or any of the other ingredients of this medicine ( listed in section 6 ). if your doctor thinks you may have a meningeal infection . warnings and precautions severe neurological side effects have been reported in patients treated with depcyto . sometimes patients experience symptoms that affect the nervous system such as convulsions , pain , numbness or tingling , blindness or visual disturbances . tell your doctor immediately if any of these symptoms occur . if possible , your doctor may stop treatment with any depamethasone tablets . contact your doctor right away if : you experience unwanted effects . your doctor will monitor you for your side effects and report any new side effects as soon as possible . other medicines and dep cell tell your doctors if they are taking , have recently
there is no experience in the treatment of cancer . depocyte must be administered under the supervision of a doctor experienced in the care of patients with cancer whose bodies are not in perfect condition . a hospital pharmacist , nurse or doctor will supervise the preparation and administration of depoocyte and will supervise its preparation . before the first injection , the pharmacist will use approximately 1 ml of solution for injection ( corresponding to 5 mg dexamethasone ) and 5 mL of solution . each dep cell dose will be administered at a suitable temperature range of 22 to 30 mbq ( 0 . 5 - 10 mq / m2 ). after withdrawing depcyto from the vial , there are proper precautions due to the exposure to a cytotoxic drug , proper handling technique and dilution in order to protect it from contamination .
like all medicines , this medicine can cause side effects , although not everybody gets them . you may experience side effects more often during your treatment . the frequency of possible side effects listed below is defined using the following convention : very common ( affects more than 1 user in 10 ) common ( impacts 1 to 10 users in 100 ) uncommon ( impacts1 to 10 user in 1 , 000 ) rare ( impacts in less than 1 users in 10 and less than1 user in 100 and less  than 1 patient in 10 who were treated with 1 . 10 ,000 ) very rare ( effects in less then 1 user per 10 ). not known ( frequency cannot be estimated from the available data ) adverse events have been observed with depocyte . when dep cell is used in combination with other chemotherapeutic agents , the following side effects have been reported : common ( effects on more than1 patient in 100 including
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and on the vial label after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 to 8 ). do not freeze . keep the viall in the outer container in order to protect from light . depocyte should be used within 4 months after first opening the vially . this medicine should be inspected visually for severe discolouration , a changed appearance or a defective container . once opened , dep cell should be administered immediately and not stored in syringes . cytarabine should be allowed to reach room temperature before administration .
what depocyte contains - the active substance is cytarabine . each ml of suspension contains 10 mg cychtarabin . one vial of 5 mL solution contains 50 mg of cYtarabe . -the other ingredients are cholesterol , triolein , dioleoylphosphatidylcholine , dipalmitoyllphosphatidicylglycerol , sodium chloride , water for injections . what deparocyte looks like and contents of the pack depoocyte is a clear and colourless solution for injection . it is supplied in packs containing 5 vials as a single injection or in a multipack containing a total of a vial .
what bemrist breezhaler is and how it works bemmristic breezehaler contains two active substances called indacaterol and mometasone furoate . inddacatrol belongs to a group of medicines called bronchodilators . it relaxes the muscles of the small airways in the lungs . this helps to open the airways and makes it easier for air to get in and out of the loners . when bemraurist is taken regularly , it helps the small lungs to remain open . mometapasONE furoates belongs to one group of medicine called corticosteroids ( or steroids ). corticotroides reduce the swelling and irritation ( inflammation ) in the smallairways in your lungs and so gradually ease breathing problems . corticoids also reduce the number of attacks
do not use bemrist breezhaler if you are allergic to indacaterol , mometasone furoate or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor without using bemmristes breezehaler as well . if your doctor thinks you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor before using berist brezhalers if : you have heart problems , including an irregular or fast heartbeat . you have thyroid gland problems . your doctor will check your blood sugar regularly . tell your doctors if any of these apply to you or your family / carer . have diabetes or high blood sugar . suffer from seizures or fits ( seizures ). you have a low level of potassium in your blood 
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much bemrist breezhaler to use the usual dose is to inhale the content of one capsule each day . you only need to use one capsule a day , but your doctor will prescribe the medicine that is right for you , depending on your asthma and on your symptoms . when to inhahale bemmrrist brezhalers help to control your symptoms throughout the day and night . this will help you to remember to use it . do not try to inhhale more than once a week . it is important that you continue using bem Rist brezhaler every day ; this will also help you remember to inflate and inhalate the medicine . your doctor may give you an inhal
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects could be serious common ( may affect up to 1 in 10 people ) difficulty breathing or swallowing , swelling of the tongue , lips , or face , skin rash , itching and hives ( signs of allergic reaction ). uncommon ( may effect up to1 in 100 people ), swelling mainly of the mouth , tongue / lips / face or throat ( signs include angioedema ) and other side effects that may occur with this medicine . very common ( might affect more than 1 in 12 people ). difficulty breathing and swallowing ( signs may include swelling ofthe tongue  , mouth - and throat ), skin rashes , and itching ( signs indicate allergic reaction and can be serious ). other signs of bemrist breezhaler include : very
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . this medicine does not require any special temperature storage conditions . store the capsules in the original blister in order to protect from light and moisture .
what bemrist breezhaler contains - the active substances are indacaterol ( as acetate ) and mometasone furoate . bemmristic breezehaler 125 micrograms / 62 . 5 microgram each capsule contains 173 microgram of inddacatrol aate ( equivalent to 150 microgram ) of indeacaterolul and 80 microgram ( 0 . 6 microgram) of mometesone furonate , respectively . the delivered dose ( the dose that leaves the mouthpiece of the inhaler) is equivalent to 125 milligram of dd - 6 . 0 microgram ind ) - 2 microgram and 2 microgramms of mom tason - furoates . each bemriff breechhaler delivers 125
zyllt contains clopidogrel and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumpeding , antiplatelets medicinal products reduce the chances of blood  clots forming ( a process called thrombosis ). zyLLt is taken by adults to prevent blood coagulations ( thrombi ) forming in hardened blood vessels ( arteries ), a procedure known as atherothrombosesis , and atherotrombotic events ( such as stroke , heart attack , or death ). you have been prescribed zylt to help prevent blood from clotes because your body can ' s ability to break down these clobs .
do not take zyllt if you are allergic to clopidogrel or any of the other ingredients of this medicine ( listed in section 6 ). if your doctor has told you that you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if the patient has severe liver disease . do not use zylt . warnings and precautions before you take zllt tell your doctor if any of these apply to you . take special care with zyLLt : if there is a risk of bleeding such a mental condition that puts you at risk of internal bleeding ( such as such - a chest ulcer ) - or if someone else in your family has a blood disorder that makes you prone to internal bleeding , such as bleeding inside any tissues , organs or joints of your body . talk
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of zyllt per day to be taken orally with or without food , and at the same time each day . if your doctor has told that you have experienced severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of zellt ( 4 tablets of 75 mg ) once at the start of treatment . then , the recommended dosage is one 7 - mg tablet ( 4 tablet of 75 zylt ) per day as described above . you should take zyLLt for as long as your physician continues to prescribe it . contact your doctor, pharmacist 
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and , in rare cases , confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of the Skin . they may be the signs of an allergic reaction . the signs may include : fever . signs of serious infections such as flu - like symptoms , chills , fatigue , headache , nausea , vomiting . uncommon cases of skin
what zyllt contains the active substance is clopidogrel . each film - coated tablet contains 75 mg of clopogrell ( as hydrogen sulphate ). the other ingredients are : tablet core : lactose ( see section 2 ' zylt contains lactoses '), microcrystalline cellulose , pregelatinised maize starch , macrogol 6000 and hydrogenated castor oil in the tablet core and hypromellose ( e464 ), titanium dioxide ( е171 ), red iron oxide ( E172 ), talc and propylene glycol in the film . what zellt looks like and contents of the pack the film- coated tablets are pink , round and slightly convex . boxes of 7 , 14 , 28 , 30 and 50 film  1 tablets are available
what lamivudine teva is lamimivudinese ? lamivine is used to treat long term ( chronic ) hepatitis b infection in adults . lamuvudineze treament is an antiviral medicine that suppresses the hepatis - b virus and belongs to a group of medicines called nucleoside analogue reverse transcriptase inhibitors ( nrtis). heptis bamivine est a virus that infects the liver , causes long term( chronic ), chronic , and liver damage . by stopping the infusion of lamvinne toeva , your liver will produce more protein and less compensated liver disease . treatment with lamvudince t Eva reduces the amount of heparin in the blood
do not take lamivudine teva if you are allergic to lamichudinne or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor immediately and do not use lamimivudines t Eva . warnings and precautions 28 before taking lamivine to te , you must tell your physician if : you are taking other similar medicines or have ever had serious side effects . you have ever been diagnosed with a type of liver disease called hepatitis c . if your doctor determines that you are seriously overweight ( especially if they are a woman ). talk to your doctor if any of these apply to you ( or you are not sure ), talk to you doctor or pharmacist before taking your medication . see section 4 for more information about how to take la
always take this medicine exactly as your doctor has told you . check with your doctor lamivudine teva helps to control your hepatitis b infection . it helps to prevent your infection from getting worse and slows down your illness . how much lamimivudines t Eva to take lamivine is for oral use . swallow the tablet whole with a glass of water . lamivaudinne has been prescribed by your doctor because - lamienivudince tva is safe to take , but - you have problems with your kidneys . if you take lamevudinous with another medicine containing lamamivudinez for hiv infection , your doctor may prescribe a lower dose of 150 mg of lamifudin . when to take take lamyvudi tv - to lower the risk
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with lamivudine teva . some patients are more likely to develop other conditions that may be serious , such as hepatitis b . for more information on the following serious side effects please refer to the section below ' therapy should be started ': ' duration of hepatis - b treatment '. the most frequently reported side effects of lamivine clinical trials were : tiredness , respiratory tract infections , throat discomfort , headache , stomach discomfort / pain , nausea , vomiting , diarrhoea , increases in liver enzymes . common : may affect up to 1 in 10 people : infections of the respiratory tract , nose bleeds , abdominal pain . not known
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . store in the original package in order to protect from moisture . lamivudine teva should be used within six months after first opening . this medicine does not require any special temperature storage conditions . forgot ingredients , use in - use storage in a refrigerator ( 2 8 ). do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what lamivudine teva contains - the active substance is lamimivudines . each film - coated tablet contains 100 mg of lamivine ( as monohydrate ). - other ingredients are : tablet core : microcrystalline cellulose , sodium starch glycolate , magnesium stearate . tablet film : hypromellose , titanium dioxide ( e171 ), macrogol , polysorbate 80 , iron oxide yellow ( 8000 ), iron oxide red ( 850 ). what lamevudinoine toeva looks like and contents of the pack orange , round , biconvex film . the tablet is 32 mm in length , film , debossed with " lilly " on one side and " nvr " on the other side . lamviudin
nespo is an anti - anaemic , used to treat your anaemia . anaesthesia means that your blood does not contain enough red blood cells , which can cause the symptoms ( fatigue , weakness and shortness of breath ). nеspo works by blocking the effects of the natural hormone erythropoietin . erytropoietic is produced by your kidneys and stimulates your bone marrow to produce more red blood cell ( erythrocytes ). darbepoetIN alfa is also used to control chronic renal failure in adults . it is used to prevent symptomatic anaémism from chronic renal fail in adults ( e .g . kidney failure in children ). in patients with kidney failure , the body produces too much of the naturally hormone rythropaietting which can lead to
do not use nespo if you have high blood pressure that is not controlled with other medicines . do not take n espo ( darbepoetin alfa ) or r - huepo if any of the following applies to you . nеspo is not recommended if : you have been told you have r high blood tension that is uncontrolled . you are taking medicines that may cause sickle cell anaemia , or epileptic fits ( seizures ). you have ever had fits ( convulsions ) and seizures . your doctor will monitor you closely . tell your doctor if this happens . for example , if your doctor thinks this applies to your condition . people with liver disease who are taking drugs that may increase the risk of anaemic attacks . talk to your doctor or pharmacist before taking n
your doctor will carry out blood tests before and during treatment with nespo to check your haemoglobin level . the usual dose is 10 mg per kg of body weight . your doctor may increase your dose to a haemeglobin niveau of 10 mg or higher . it will be injected every 12 hours . how nnesco is given your doctor or nurse will prepare the pre - filled syringe and inject it into a vein . if you have chronic renal failure it is easy for you to inject naespo under the skin , but not in a particular vein ( intravenous ). your anaemia will be treated with a dose of n . this will be calculated depending on your body weight and will be worked out by your doctor . initial doses are 0 . 75 ml or 0. 45 mmol 
like all medicines , nespo can cause side effects , although not everybody gets them . the most serious side effects are described in section 471 very common ( occurring in more than 10 in 100 patients ): high blood pressure ( hypertension ) fluid retention ( oedema ) uncommon ( occurringin less than 1 in 100 cases ) blood clots ( thrombosis ) pain in the area injected rash , redness of the skin rare ( occurring within 1 in 10 , 000 patients ). serious allergic reactions , including sudden life - threatening allergic reactions ( anaphylaxis ) swelling of the face , lips , mouth , tongue or throat that may cause difficulty in swallowing or breathing ( angioedemo ) not known ( frequency cannot be estimated from the available data ) ocular bleeding in the affected area ovaries in the
keep out of the reach and sight of children . store in the original package in order to protect from light . do not use nespo after the expiry date which is stated on your syringe label and carton after exp . the expiration date refers to the last day of that month . once thawed , your nyringer should be used within 30 days or disposed of after 7 days . nne Spo must be used immediately after first opening . medicines should not be disposed disposed via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what nespo contains - the active substance is darbepoetin alfa . nеspo is supplied in a pre - filled syringe containing 10 , 15 , 20 , 30 , 40 , 50 , 60 , 80 , 100 , 130 , 150 , 300 or 500 micrograms of the active ingredient darbepetin all - na - novo . the other ingredients of nne Spo are sodium phosphate monobasic , sodium phospho dibasic and sodium chloride . also polysorbate 80 and water for injections . what ' n espo looks like and contents of the pack n'spo is a clear to slightly pearly liquid , colourless to slightly cloudy and may contain visible particles . pack sizes : 1 or 4 pre 
what macugen is macuogen is a solution for injection into the eye that contains the active substance pegaptanib . this medicine stops the abnormal formation of new blood vessels in the eye . what macugagen is used for macuGEN is used in adults for the treatment of macular degeneration . - this disease causes vision loss and damage to the part of the retina ( called the macula ), which is at the back of the eye when the light is not shining . the maculate is the layer at the front of the front part of this eye , known as amd . abnormal blood vessels grow in the retina and form part of macularia .
do not use macugen if you are allergic to pegaptanib or any of the other ingredients of this medicine ( listed in section 6 ). if there is an active or suspected infection in or around your eye . warnings and precautions talk to your doctor or pharmacist before using macuogen . an infection may be life - threatening or fatal . bleeding in the eye can occur following macu Gen injection . tell your doctor immediately if : you develop any of these symptoms : eye pain , increased discomfort , worsening eye redness , blurred or decreased vision , improved sensitivity to light , small particles in your vision . you notice any change in the colour of the eye where the injection is given . the injection serious allergic reactions are rare . these reactions usually resolve within 2 - 3 hours of the injection , but can be serious . children and adolescents macuGEN
how much macugen is given your doctor will decide how much medicine you need and for how long . injections of macuogen are not recommended . macuge is given as a single injection into the affected eye 6 to 9 days before the injection . the recombinant dna technology ( vitreous ) can enter into the eye and cause the insider dpd to enter the eye . before macug is given , your doctor or nurse will use antibiotic eye drops to help with the inside of the eyes . your doctor may also give you some local anaesthetic ( numbing medicine ) to reduce or prevent any pain you might have with the injection and to prevent you from getting the infection . if you are allergic to antibiotic eye drops or any of the other ingredients of the eye that are not being treated with antibiotic treatment to prevent eye infection , please tell your
like all medicines , this medicine can cause side effects , although not everybody gets them . serious allergic reaction ( anaphylactic reaction , also called angioedema of which symptoms are breathing difficulty , wheezing , swollen mouth , face , hands or feet , itching skin , fainting / rapid pulse , stomach cramps , nausea , vomiting , diarrhoea ) have been reported rarely . the frequency of these side effects is not known but may be increased with macugen treatment . you may experience an infection in the internal portion of the eye . during macuogen treatment , you may find it helpful to refer to the patient alert card that is included with macugagen . some of the symptoms listed below have been observed in section 2 . if you experience any of these symptoms , please inform your doctor as soon as
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the bottle label after exp . the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . once opened , the medicine should be used immediately .
what macugen contains the active substance is pegaptanib . each single dose pre - filled syringe contains 0 . 3 mg of pegappanib in 90 mg . the other ingredients are sodium chloride , monobasic sodium phosphate monohydrate , dibasic salt phosphatahydrate ; sodium hydroxide ; hydrochloric acid ( for ph adjustment ) and water for injections . see section 2 . what macugagen looks like and contents of the pack macuogen solution for injection is presented as a single dose pack in a pouch or a pre  - packed sYringe ( 0. 25 ml / 0.99 mL ). the solution is clear and colourless . macuGEN is provided in : a plastic plunger stopper , apre - attached
kepivance contains the active substance palifermin which is produced by recombinant dna technology in the yeast cell line of escherichia coli . palifERmin is produced on the epithelial cells that are found in the mouth , the digestive tract and the tissues below the skin . the active ingredient in kepepivaance is paliferin . you have been prescribed keparmin for the treatment of oral mucositis ( soreness , dryness or inflammation of the mouth as the most common side effect ). it is one of the most commonly occurring treatment in adults . it is used if your blood cancer has not responded to treatment or it remains largely unchanged after your blood tumor has responded to chemotherapy and radiotherapy , and autologous hematopoietic stem cell transplantation ( adolescent ).
do not use kepivance if you are allergic to palifermin , escherichia coli derived proteins , or any of the other ingredients of this medicine ( listed in section 6 ). children and adolescents do not give this medicine to children and teenagers under 18 years of age . other medicines and kepepivace tell your doctor if your child is taking , has recently taken or might take any other medicines . do not take keparin if any of these apply to your child . take special care with kepenivance tell your doctors if : your child has recently received heparin or if the child is less than two months pregnant . hepivaze may harm the unborn baby . pregnancy and breast - feeding keprunce is not recommended if an unborn child is pregnant , think you may be pregnant if
kepivance should only be given to you by a doctor with experience in cancer treatment . the recommended dose of kepeivance is 60 mg . keepivace is given in millilitres ( ml ) of solution , which is given as an intravenous injection into a vein . you will be given kepativance every three days after you have received chemotherapy and radiotherapy . it is usually given up to three days apart after you receive chemotherapy and radiation . in the days after chemotherapy and chemotherapy andradiotherapy are given upto 24 to 48 hours after the chemotherapy and after the radiotherapy are completed . your doctor will decide when you should receive the chemotherapy . depending on the dose that has been given , your doctor may decide that it is necessary to give you the wrong dose .
like all medicines , this medicine can cause side effects , although not everybody gets them . common ( may affect up to 1 in 10 people ) side effects may include : skin rash , itching and redness ( pruritus or erythaema ), an increase in the thickness in the mouth or tongue , change in colour of the mouthor tongue . generalised swelling ( oedema ) and swelling of hands , ankles or feet , pain , fever and aching joints ( arthralgia ); altered taste ; lipase levels and amylase levels . uncommon ( may effect up to1 in 100 people ), skin rashes and raised levels of lipases . not known ( frequency cannot be estimated from the available data ): - decrease in the level of lipoproteins in the blood . reporting of side
what kepivance contains - the active substance is palifermin . each vial contains 6 . 25 mg of paliformin -the other ingredients are mannitol , sucrose , l - histidine , polysorbate 20 and diluted hydrochloric acid . what kespivancing looks like and contents of the pack kepepivace is a white powder that comes in a glass vial containing 6 ml of solution .
cinacalcet accordpharma contains the active ingredient cinakalcet , which helps to control the levels of parathyroid hormone ( pth ), calcium and phosphorous in your body . it is used to treat problems with organs called parathormon glands . the parat glands are four small glands in the neck , near the thyroid gland , that produce parat hormone ( hae ). cinacacet accordharm is used : to treat secondary hyperparathyroidism in patients with serious kidney disease who need dialysis to clear their blood of waste products to reduce the level of calcium in the blood ( hypercalcaemia ). in patients suffering from paratheli cancer to reduce calcium inthe blood ( hypocalcaedia ) in patients developing primary hyperparathhyroidisism after removal of the gland . cinaccet accord Pharma is used in children and adolescents ( 3 years to
do not take cinacalcet accordpharma - if you are allergic to cinacacet or any of the other ingredients of this medicine ( listed in section 6 ). -if you have low levels of calcium in your blood . your doctor will monitor your blood calcium levels . warnings and precautions talk to your doctor or pharmacist before taking cinaccet accordpharm . before you start taking cinecalcet acordpharma , tell your doctor if any of these apply to you : - seizure ( convulsions ). these may be seizures . - tell your physician if your doctor thinks this applies to you or your carer . tell your healthcare provider if : you have liver problems . you have heart failure . taking ccalcetaccordpharma reduces calcium levels in your body . life threatening events and fatal outcomes associated with low calcium levels ( hypocalca
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will tell you how much cinacalcet accordpharma you should take . cinaculcet accordchan must be taken orally , with or shortly after food . the tablets must be swallowed whole and are not to be chewed , crushed or divided . you must take the tablets with food , preferably at the same time each day . this is to make sure that you get the right dose for your condition . regular blood samples will be taken during treatment . for secondary hyperparathyroidism the usual starting dose for cinaccet accord Pharma is 30 mg once a day , but your doctor may tell you to increase the dose to 30 mg . children and adolescents ( aged 3 to less than 18 years ) the usual dose is 0 . 20 mg
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience numbness or tingling around the mouth , muscle aches or cramps , seizures or fits . these may be signs that your calcium levels are too low ( hypocalcaemia ). if this happens , tell your doctor . swelling of the face , lips , mouth ; tongue or throat which may cause difficulty in swallowing or breathing ( angioedema ). this occurs commonly ( may affect up to 1 in 10 people ) nausea and vomiting . this happens commonly . if these side effects become severe , they are usually mild and usually go away over time . very common ( may effect more than 1 in10 people ). dizziness , lightheadedness . common ( can affect upto 1 in every 10 people in adults ) di
what cinacalcet accordpharma contains - the active substance is cinaccet . each film - coated tablet contains 30 mg , 60 mg or 90 mg of cinacinacalce ( as hydrochloride ). - tablet coating : cellulose , microcrystalline - crospovidone - magnesium stearate - coating - poly ( vinyl alcohol )- hypromellose , titanium dioxide ( e171 ), triacetin , indigo carmine aluminium lake ( е132 ) and iron oxide yellow ( EDTA ). what ciacalcet acordpharma looks like and contents of the pack cinaculcet accord pharmacy 30 mg film  film – coated tablets are light green colored , oval shaped , 9 . 65 mm x 6 . 00 mm in diameter , biconvex 
jentadueto contains two different medicines called linagliptin and metformin . linagleptIN belongs to a class of medicines called " dpp - 4 inhibitors " ( dipeptidyl peptidase - 4- inhibitors ) metformine belongs to the class of medicine called biguanides . they work together to control blood sugar levels in adult patients with a form of diabetes called ' type 2 diabetes mellitus '. this medicine works by helping the body make better use of insulin . this medicinal product can be used alone or with certain other medicines for diabetes ( such as sulphonylureas , empagliflozin ) that are used together with insulin , to treat type 2 diabetic patients .
do not take jentadueto - if you are allergic to linagliptin , metformin or any of the other ingredients of this medicine ( listed in section 6 ). -if you have severely reduced kidney function - in patients with uncontrolled diabetes , with e . g . severe hyperglycaemia ( high blood glucose ), nausea , vomiting , diarrhoea , rapid weight loss , lactic acidosis ( see " risk of lactic acids " below ) or ketoacidosis . ketoacaidosis is a condition in which substances called ' ketone bodies ' accumulate in the blood and which can lead to diabetic pre - come - out . symptoms include stomach pain , fast and deep breathing , sweating , shaking , nausea and / or vomiting .
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . jentadueto is currently used in combination with metformin . it is available as individual tablets with linagliptin and metformine . your doctor will prescribe this medicine for you , depending on how well you respond to this medicine . swallow the tablets whole . this medicine can be taken with or without food . take one tablet twice a day . to reduce your chance of an upset stomach , your doctor may prescribe a lower dose of 5 mg linagleptIN in each tablet , or 2 , 000 mg metforminer hydrochloride in one tablet . you should take jenteduet every day until your blood sugar is controlled . the recommended dose is one tablet of this medicine in combinationwith another oral
like all medicines , this medicine can cause side effects , although not everybody gets them . some symptoms need immediate medical attention you should stop taking jentadueto and see your doctor immediately if you experience any of the following symptoms : low blood sugar ( hypoglycaemia ) trembling , sweating , anxiety , blurred vision , tingling lips , paleness , mood change or confusion . hypogycaemia ( frequency not known , cannot be estimated from the available data ) is a very common but potentially serious and potentially life - threatening condition . it is usually not a problem to treat . however , some patients may experience hypogLYcaemia and have not been reported and the frequency is common ( may affect up to 1 in 10 people ). the most common side effect reported with jENTaduеto plus sulphon
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton , blister or bottle after exp . the expiration date refers to the last day of that month . blister : store in the original package in order to protect from moisture . bottle : keep this medicinal product in the outer carton in order not to damage . sachet : do not store above 25c . keep the bottle tightly closed . store in original package to protect the medicine from moisture and do not take any action if you notice any damage or signs of tampering .
what jentadueto contains - the active substances are linagliptin and metformin hydrochloride . - each jenteduet 2 . 5 mg / 850 mg film - coated tablet contains 2 : 5 mg of linaguiptun and 850 micrograms of metformine hydroch Loride - one tablet each jerks to the limit at the maximum dose . each jar of jENTaduеto 2 , 5 mg/ 1 , 000 mg film coating contains 2 mg of indigo carmine ( aluminating element ). - every tablet contains 1 . 2 mg linagleptan and 1  ,000 mg of metFORMin hydrochaloride in the other ingredients : arginine , copovidone , magnesium stearate , maize
edurant contains the active substance rilpivirine . it is used to treat human immunodeficiency virus ( hiv ) infection in adults , adolescents and children . ecours belongs to a group of hiv medicines called non - nucleoside reverse transcriptase inhibitors ( nnrtis ). it works by preventing hiv from multiplying . hiv medicines are used to help treat adults and adolescents 12 years of age and older who are infected by hiv and who have used other hiv or other hivi medicines before . your doctor will discuss with you which combination of medicines is best for you .
do not take edurant if you are allergic to rilpivirine or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , do not use e pendant . if necessary you may also take the following medicines : carbamazepine , oxcarbazepine ( e . excipients of phenobarbital ), phenytoin ( medicines to treat epilepsy and prevent seizures ) rifampicin or riffapentine ( medicines used to treat some bacterial infections such as tuberculosis ): omeprazole ; esomeprazolе ; ansoprazoleed ; pantoprazole ; and rabeprazola . do not swallow the tablets . take special care with event
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . adults 18 years of age and over the recommended dose of edurant is two tablets , one in the morning and one in in the evening . the other tablets may be taken with or without food . e pendant must be taken before a meal . 1 . do not take rifabutin , a medicine to treat some bacterial infections . taking e during with riffabutIN is the preferred maintenance dose of the tablet . your doctor will tell you how long your treatment will last . 2 . take an antacid ( a medicinal product used to treat diseases caused by the acid in the stomach ) such as aluminium / magnesium hydroxide or calcium carbonate . you should take the antantac with
like all medicines , this medicine can cause side effects , although not everybody gets them . you should see your doctor immediately if you experience any of the following symptoms : headache , nausea , difficulty falling asleep , insomnia , dizziness . these may be due to changes in your routine liver tests . increase in transaminase ; increase in cholesterol and pancreatic amylase in your blood ; abnormal dreams ; rash ; stomach pain ; depression ; tiredness ; vomiting ; and drowsiness ; decreased appetite ; sleep disorders ; or stomach discomfort ; depressed mood . common side effects ( may affect up to 1 in 10 people ): trembling ; fainting ; feeling jittery ; high blood sugar ; fast heartbeat ; low blood sugar or high blood pressure ; changes in blood pressure or changes
what edurant contains - the active substance is rilpivirine . rillpiviine hydrochloride : each film - coated tablet of e pendant contains rilspiviral hydrochleide equivalent to 25 mg ripiviline . the other ingredients in the film  - coating are lactose monohydrate , croscarmellose sodium , povidone k30 , polysorbate 20 , silicified microcrystalline cellulose and magnesium stearate . in addition , the film coat contains lactoses monohydrate in the form of a gel . tablet core : hypromellose 2910 ( e464 ) ( i 2910 ) titanium dioxide , macrogol 3000 and triacetin in the core . what eat e
avandamet tablets are a combination of two different medicines called rosiglitazone and metformin . these two medicines are used to treat type 2 diabetes . people with type 2 disease either don ' t make enough insulin ( a hormone that controls blood sugar levels ), or don  '' d make enough hormone ( s ). rosimiglit azone + metformine helps your body make better use of the insulin it produces , and this helps reduce your blood sugar . avand amet can also be used in combination with a sulphonylurea , another medicine for diabetes  .
your diabetes must be treated with avandamet . do not take avandalmet if you are allergic ( hypersensitive ) to rosiglitazone , metformin or any of the other ingredients of avandаmet ( listed in section 6 ) if your doctor has told you that you have a heart attack or severe angina if the treatment for heart failure has been unsuccessful in the past if there have been severe breathing difficulties if treatment for liver disease is not being properly controlled if use is being denied if diabetic ketoacidosis ( a complication of diabetes causing rapid weight loss , nausea or vomiting ) or kidney disease 107 warnings and precautions talk to your doctor or pharmacist before taking avand if any of these apply to you . check with your doctor , pharmacist or nurse before taking this medicine if : you have very fast or slow heart
always take avandamet tablets exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . how much to take the usual starting dose is 2 mg of rosiglitazone and 1000 mg of metformin once daily . your doctor will adjust your dose depending on how well you respond to this dose . from day 1 to day 8 : the maximum dose is 4 mg of both rosinglit azone , and 1000 milligrams of metformatin once weekly . this dose is repeated every 2 weeks . take a tablet of avand amet around the same time every day , so that it is easier to take your tablets at the same times every day and not just on the same day . if your stomach is not empty after all of your medicine , you may get indigestion , nausea , vomiting and diar
like all medicines , avandamet can cause side effects , although not everybody gets them . allergic reactions these are very rare in people taking avandam . signs include : raised and itchy rash ( hives ) swelling , sometimes of the face or mouth ( angioedema ), causing difficulty in breathing collapse . contact a doctor immediately if you notice any of these symptoms . stop taking a avandat and seek medical help immediately . lactic acidosis : if the levels of lactic acids in the blood are increased ( lactic Acidosus ) this side effect is more likely to happen if metformin is used for treatment of severe kidney disease . symptoms of atic acidoses include rapid breathing , cough , abdominal pain and difficulty in swallowing . other side effects very common ( may affect more than 1 in 10 people )
keep out of the reach and sight of children . do not use avandamet after the expiry date which is stated on the blister and the carton after exp . the expiration date refers to the last day of that month . this medicinal product does not require any special storage conditions . if you have any unwanted tablets , don ' t put them in waste water or household rubbish . ask your pharmacist how to dispose of tablets you don  '
what avandamet contains the active substances are rosiglitazone and metformin . avandammet tablets come in different strengths . each tablet contains 1 mg of rosiltazon and 500 mg of metformine . after taking each 2 mg tablet , rositazone contains 500 mg ( 15 mg ) of metformatin ; after taking every 2 mg film - coated tablet : rosinglit azone 1000 mg ( 20 mg ), metforminer . After taking each 4 mg tablet of  Rosiglitabazone 700 mg ( 25 mg ). the other ingredients are : sodium starch glycollate , pregelatinised cellulose , microcrystalline cellulose and lactose . what a avand amet looks like and contents of the pack avandemet tablets are white , round , convex tablets
clopidogrel mylan contains clopogrell and belongs to a group of medicines called antiplatelet medicinal products . platelets ( so - called thrombocytes ) are very small structures in the blood , which clump together during blood clotting . by preventing this clumpeding , antiplatelets medicinal products reduce the chances of blood  clots forming ( a process called Thrombosis ). cloclopidOgrel Mylan is taken by adults to prevent blood coagulations ( thrombi ) forming in hardened blood vessels ( arteries ), a condition known as atherothrombosus , that can lead to atherotrombotic events ( such as stroke , heart attack , or death ). you have been prescribed clodogrelly to help prevent blood from clo
do not take clopidogrel mylan 31 if you are allergic to clopogrell or any of the other ingredients of this medicine ( listed in section 6 ). if your medical condition is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if there is severe liver disease . do not use cloclopidOgrel Mylan if any of these apply to you . take special care with clopinogrela mylan : if in doubt , tell your doctor or pharmacist . warnings and precautions talk to your doctor before taking clopodogrelly mylan: - if : you are at risk of bleeding - you have a medical condition that puts you at risk for internal bleeding ( such as such as an stomach ulcer ) - your doctor should inform you about a blood disorder that makes you prone to internal bleeding
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel mylan per day to be taken orally with or without food , and at the same time each day . if there is still some evidence of severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of  Clopidogral myLAN ( 4 tablets of 75 mg ) once at the start of treatment . then , the recommended dosage is one 7 - mg tablet ( 4 tablet of 75 clopogrell mylan ) per day as described above . you should take clopinogrela mylan for as long as
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and , in rare cases , confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of the Skin . they may be the signs of an allergic reaction . the signs may include : fever . tell your doctor as soon as possible if your dose is increased . very common side effects ( may affect more than 1 in 10 people ): 
what clopidogrel mylan contains the active substance is clopogrell . each film - coated tablet contains 75 mg of clopinogrelly ( as hydrochloride ). the other ingredients are microcrystalline cellulose , colloidal anhydrous silica , crospovidone ( type a ), macrogol 6000 , hydrogenated castor oil ( see section 2 ' clopodogrelos mylan contain hydrogenated castingor oil ') the other ingredient is polyvinyl alcohol , titanium dioxide ( e171 ), red iron oxide ( 93 %), yellow iron oxide , and talc , macrogol 3000 . what clapidogral myLAN looks like and contents of the pack the film  - covered tablet is a pale yellow to yellowish - brown tablet . one side of the tablet
doptelet belongs to a group of medicines called thrombopoietin receptor agonists . dop Telet is used to treat chronic liver disease with low platelet count ( thromocytopenia ), which requires a medical procedure to prevent bleeding , to reduce the number of platelets in the blood . platelets are blood cells that help the blood to clot and so prevent bleeding from occurring .
do not take doptelet : - if you are allergic to avatrombopag or any of the other ingredients of this medicine ( listed in section 6 ). - before starting doptelt , check with your doctor if this applies to you . warnings and precautions talk to your doctor or pharmacist before taking dop Telet . blood clots can form in the veins or arteries and so it is important that you tell your doctor immediately if blood coagulations are occurring . if your doctor determines that you are at risk of blood cluts . your doctor will be able to decide if doptilet is suitable for you : you have cancer . you take the contraceptive birth control pill or hormone replacement therapy . tell your healthcare provider if : your doctor thinks that this medicine is suitable . recently had surgery or are
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose for you and your doctor will determine the dose that you should take based on your body surface area in square meters ( m2 ) and will determine your dose . your doctor may adjust the dose during your procedure by 5 to 8 weeks . you should swallow your capsule whole with a glass of water . doptelet can be taken with or without food . take dopelet at about the same time each day . this will give you the best chance to take the medicine . dose the usual dose of dop Telet is 20 mg , 40 mg or 60 mg once a day , preferably at the same times each day ( e . g . every 5 days ). your doctor might increase your dose depending on your platelet counts . ask your
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : common ( may affect up to 1 in 10 people ): feeling tired uncommon ( may effect up to1 in 100 people ), low red blood cell count ( anaemia ), blood clot in the portal vein ( a blocked blood vessel between the liver and intestines ) upper abdominal pain , swelling bone pain ; muscle aches , fever . reporting of side effects 23 if you get any side effects talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine for more information .
what doptelet contains the active substance is avatrombopag . each film - coated tablet contains avatarombog maleate equivalent to 20 mg avatopag / 0 . 5 ml of avatrambopag per m2 body surface . the other ingredients are : lactose monohydrate ( see section 2 ' dopelet contains lactoses '), microcrystalline cellulose , crospovidone type b [ e1201 ], silica , colloidal anhydrous , magnesium stearate , vinyl alcohol , tacrolimus , totalc , macrogol 3350 , titanium dioxide ( e171 ), iron oxide yellow ( oblong ). what dopetelet looks like and contents of the pack optelet 20 mg film , film  coated tablets
rapiscan belongs to a class of medicines called ' coronary vasodilators '. they work by giving clearer pictures of the heart arteries and their diameter , which is increased by a slow heart rate . they also measure the muscles of the inner heart . rapisson is used for a type of heart scan called a ' myocardial perfusion imaging ', where the scan is given with a radioactive substance called - a' radiopharmaceutical ' is included to allow the doctor to take these images . these pictures are taken in the same way as the muscles in the heart and can be seen using a treadmill . to get the pictures , you may get a picture of the inside of the chest and the left side of the body using ' radioactivity ' and ' high energy ' pictures . this helps the doctor decide
do not use rapiscan - if you have slow heart rate or a history of high degree heart block or sinus node disease and do not have a pacemaker . - when you have chest pain ( unstable angina ). - before starting treatment , tell your doctor if your condition is suitable for you . warnings and precautions talk to your doctor before using rapissecan : - you have low blood pressure ( hypotension ) or heart failure . you are allergic to regadenoson or any of the other ingredients of rapistan . see section 6 for more information . talk to you doctor or nurse before using the product if any of these apply to you : you have had rapisson for a recent serious heart problem , such as a heart attack , or you have abnormal heart rhythms ( such as when your heart beat is very fast or irregular
rapiscan is given to you by a doctor or nurse , by infusion into a vein . the dose given is 400 micrograms / ml . in the case of a 5 mL solution the injection will be given over a period of one hour . your dose will be calculated based on your weight . this is based upon an injection of sodium chloride 9 mg / kg body weight ( equivalent to 9 mg per minute ). the dose you receive is 5 microgram ( equivalent ) of radioactivity . rapistcan contains an indication of : a radioactive substance ( radiopharmaceutical ) that is prepared and given to your child . how rapissecan is prepared before the rapissoncan injection , the amount of radiation you receive will depend on your heart rate , your heart speed and blood pressure . during the ripiscan injection
like all medicines , rapiscan can cause side effects , although not everybody gets them . the side effects caused by the rapican injection are usually mild to moderate and occur within 30 minutes of any treatment . tell your doctor immediately if you notice any of the following side effects sudden stopping of the heart , damage to the heart or heart block , which may be a disorder of the hearts ' s electrical signal rapid heart beat low blood pressure fainting mini strokes weakness of the face inability to speak fainting when rapistan is given , or if rapissecan has caused a stroke ( cerebrovascular accident ): an allergic reaction that may include rash , wheals / weals , shortness of breath , cough , diarrhoea , nausea , vomiting , itching , pain in the muscles , increased blood pressure
viagra contains the active substance sildenafil which belongs to a group of medicines called phosphodiesterase type 5 ( pde5 ) inhibitors . it works by helping to relax the blood vessels in your penis , allowing blood to flow into your penus when you get sexually excited . viagra will only help you to get an erection if you are sexually stimulated . this medicine is a treatment for adult men with erectile dysfunction , sometimes called impotence . that is when a man cannot get , or keep a hard , hard - coloured , and edgfr . suitable for sexual activity .
do not take viagra - if you are allergic to sildenafil or any of the other ingredients of this medicine ( listed in section 6 ). -if you take medicines called nitrates , as the combination may lead to a dangerous fall in your blood pressure . tell your doctor if any of these medicines are used to treat angina pectoris ( or " chest pain "). if the medicines are made from nitric oxide donors such as amyl nitsitrite , because the combination could lead to such a drop in your life . - because the combined use of riociguat may also lead to an increased risk of this drug . talk to your doctor before taking rifampicin . this drug is used to relieve pulmonary arterial hypertension ( i .e ., high blood pressure in the lungs ) and
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended starting dose is 50 mg of viagra . you should not take viagra film - coated tablets ( called " viagra orodispersible tablets "). you should take viagra about one hour before you plan to have sex . swallow the tablet whole with a glass of water . viagra can be taken with or without food . it is important that you take viagra every day . this will help you to get an erection if your doctor tells you to . if it is not , or has been , sexually stimulated , you should tell your doctor straight away . taking viagra with food will not help you get an an  Erection even if the effect of viagra on your erеction lasts long enough for you to complete
like all medicines , this medicine can cause side effects , although not everybody gets them . the side effects reported in association with the use of viagra are usually mild to moderate and of a short duration . if you experience any of the following serious side effects stop taking viagra and seek medical help immediately : - an allergic reaction - this occurs uncommonly ( may affect up to 1 in 100 people ) symptoms include sudden wheeziness , difficulty in breathing or dizziness - swelling of the eyelids , face , lips or throat . chest pains - get in a semi - sitting position and try to relax . do not use nitrates to treat your chest pain . prolonged and sometimes painful erections have been reported rarely ( may effect up to1 in 1 , 000 people ). if your errect , you should have been observed for 4 hours
what viagra contains - the active substance is sildenafil . each tablet contains 25 mg of sildanafil ( as the citrate salt ). - other ingredients are : tablet core : microcrystalline cellulose , calcium hydrogen phosphate ( anhydrous ), croscarmellose sodium , magnesium stearate . film coat : hypromellose , titanium dioxide ( e171 ), lactose monohydrate , triacetin , indigo carmine aluminium lake ( е132 ). what viagra looks like and contents of the pack viagra film - coated tablets have a rounded - diamond shape with a diameter of 25 mm . the tablets are provided in blister packs containing 2 , 4 , 8 or 12 tablets . not all pack sizes may be marketed .
sifrol contains the active substance pramipexole and belongs to a group of medicines known as dopamine agonists , which stimulate dopa in the brain . stimulation of the dopam receptors triggers nerve impulses in the body that help to control body movements . sIfrol is used to : - treat the symptoms of primary parkinson ' s disease in adults . it can be used alone or in combination with levodopa ( another medicine for parkinsons ' disease ). - relieve the symptoms associated with moderate to severe primary restless legs syndrome in adults and children .
do not take sifrol - if you are allergic to pramipexole or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor before taking sfrol . tell your doctor if any of these apply to you . - tell your healthcare provider if : you have ever had any medical conditions or symptoms , especially any of those that are not related to your condition . these include : kidney disease . hallucinations ( seeing , hearing or feeling things that aren ' t there ). most hallucinosations are visual . dyskinesia ( e .g . abnormal , uncontrolled movements of the limbs ). if your doctor has told you that you have advanced parkinson 's disease , you will also be given levodopa to treat
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor if you are not sure . sifrol should be used during treatment of parkinson ' s disease . the recommended dose is 3 tablets on the first week . during the first weeks , the usual dose is 1 tablet of sIfrol 0 . 088 mg twice daily ( equivalent to 0. 264 mg ). after 1 week , another dose of  0 ( 0
like all medicines , this medicine can cause side effects , although not everybody gets them . evaluation of these side effects is based on the following frequencies : very common may affect more than 1 in 10 people common may effect up to 1 in every 10 people uncommon may affect up to1 in 100 people rare may affectup to 1 to 1 , 000 people very rare may effect less than 1 per 10 ,000 people not known frequency cannot be estimated from the available data if you suffer from parkinson ' s disease , you may experience the following side effects during treatment : - dyskinesia ( e . g . abnormal , uncontrolled movements of the limbs ) - dizziness - nausea ( sickness ) common : urge to behave in an unusual way - hallucinations ( seeing , hearing or feeling things that are not there ) confusion - tired
what sifrol contains the active substance is pramipexole . each tablet contains 0 . 088 mg , 0. 18 mg / 0 in 10 , or 0
emadine is a medicine used for the treatment of seasonal allergic conjunctivitis of the eye . it belongs to a group of allergic conditions that affect the white part of the eyes , which causes the allergic reaction . allergic conjonctivits may be caused by exposure to some materials ( allergens ) which cause allergic reactions such as itching , redness and swelling of the surface of your eye , if you feel worse during these reactions .
do not take emadine if you are allergic to emedastine or any of the other ingredients of this medicine listed in section 6 . if your doctor or pharmacist tells you to take a different dose , follow the instructions in section 7 . children and adolescents do not give this medicine if the child - bearing age is less than 3 years old . this is because emastone contains benzalkonium chloride ( e1520 ) as e madine is not recommended in this age group . see section 6 " warnings and precautions " and " use in children and teenagers ". in clinical trials conducted with eMDine , the child and adolescents had lower doses . therefore , your child ' s doctor may wish to monitor the child' 's kidney or liver problems . talk to your doctor if any of these affect the
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is 3 drops in each eye . you should keep using this medicine for as long as your eyes stay open . emadine is for use in children aged 3 years and above . use in babies and children aged 1 year and above and for children aged 2 years and older . do not give this medicine to children under 1 year of age . before giving this medicine , your doctor will tell you how to dispose of it . how to use wash your hands before using the e madine bottle . wash your hand . twist off the bottle , remove the cap , and replace the cap with snap collar . hold the bottle and tamper evident snap collar at the back of the bottle as shown in grey on the inside . thumb and middle finger 
like all medicines , this medicine can cause side effects , although not everybody gets them . you can usually carry on taking the drops , unless the effects are serious . common side effects ( may affect up to 1 in 10 people ) effects in the eye : eye pain , itchy eye and eye redness . uncommon side effects that may affect more than 1 in 100 people ), effects in and around the eye: corneal disorder ( abnormal eye sensation ), increased tear production , tired eyes , eye irritation , blurred vision , corneal staining . side effects where the frequency is not known ( frequency cannot be estimated from the available data ): effects in or around the eyes : corneally increased tear output , increased tear manufacturing , decreased tear production and increased tear formation . if you notice any of the side effects above , talk to your doctor . reporting of side effects 25 
keep out of the reach and sight of children . do not use emadine after the expiry date which is stated on the carton and the blister after exp . the expiration date refers to the last day of that month . store below 25 . keep the blister in the outer carton in order to protect from light and moisture . this medicine does not require any special storage conditions . you should throw away the blister safely . e madine will not be returned to the pharmacy . it is recommended that you use a single dose once every three weeks . once the blister has been opened , use immediately .
what emadine contains the active substance is emanuele . each vial contains 0 . 5 mg of difumarate . the other ingredients are benzalkonium chloride , trometamol , sodium chloride and hypromellose , purified water , hydrochloric acid and sodium hydroxide . these substances are added to keep acidity levels ( ph levels ) normal . what  e madine looks like and contents of the pack emagine is a liquid ( a solution ) supplied in a 5 ml or 10 mL plastic ( drop - container ) bottle with a screw cap .
levetiracetam is an antiepileptic medicine ( a medicine used to treat seizures in epilepsy ). levetiractam actavis is used : on its own in adults and adolescents from 16 years of age with newly diagnosed epilepilepsy , to treat a certain form of epilexia . epilempsy is a condition where the patients have repeated fits ( seizures ). the medicine works by reducing the amount of pus in the blood . levetirasetam has a particular form of the epilepic type involving areas of the brain , but could then extend to larger areas on both sides of the cerebral ( partial onset seizure with or without secondary generalisation ). when levetiratetam becomes used in combination with other antiepepilpic medicines to treat partial initiation seizures with or with orwithout generalisation in adults , adolescents , children and
do not take levetiracetam actavis if you are allergic to levetiractam , pyrrolidone derivatives or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor before taking levetirasetam actsavis and if any of your medical conditions , including medical conditions or human rights , notice any change in your dose , particularly if your kidney problems , follow your doctor ' s instructions . he / she may decide if the dose should be adjusted . you should also tell your doctor about any slow down in the growth or unexpected puberty development of your child . some people being treated with anti - epileptics such as levetiratetam actingavis have had thoughts of harming or killing themselves . tell your doctors if , for any symptoms of depression and /
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . take levetiracetam actavis twice each day - once in the morning and once inthe evening . monotherapy dose in adults and adolescents ( from 16 years of age ): general dose : between 1 , 000 mg and 3 , 3 . 000 mg levetiractam actingavis is taken twice a day , in two equal doses . add - on therapy dose in adult and adolescents from 16 year of age ( 12 to 17 years ) weighing 50 kg or more : general dosage : 1 . 1 mg twice - day . maximum daily dose , between 3 - 4 tablets of 1  , 500 mg and 2 tablets of 250 mg in the evening , with or without food . additional doses in
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately , or go to your nearest emergency department , if you experience : weakness , feel light - headed or dizzy or have difficulty breathing , as these may be signs of a serious allergic ( anaphylactic ) reaction ; swelling of the face , lips , tongue and throat ( quincke ' s oedema ); flu - like symptoms and a rash on the face followed by an extended rash with a high temperature , increased levels of liver enzymes seen in blood tests and an increase in a type of white blood cell 56 ( eosinophilia ) and enlarged lymph nodes ( drug reaction ).
what levetiracetam actavis contains the active substance is called levetiractam . one tablet of levetiratetam actsavis 250 mg contains 250 mg levetiratam ; one tablet in levetiragetam actingavis 500 mg contains 500 mg levracetm . two tablets of levragetm actavises 750 mg contain 750 micrograms levetiraitam : one tablet levetiratis 1 , 000 mg contains 1  , 1000 mg levetam the other ingredients are crospovidon , povidone , silica colloidal anhydrous , magnesium stearate . what levretiractin looks like and contents of the pack levetiractavis is a white , round , flat , bevelled edge tablet , engraved with " lz " on one side and
what incruse ellipta is this medicine contains the active substance umeclidinium bromide , which belongs to a group of medicines called bronchodilators . what increse
do not use incruse ellipta 27 - if you are allergic to umeclidinium or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor and do not administer this medicine . warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine you should not use this medicine in patients with asthma ( see section 4 ). talk to you doctor before using incrussé ellippta if any of these apply to you ( or you are not sure ), talk to a doctor or pharmacist before using your medicine , because your doctor may need to adjust your dose . if incruses ellimpta is not indicated for use in patients suffering from asthma . tell your physician if your doctor thinks it is not appropriate for you . heart problems . an eye problem called narrow -
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one inhalation every day at the same time of day . you only need to inhale once a day because the effect of this medicine lasts for 24 hours . don ' t use more than your doctor tells you to use . use incruse ellipta regularly it is very important that you use increse
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions allergic reactions are uncommon ( may affect up to 1 in 100 people ). if you have any of the following symptoms after taking incruse ellipta , stop taking this medicine and tell your doctor immediately : itching skin rash ( hives ) or redness 29 other side effects may include : common ( may effect up to1 in 10 people ) faster heart beat painful and frequent urination ( may be signs of a urinary tract infection ) common cold infection of nose and throat cough feeling of pressure or pain in the cheeks and forehead . these may be symptoms of ear infection . common cold incrussé ellippa may also cause coughing up of fluid in the lungs . uncommon ( might affect upto 1 in 1000 people ), but may also include a
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label of the inhaler after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 to 8 ). do not freeze . keep the inhaled tray in the sealed tray in order to protect from light . after first opening , the inflater can be used for up to 6 weeks . before first opening the inhlerer , write the date on the inflator label on the tray of the tray . write the month of opening on the outer carton of the product in the space provided . once the tray is opened , discard the inflamer after 30 . discard the container after this time period . always leave the ink container in the outer box . medicines should not be disposed of via wastewater or
what incruse ellipta contains - the active substance is umeclidinium bromide . each single inhalation provides a delivered dose ( the dose leaving the mouthpiece ) of 55 micrograms umeklidinium ( equivalent to 65 microgram of umeclinium bromide ). -the other ingredients are lactose monohydrate ( see section 2 under ' incrusite ellippta has a low content content ') and magnesium stearate . what incluse is incrussé ellimpta looks like and contents of the pack incruses ellipe ellipinta is an inhalations powder , pre - dispensed . the ellipita inhaler consists of a grey plastic body , a light green mouthpiece cover and a dose counter . it is
nucala contains the active substance mepolizumab , which is a monoclonal antibody , a type of protein that helps to control severe asthma in adults and children aged 6 years and older . severe asthma is caused by too many eosinophils , an important white blood cell that lines the lungs , in the form of eopenophilic asthma . asthma nucală is used to treat asthma attacks in adults , adolescents and children who are already taking medicines called high dose inhalers . it is used if your asthma is not well controlled by these medicines . in addition , you may also take medicines called oral corticosteroids . nucalа may help to control your asthma if you do not have the ee . g ., mepolizamab has the activity of a protein called interleukin - 5 .
do not use nucala if you are allergic to mepolizumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using this medicine . this medicine is used for worsening asthma 58 asthma - related side effects , as nucalа can cause their asthma to get worse . do not stop nucalal unless your doctor tells you to . if your asthma does not improve after nucalá treatment , you must tell your doctor . you may be allergic to other ingredients in nucală . injection site reactions medicines of this type ( monoclonal antibodies ) can cause severe allergic reactions when they are injected into your body . see section 4 for more information about possible side effects of a similar reaction . your doctor may decide to monitor you more closely after you have received nucal . parasitic infections
nucala is given by injection under the skin ( subcutaneous injection ). the recommended dose is 12 units per kilogram of body weight , given once every 12 hours . the dose will be 100 units in 1 hour . use the pre - filled pen to check that you have received nucalа . your doctor will decide how many injections you need . if you have questions about how nucalá will be given , ask your doctor . treatment with nucalal can be started at any time during your treatment with Nucala . do not stop using nucalaci without talking to your doctor first . stopping the treatment with a dose of nucalar may cause your asthma symptoms to come back or get worse after you have been given more than once a month . this will help to reduce your asthma attacks . it may also help to stop your asthma problems from getting worse after a few injections of nuCALa
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with nucala : allergic reactions allergic or allergic - like reactions are common ( may affect up to 1 in 10 people ). they usually occur within minutes to a few hours of the injection . sometimes symptoms include chest tightness , cough , difficulty breathing fainting , dizziness / feeling lightheaded ( due to , or a drop in blood pressure ) swelling of eyelids , face , lips , tongue or mouth hives rash tell your doctor immediately if you have a reaction similar to / or similar reaction .
keep out of the sight and reach of children . do not use nucala after the expiry date which is stated on the pen label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . keep the nucal - pre - filled pen in the outer carton in order to protect from light . after first opening or if carried as a spare you can carry your pen with you and keep it at room temperature ( not above 25 ) for up to 7 days . once removed from the refrigerator , you can return the pen to the refrigerator and keep the pen at room temperatures ( not below 25 ). you must throw away the pen as soon as you are ready to throw away . you must discard the pen after 7 days of use .
what nucala contains the active substance is mepolizumab . 1 ml solution contains 100 mg of mepolizamab in each millilitre . the other ingredients are sucrose , sodium phosphate dibasic heptahydrate , citric acid monohydrate . polysorbate 80 , edta disodium dihydrate and water for injections . what nukala looks like and contents of the pack nucală is presented as a clear and colourless solution for injection ( injection ) in a pack containing 1 or a multipack containing 3 packs of 1 . not all pack sizes may be marketed .
what ninlaro is nINlarro is an anticancer medicine that contains the active substance ixazomib , which is a ' proteasome inhibitor '. what nicotinlarao is used for n inlaroooo is used to treat adult patients with a cancer of the bone marrow called multiple myeloma . ixizomiber reduces cell survival by stopping myelosa cells from producing too many proteins called proteasoms , such as proteins found in the blood . what are the benefits of using ninklar are protease inhibitors . how nninlaaro works ninelaroop is used in adults to treat multiple myélomas . the active ingredient in nilaro are lenalidomide and dexamet
do not take ninlaro if you are allergic to ixazomib or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor and do not give n inlaroooo . warnings and precautions talk to your doctor , pharmacist or nurse before taking nnlar . talk to you doctor if any of these apply to you before taking the medicine . before you start treatment with nlro , make sure that you tell your physician if : you experience bleeding , persistent nausea , vomiting or diarrhoea you have nerve problems such as tingling , numbness , swelling or a persistent rash you have liver or kidney problems . your doctor may decide to reduce the dose , or stop treatment with the first few weeks before starting nilaro
ninlaro is used to treat multiple myeloma . always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . n inlarro must be taken together with lenalidomide , a medicine containing dexamethasone , an anti - inflammatory medicine . how much ninklarou to take ? your doctor will tell you exactly which dose of lenaldomide and dexamhasone to take ( usually 4 - week cycles ). nninlaaro should be taken once a day on the same day of the week . it is taken for the first 3 weeks of each year . after the 4 , 6 - month period , the dose will be increased to 25 mg lenaliadomide plus 25 mg dexaland once
like all medicines , this medicine can cause side effects , although not everybody gets them . very common serious side effects ( may affect more than 1 in 10 people ) low platelet counts ( thrombocytopenia ) nose bleeds easily bruise nausea vomiting diarrhoea numbness , tingling or burning of the hands or feet ( peripheral neuropathy ) swelling of the legs or feet( peripheral oedema ) skin rash ( itchy ) anywhere on the body . rare side effects are ( may effect up to 1 in 1 , 000 people ). these are the signs of low platelets , which are : low plateLET counts ( not known ): fits ( convulsion ) swollen legs ( peripheral neuropathy ) fever ( peripheral leukopenia ). shivering ( somnolence ) not
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the blister or carton after exp . the expiration date refers to the last day of that month . store below 30 . once the capsule has been opened , use it immediately . this medicine does not require any special storage conditions . DO not use if you notice any damage or signs of tampering to medicine packaging . only use ninlaro if the contents are clear and colourless . discard any unused capsules . these measures will help protect the environment .
what ninlaro contains - each hard capsule contains 2 . 3 mg of ixazomib . each capsule contains 3 . 4 mg of the active substance , ixazamibid . the other ingredients are : capsule content : microcrystalline cellulose , magnesium stearate , and talc . capsule shell : gelatin , titanium dioxide ( e171 ), red iron oxide ( E172 ). printing ink : shellac , propylene glycol , potassium hydroxide , black iron oxide . nninlaaro 3 mg hard capsules containing ixizomibe each capsule consists of 3 mg ixozomia . box containing 3 mg and 3 mg in ixzazomimib citrate . printing inked : titanium dioxide , red
do not use palforzia : - if you are allergic to peanuts or arachis hypogaea . warnings and precautions talk to your doctor or pharmacist before using palforizia - children and adolescents do not give this medicine to children and teenagers aged 4 to 17 years . during treatment , your doctor will check whether you have developed peanut allergy , especially peanut ( desensitisation ) after you have been given palfor zia , as allergic reactions may occur . palforza is not recommended for use in children and non - food allergies . talk to you doctor or nurse before you are given palfordzia for any reason .
do not take palforzia if you are allergic to peanut allergy or any of the other ingredients of palforza ( listed in section 6 ). if your asthma is not controlled , you have a problem swallowing . warnings and precautions talk to your doctor or pharmacist before taking palforizia . long term problems with your digestive system have been reported , including a severe mast cell disorder or severe or life - threatening anaphylaxis . these patients should be evaluated before starting treatment with palfor zia , and at least 60 days after stopping treatment . if this applies to you , tell your doctor before taking your palforzaa : if the symptoms of peanut allergy become severe , do not stop taking pal forzia and talk to a doctor straight away . you might get an allergic reaction during treatment with paleforzio . talk to you doctor 
always take this medicine exactly as your doctor has told you . check with your doctor if you are not sure . this is important because it will not affect the way you take it . allergy if allergic reactions ( anaphylaxis ) occur , your doctor will monitor you for 3 months after you have started treatment with palforzia . initial dose escalation . you will then have two initial dose phases . these treatment phases are called the initial dose elevation and up - dosing phases , and you may decide to stop taking palforizia if your condition returns . stopping treatment with paleforziа can cause desensitisation to the medicine during the day if , for example , you start feeling unwell , or if there is a problem with your asthma , it can be called initial dose evolution . initially dose ealation will be repeated every
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with palforzia : - severe allergic reactions . tell your doctor or nurse straight away if you get any of the following symptoms after taking palforizia . they usually go away within a few days of the reaction . - trouble breathing - throat tightness - feeling of fullness , trouble swallowing or speaking - changes in voice - dizziness / fainting - extreme stomach cramps or pain - vomiting , diarrhoea - serious flushing or itching of the skin palfor zia may cause problems with the stomach and digestive system . these include : reflux disease of the stomach or digestive system ( gastrointestinal disorders ). - indigestion , heartburn , pain in the chest , nausea , vomiting
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the expiration date refers to the last day of that month . store below 25 . this medicine does not require any special storage conditions . any hard lumps of powder should be thrown away .
what palforzia contains the active substance of palforizia is 0 . 5 mg , 1 mg / 10 mg or 20 mg . the other ingredients are microcrystalline cellulose , colloidal anhydrous silica and magnesium stearate palforziea 100 mg oral powder in capsules after opening microcrystalline ( cellulose and colloidal anihydrous silica , magnesium STEarate pah ). 300 mg oral poudre in sachet microcrystalline
zerene belongs to a class of substances called benzodiazepine - related medicinal products , which consists of preparations with hypnotic actions and sleeping problems . sleeping problems usually last a long time and are most likely to occur during or after treatment . treatment should be started if you have problems sleeping during the day .
do not take zerene if you have hypersensitivity ( an allergy ) to zaleplon or any of the other ingredients of zere sleep apnoea syndrome . you may have been treated with zerentene for short periods if your doctor thinks you have it , or you have severe kidney or liver problems . tell your doctor if any of these apply to you . if so , tell your nurse . warnings and precautions talk to your doctor before taking zerenedene you may develop myasthenia gravis ( very weak or tired muscles ), severe breathing or chest problems if they occur . children and adolescents do not give this medicine to children or adolescents under 18 years of age . the safety and efficacy in children and teenagers has not been established in this population . your doctor will monitor you carefully for undesirable effects . take
always take zerene exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . the usual dose is 10 mg once a day , with or without difficulty falling asleep . use in people over 65 years of age and older , if your doctor determines that you have mild to moderate liver problems , your doctor may adjust your dose to 65 mg once daily , or 5 mg once weekly , depending on your condition . if there is no mild to medium liver problems your doctor will adjust your dosage to 5 mg , once daily depending on how you respond to the capsule . swallow the capsule whole , do not open or dissolve the capsule as it may become cloudy . do not chew or crush the capsule to avoid contact with the capsule and contact your doctor immediately , as the contents may change colour or become cloudier . an overdose may make you increasingly 
like all medicines , zerene can cause side effects , although not everybody gets them . tell your doctor or pharmacist if you notice any other changes in your health . the frequency of possible side effects listed below is defined using the following convention : 36 very common ( affects more than 1 user in 10 ) common (affecting 1 to 10 users in 100 ) uncommon (affecting 10 to 1 user per 1 , 000 ) rare (affecting less than 1 users in 10 to 10 patients in 10 000 ), very rare ( affecting less than1 user in10 ,000 ) not known ( frequency cannot be estimated from the available data ). as with all medicines the side effects in this population are not known : if any other change in your healthcare system is affected , please tell your healthcare professional . side effects that may occur are : common : may affect more than1 in 10 people ; memory difficulties 
what zerene contains the active substance is zaleplon 5 mg . the other ingredients are : microcrystalline cellulose , pregelatinised starch , silicon dioxide , sodium lauryl sulphate , magnesium stearate , lactose monohydrate , indigo carmine ( e132 ), titanium dioxide ( s - 1310 ). printing ink : shellac , titanium dioxide . printing inka : red iron oxide ( eremite ), yellow iron oxide , black iron oxide( e172 ), sodium laauryl  sulfate . inks : silicon dioxide ( ca - 13050 ), shellaca , lecithin , simethicone . what rozene looks like and contents of the pack zerène 5 mg hard capsule
